Colon/Rectal Adenocarcinoma: Paradigm Report
Maintained by TCGA GDAC Team (Broad Institute/Dana-Farber Cancer Institute/Harvard Medical School)
Overview
Introduction

PAthway Representation and Analysis by Direct Inference on Graphical Models (PARADIGM) predicts the activity of a diverse set of molecular concepts such as genes, complexes, and processes. The predicted activities are called Inferred Pathway Levels (IPLs) and are derived from a probabilistic belief propagation strategy that incorporates multimodal data such as copy number and gene expression estimates with a concept's pathway context.

Summary

There were 48 significant pathways identified in this analysis.

Table 1.  Get Full Table Top 10 out of 131 pathways in order of significance.

Pathway.Name Avg.Num.Perturbations
IL23-mediated signaling events 43
TCGA08_p53 34
HIF-1-alpha transcription factor network 32
Ephrin B reverse signaling 32
IL4-mediated signaling events 28
Fc-epsilon receptor I signaling in mast cells 27
Wnt signaling 27
Syndecan-1-mediated signaling events 25
Endothelins 25
Signaling mediated by p38-alpha and p38-beta 25
Results

The following list describes the columns found in Table 2.

  • Pathway.Name = Full pathway name of curated PARADIGM pathway

  • Avg.Num.Perturbations = Average number of samples with perturbations across the pathway concepts determined by a background permutation model (>2 standard deviations away from the permuted distribution)

  • Total.Perturbations = Total number of perturbed concepts across all samples (>2 standard deviations away from the permuted distribution)

  • Num.Entities = Number of concepts that belong to the pathway

  • Min.Mean.Truth = Minimum IPL for concepts in the pathway among real samples

  • Max.Mean.Truth = Maximum IPL for concepts in the pathway among real samples

  • Min.Mean.Within = Minimum IPL for concepts in the pathway among null samples using "within permutation" (values are permuted across genes)

  • Max.Mean.Within = Maximum IPL for concepts in the pathway among null samples using "within permutation" (values are permuted across genes)

  • Min.Mean.Any = Minimum IPL for concepts in the pathway among null samples using "any permutation" (values are permuted across samples and genes)

  • Max.Mean.Any = Maximum IPL for concepts in the pathway among null samples using "any permutation" (values are permuted across samples and genes).

Table 2.  Get Full Table This summary table provides a report of cancer type specific pathway perturbations. Click on the links in the first column to display more detailed results for each pathway.

Pathway.Name Avg.Num.Perturbations Total.Perturbations Num.Entities Min.Mean.Truth Max.Mean.Truth Min.Mean.Within Max.Mean.Within Min.Mean.Any Max.Mean.Within.1
IL23-mediated signaling events 43 2621 60 -0.62 0.035 1000 -1000 -0.065 -1000
TCGA08_p53 34 238 7 -0.082 0.029 1000 -1000 -0.002 -1000
HIF-1-alpha transcription factor network 32 2455 76 -0.29 0.041 1000 -1000 -0.043 -1000
Ephrin B reverse signaling 32 1580 48 -0.25 0.05 1000 -1000 -0.028 -1000
IL4-mediated signaling events 28 2628 91 -0.61 0.49 1000 -1000 -0.079 -1000
Fc-epsilon receptor I signaling in mast cells 27 2705 97 -0.18 0.036 1000 -1000 -0.056 -1000
Wnt signaling 27 192 7 -0.12 0.031 1000 -1000 -0.017 -1000
Syndecan-1-mediated signaling events 25 876 34 -0.13 0.042 1000 -1000 -0.03 -1000
Endothelins 25 2420 96 -0.23 0.041 1000 -1000 -0.052 -1000
Signaling mediated by p38-alpha and p38-beta 25 1136 44 -0.16 0.035 1000 -1000 -0.019 -1000
Osteopontin-mediated events 24 937 38 -0.17 0.04 1000 -1000 -0.042 -1000
IL12-mediated signaling events 21 1856 87 -0.33 0.039 1000 -1000 -0.043 -1000
Glypican 1 network 21 1009 48 -0.13 0.044 1000 -1000 -0.024 -1000
TCGA08_retinoblastoma 21 169 8 -0.03 0.036 1000 -1000 -0.004 -1000
EGFR-dependent Endothelin signaling events 21 442 21 -0.088 0.051 1000 -1000 -0.01 -1000
Noncanonical Wnt signaling pathway 20 522 26 -0.12 0.035 1000 -1000 -0.05 -1000
IL27-mediated signaling events 20 1054 51 -0.19 0.12 1000 -1000 -0.056 -1000
Thromboxane A2 receptor signaling 19 2011 105 -0.17 0.051 1000 -1000 -0.047 -1000
Calcineurin-regulated NFAT-dependent transcription in lymphocytes 19 1345 68 -0.38 0.17 1000 -1000 -0.087 -1000
Glucocorticoid receptor regulatory network 18 2074 114 -0.39 0.21 1000 -1000 -0.052 -1000
IL1-mediated signaling events 18 1123 62 -0.15 0.082 1000 -1000 -0.041 -1000
Glypican 2 network 18 75 4 -0.01 0 1000 -1000 0 -1000
FOXA2 and FOXA3 transcription factor networks 17 821 46 -0.25 0.04 1000 -1000 -0.078 -1000
FAS signaling pathway (CD95) 17 811 47 -0.31 0.057 1000 -1000 -0.029 -1000
Calcium signaling in the CD4+ TCR pathway 17 547 31 -0.2 0.032 1000 -1000 -0.06 -1000
Presenilin action in Notch and Wnt signaling 16 1019 61 -0.14 0.1 1000 -1000 -0.043 -1000
BMP receptor signaling 16 1364 81 -0.16 0.064 1000 -1000 -0.039 -1000
amb2 Integrin signaling 16 1363 82 -0.16 0.045 1000 -1000 -0.037 -1000
TCR signaling in naïve CD8+ T cells 16 1570 93 -0.084 0.051 1000 -1000 -0.039 -1000
EPHB forward signaling 16 1395 85 -0.078 0.095 1000 -1000 -0.056 -1000
Signaling events mediated by Stem cell factor receptor (c-Kit) 16 1316 78 -0.24 0.052 1000 -1000 -0.05 -1000
Canonical Wnt signaling pathway 15 797 51 -0.26 0.11 1000 -1000 -0.052 -1000
PLK2 and PLK4 events 14 44 3 -0.016 0.029 1000 -1000 -0.006 -1000
Syndecan-2-mediated signaling events 14 966 69 -0.14 0.043 1000 -1000 -0.047 -1000
Visual signal transduction: Rods 14 748 52 -0.17 0.052 1000 -1000 -0.027 -1000
Signaling events mediated by the Hedgehog family 13 712 52 -0.12 0.071 1000 -1000 -0.026 -1000
Cellular roles of Anthrax toxin 13 524 39 -0.062 0.032 1000 -1000 -0.026 -1000
Arf6 signaling events 13 845 62 -0.088 0.083 1000 -1000 -0.022 -1000
IFN-gamma pathway 13 917 68 -0.11 0.046 1000 -1000 -0.049 -1000
S1P1 pathway 13 500 36 -0.15 0.035 1000 -1000 -0.033 -1000
IL6-mediated signaling events 13 980 75 -0.12 0.047 1000 -1000 -0.04 -1000
FOXM1 transcription factor network 13 710 51 -0.24 0.033 1000 -1000 -0.12 -1000
Caspase cascade in apoptosis 12 894 74 -0.12 0.063 1000 -1000 -0.038 -1000
Nectin adhesion pathway 12 811 63 -0.052 0.054 1000 -1000 -0.041 -1000
Reelin signaling pathway 12 683 56 -0.084 0.092 1000 -1000 -0.034 -1000
Syndecan-3-mediated signaling events 12 429 35 -0.14 0.05 1000 -1000 -0.032 -1000
Stabilization and expansion of the E-cadherin adherens junction 12 909 74 -0.088 0.048 1000 -1000 -0.061 -1000
BCR signaling pathway 12 1237 99 -0.19 0.04 1000 -1000 -0.05 -1000
a4b1 and a4b7 Integrin signaling 11 58 5 0 0.033 1000 -1000 0.015 -1000
LPA receptor mediated events 11 1211 102 -0.14 0.035 1000 -1000 -0.079 -1000
E-cadherin signaling events 11 56 5 0.011 0.033 1000 -1000 0.017 -1000
IL2 signaling events mediated by STAT5 10 220 22 -0.088 0.036 1000 -1000 -0.028 -1000
Signaling events mediated by PRL 10 345 34 -0.051 0.054 1000 -1000 -0.031 -1000
Ras signaling in the CD4+ TCR pathway 10 181 17 -0.028 0.046 1000 -1000 -0.019 -1000
Sphingosine 1-phosphate (S1P) pathway 9 276 28 -0.039 0.046 1000 -1000 -0.015 -1000
JNK signaling in the CD4+ TCR pathway 9 158 17 -0.035 0.034 1000 -1000 -0.03 -1000
Ceramide signaling pathway 9 729 76 -0.088 0.069 1000 -1000 -0.025 -1000
E-cadherin signaling in the nascent adherens junction 9 722 76 -0.047 0.075 1000 -1000 -0.049 -1000
Syndecan-4-mediated signaling events 9 630 67 -0.058 0.065 1000 -1000 -0.049 -1000
Aurora B signaling 9 656 67 -0.14 0.054 1000 -1000 -0.041 -1000
Visual signal transduction: Cones 8 330 38 -0.004 0.043 1000 -1000 -0.001 -1000
Signaling events mediated by PTP1B 8 658 76 -0.087 0.059 1000 -1000 -0.036 -1000
p75(NTR)-mediated signaling 8 1112 125 -0.14 0.077 1000 -1000 -0.045 -1000
PDGFR-alpha signaling pathway 8 371 44 -0.13 0.068 1000 -1000 -0.04 -1000
IL2 signaling events mediated by PI3K 8 498 58 -0.066 0.051 1000 -1000 -0.032 -1000
HIV-1 Nef: Negative effector of Fas and TNF-alpha 8 389 45 -0.053 0.05 1000 -1000 -0.036 -1000
Nongenotropic Androgen signaling 8 459 52 -0.093 0.061 1000 -1000 -0.032 -1000
Regulation of Androgen receptor activity 8 566 70 -0.1 0.083 1000 -1000 -0.057 -1000
Hedgehog signaling events mediated by Gli proteins 7 516 65 -0.11 0.058 1000 -1000 -0.038 -1000
Arf6 downstream pathway 7 326 43 -0.034 0.041 1000 -1000 -0.032 -1000
mTOR signaling pathway 7 390 53 -0.052 0.039 1000 -1000 -0.031 -1000
RXR and RAR heterodimerization with other nuclear receptor 7 377 52 -0.07 0.092 1000 -1000 -0.029 -1000
Signaling mediated by p38-gamma and p38-delta 7 118 15 -0.022 0.03 1000 -1000 -0.032 -1000
Integrins in angiogenesis 7 670 84 -0.17 0.073 1000 -1000 -0.046 -1000
Regulation of p38-alpha and p38-beta 7 404 54 -0.031 0.067 1000 -1000 -0.032 -1000
Class I PI3K signaling events 7 551 73 -0.061 0.049 1000 -1000 -0.033 -1000
Regulation of Telomerase 7 740 102 -0.2 0.077 1000 -1000 -0.047 -1000
Insulin Pathway 7 540 74 -0.17 0.1 1000 -1000 -0.038 -1000
Plasma membrane estrogen receptor signaling 7 615 86 -0.051 0.098 1000 -1000 -0.055 -1000
VEGFR1 specific signals 7 443 56 -0.007 0.09 1000 -1000 -0.037 -1000
S1P3 pathway 7 308 42 -0.033 0.046 1000 -1000 -0.024 -1000
Hypoxic and oxygen homeostasis regulation of HIF-1-alpha 7 247 33 -0.048 0.075 1000 -1000 -0.041 -1000
PDGFR-beta signaling pathway 7 760 97 -0.05 0.096 1000 -1000 -0.041 -1000
Regulation of nuclear SMAD2/3 signaling 6 929 136 -0.073 0.05 1000 -1000 -0.042 -1000
ErbB4 signaling events 6 455 69 -0.18 0.064 1000 -1000 -0.035 -1000
Lissencephaly gene (LIS1) in neuronal migration and development 6 351 54 -0.084 0.047 1000 -1000 -0.035 -1000
EPO signaling pathway 6 345 55 -0.019 0.055 1000 -1000 -0.028 -1000
Paxillin-independent events mediated by a4b1 and a4b7 6 241 37 -0.017 0.068 1000 -1000 -0.04 -1000
Signaling events mediated by HDAC Class III 6 250 40 -0.056 0.061 1000 -1000 -0.022 -1000
Effects of Botulinum toxin 6 165 26 -0.094 0.06 1000 -1000 -0.002 -1000
Signaling events mediated by VEGFR1 and VEGFR2 6 811 125 -0.05 0.095 1000 -1000 -0.044 -1000
E-cadherin signaling in keratinocytes 6 258 43 -0.044 0.091 1000 -1000 -0.023 -1000
S1P4 pathway 6 150 25 -0.016 0.046 1000 -1000 -0.021 -1000
Signaling events activated by Hepatocyte Growth Factor Receptor (c-Met) 5 450 85 -0.18 0.075 1000 -1000 -0.052 -1000
TRAIL signaling pathway 5 280 48 -0.02 0.061 1000 -1000 -0.026 -1000
Signaling events regulated by Ret tyrosine kinase 5 448 82 -0.026 0.063 1000 -1000 -0.059 -1000
S1P5 pathway 5 98 17 -0.013 0.036 1000 -1000 -0.01 -1000
FoxO family signaling 5 339 64 -0.081 0.05 1000 -1000 -0.051 -1000
Retinoic acid receptors-mediated signaling 5 347 58 -0.11 0.067 1000 -1000 -0.04 -1000
Paxillin-dependent events mediated by a4b1 5 194 36 -0.06 0.063 1000 -1000 -0.027 -1000
Arf6 trafficking events 5 406 71 -0.049 0.037 1000 -1000 -0.033 -1000
Class IB PI3K non-lipid kinase events 5 15 3 -0.025 0.025 1000 -1000 -0.014 -1000
LPA4-mediated signaling events 4 50 12 -0.023 0.017 1000 -1000 -0.027 -1000
ErbB2/ErbB3 signaling events 4 287 65 -0.087 0.05 1000 -1000 -0.069 -1000
Coregulation of Androgen receptor activity 4 308 76 -0.076 0.056 1000 -1000 -0.03 -1000
BARD1 signaling events 4 256 57 -0.048 0.073 1000 -1000 -0.031 -1000
Aurora A signaling 4 269 60 -0.055 0.054 1000 -1000 -0.016 -1000
Aurora C signaling 4 30 7 0 0.036 1000 -1000 -0.016 -1000
PLK1 signaling events 4 414 85 -0.026 0.055 1000 -1000 -0.027 -1000
Class I PI3K signaling events mediated by Akt 4 285 68 -0.054 0.071 1000 -1000 -0.033 -1000
ceramide signaling pathway 4 204 49 -0.011 0.05 1000 -1000 -0.028 -1000
HIF-2-alpha transcription factor network 4 209 43 -0.038 0.053 1000 -1000 -0.045 -1000
Role of Calcineurin-dependent NFAT signaling in lymphocytes 4 353 83 -0.04 0.07 1000 -1000 -0.024 -1000
TCGA08_rtk_signaling 4 105 26 -0.027 0.058 1000 -1000 -0.009 -1000
IGF1 pathway 4 235 57 -0.025 0.083 1000 -1000 -0.033 -1000
Regulation of cytoplasmic and nuclear SMAD2/3 signaling 3 80 23 0.003 0.038 1000 -1000 -0.023 -1000
Ephrin A reverse signaling 3 26 7 -0.002 0.037 1000 -1000 0 -1000
Atypical NF-kappaB pathway 3 95 31 -0.015 0.045 1000 -1000 -0.014 -1000
Angiopoietin receptor Tie2-mediated signaling 3 332 88 -0.17 0.099 1000 -1000 -0.073 -1000
Neurotrophic factor-mediated Trk receptor signaling 3 470 120 -0.016 0.092 1000 -1000 -0.043 -1000
p38 MAPK signaling pathway 3 141 44 0 0.059 1000 -1000 -0.021 -1000
Signaling events mediated by HDAC Class II 2 170 75 -0.017 0.066 1000 -1000 -0.021 -1000
Insulin-mediated glucose transport 2 81 32 -0.013 0.044 1000 -1000 -0.023 -1000
Signaling events mediated by HDAC Class I 2 251 104 -0.047 0.079 1000 -1000 -0.029 -1000
Nephrin/Neph1 signaling in the kidney podocyte 1 55 34 -0.043 0.085 1000 -1000 -0.028 -1000
Canonical NF-kappaB pathway 1 40 39 0 0.076 1000 -1000 -0.027 -1000
Circadian rhythm pathway 1 26 22 -0.012 0.073 1000 -1000 -0.04 -1000
Sumoylation by RanBP2 regulates transcriptional repression 1 27 27 0 0.049 1000 -1000 -0.03 -1000
Alternative NF-kappaB pathway 1 15 13 0 0.09 1000 -1000 0 -1000
Rapid glucocorticoid signaling 0 15 20 0 0.041 1000 -1000 -0.002 -1000
Arf1 pathway 0 44 54 -0.001 0.065 1000 -1000 -0.018 -1000
Total 1377 80415 7203 -13 8.2 131000 -131000 -4.5 -131000
IL23-mediated signaling events

Figure S1.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S1.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CCL2 -0.51 0.61 -10000 0 -1.3 70 70
IL23A -0.56 0.63 -10000 0 -1.3 75 75
NF kappa B1 p50/RelA/I kappa B alpha -0.48 0.59 -10000 0 -1.2 73 73
positive regulation of T cell mediated cytotoxicity -0.53 0.65 -10000 0 -1.3 69 69
ITGA3 -0.48 0.57 -10000 0 -1.2 65 65
IL17F -0.3 0.35 -10000 0 -0.74 64 64
IL12B -0.018 0.074 -10000 0 -0.43 3 3
STAT1 (dimer) -0.5 0.62 -10000 0 -1.3 69 69
CD4 -0.44 0.53 -10000 0 -1.2 59 59
IL23 -0.54 0.59 -10000 0 -1.2 75 75
IL23R -0.12 0.36 -10000 0 -1.4 14 14
IL1B -0.56 0.64 -10000 0 -1.4 69 69
T-helper cell lineage commitment 0 0 -10000 0 -10000 0 0
IL24 -0.45 0.54 -10000 0 -1.1 63 63
TYK2 -0.009 0.041 -10000 0 -10000 0 0
STAT4 0.02 0.079 -10000 0 -0.33 9 9
STAT3 0.034 0.007 -10000 0 -10000 0 0
IL18RAP -0.067 0.19 -10000 0 -0.37 50 50
IL12RB1 -0.011 0.044 -10000 0 -0.24 1 1
PIK3CA 0.035 0.006 -10000 0 -10000 0 0
IL12Rbeta1/TYK2 -0.008 0.055 -10000 0 -10000 0 0
IL23R/JAK2 -0.13 0.35 -10000 0 -1.3 14 14
positive regulation of chronic inflammatory response -0.53 0.65 -10000 0 -1.3 69 69
natural killer cell activation 0.01 0.019 0.081 11 -10000 0 11
JAK2 -0.026 0.089 -10000 0 -0.3 12 12
PIK3R1 0.028 0.062 -10000 0 -0.48 3 3
NFKB1 0.032 0.007 -10000 0 -10000 0 0
RELA 0.033 0.005 -10000 0 -10000 0 0
positive regulation of dendritic cell antigen processing and presentation -0.51 0.55 -10000 0 -1.2 75 75
ALOX12B -0.45 0.53 -10000 0 -1.2 62 62
CXCL1 -0.55 0.62 -10000 0 -1.3 78 78
T cell proliferation -0.53 0.65 -10000 0 -1.3 69 69
NFKBIA 0.025 0.044 -10000 0 -0.31 3 3
IL17A -0.24 0.28 -10000 0 -0.56 64 64
PI3K -0.47 0.6 -10000 0 -1.2 68 68
IFNG -0.03 0.06 0.13 7 -0.13 37 44
STAT3 (dimer) -0.44 0.57 -10000 0 -1.1 68 68
IL18R1 0.003 0.097 -10000 0 -0.28 18 18
IL23/IL23R/JAK2/TYK2/SOCS3 -0.24 0.32 -10000 0 -0.75 37 37
IL18/IL18R -0.072 0.19 -10000 0 -0.35 52 52
macrophage activation -0.024 0.022 -10000 0 -0.047 68 68
TNF -0.51 0.58 -10000 0 -1.2 70 70
STAT3/STAT4 -0.47 0.6 -10000 0 -1.2 69 69
STAT4 (dimer) -0.5 0.63 -10000 0 -1.3 69 69
IL18 -0.027 0.16 -10000 0 -0.42 26 26
IL19 -0.45 0.53 -10000 0 -1.1 61 61
STAT5A (dimer) -0.5 0.62 -10000 0 -1.3 69 69
STAT1 0.015 0.067 -10000 0 -0.2 18 18
SOCS3 0.013 0.091 -10000 0 -0.31 13 13
CXCL9 -0.62 0.66 -10000 0 -1.3 91 91
MPO -0.44 0.53 -10000 0 -1.2 58 58
positive regulation of humoral immune response -0.53 0.65 -10000 0 -1.3 69 69
IL23/IL23R/JAK2/TYK2 -0.57 0.74 -10000 0 -1.5 69 69
IL6 -0.56 0.64 -10000 0 -1.3 76 76
STAT5A 0.027 0.049 -10000 0 -0.26 5 5
IL2 0.026 0.028 -10000 0 -10000 0 0
positive regulation of tyrosine phosphorylation of STAT protein 0.01 0.019 0.081 11 -10000 0 11
CD3E -0.44 0.53 -10000 0 -1.1 64 64
keratinocyte proliferation -0.53 0.65 -10000 0 -1.3 69 69
NOS2 -0.44 0.53 -10000 0 -1.1 71 71
TCGA08_p53

Figure S2.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S2.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CDKN2A -0.036 0.1 -10000 0 -0.22 41 41
TP53 -0.061 0.13 0.26 2 -0.3 41 43
Senescence -0.082 0.13 0.26 2 -0.26 64 66
Apoptosis -0.082 0.13 0.26 2 -0.26 64 66
Activated_Oncogenes 0 0 -10000 0 -10000 0 0
MDM2 0.022 0.076 0.24 19 -10000 0 19
MDM4 0.029 0.053 -10000 0 -0.39 3 3
HIF-1-alpha transcription factor network

Figure S3.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S3.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PKM2 -0.21 0.44 -9999 0 -0.91 45 45
HDAC7 -0.001 0.006 -9999 0 -10000 0 0
HIF1A/ARNT/Cbp/p300/Src-1 -0.15 0.39 -9999 0 -0.8 32 32
SMAD4 0.017 0.063 -9999 0 -0.48 3 3
ID2 -0.22 0.46 -9999 0 -0.93 45 45
AP1 -0.08 0.16 -9999 0 -0.35 46 46
ABCG2 -0.23 0.46 -9999 0 -0.93 47 47
HIF1A -0.02 0.1 -9999 0 -0.32 7 7
TFF3 -0.22 0.46 -9999 0 -0.94 46 46
GATA2 0.018 0.06 -9999 0 -0.39 3 3
AKT1 -0.021 0.095 -9999 0 -0.31 3 3
response to hypoxia -0.036 0.073 -9999 0 -0.17 5 5
MCL1 -0.21 0.45 -9999 0 -0.91 45 45
NDRG1 -0.22 0.44 -9999 0 -0.92 44 44
SERPINE1 -0.22 0.44 -9999 0 -0.9 47 47
FECH -0.24 0.43 -9999 0 -0.92 46 46
FURIN -0.21 0.44 -9999 0 -0.9 46 46
NCOA2 0.026 0.052 -9999 0 -0.48 2 2
EP300 -0.038 0.12 -9999 0 -0.32 16 16
HMOX1 -0.22 0.45 -9999 0 -0.93 46 46
BHLHE40 -0.23 0.43 -9999 0 -0.9 45 45
BHLHE41 -0.23 0.43 -9999 0 -0.9 45 45
HIF1A/ARNT/SMAD3/SMAD4/SP1 -0.017 0.15 -9999 0 -0.36 7 7
ENG -0.031 0.12 -9999 0 -0.4 3 3
JUN -0.025 0.15 -9999 0 -0.41 25 25
RORA -0.23 0.46 -9999 0 -0.93 46 46
ABCB1 -0.29 0.49 -9999 0 -1.1 49 49
TFRC -0.22 0.45 -9999 0 -0.89 47 47
CXCR4 -0.23 0.47 -9999 0 -0.94 49 49
TF -0.21 0.45 -9999 0 -0.9 46 46
CITED2 -0.21 0.44 -9999 0 -0.9 45 45
HIF1A/ARNT -0.21 0.54 -9999 0 -1.1 41 41
LDHA -0.001 0.12 -9999 0 -0.95 2 2
ETS1 -0.22 0.44 -9999 0 -0.91 45 45
PGK1 -0.21 0.45 -9999 0 -0.91 45 45
NOS2 -0.23 0.43 -9999 0 -0.9 45 45
ITGB2 -0.23 0.46 -9999 0 -0.93 47 47
ALDOA -0.21 0.44 -9999 0 -0.9 45 45
Cbp/p300/CITED2 -0.22 0.45 -9999 0 -0.95 41 41
FOS -0.07 0.17 -9999 0 -0.32 56 56
HK2 -0.21 0.45 -9999 0 -0.9 46 46
SP1 -0.007 0.069 -9999 0 -0.18 5 5
GCK -0.031 0.21 -9999 0 -1.4 2 2
HK1 -0.21 0.44 -9999 0 -0.9 45 45
NPM1 -0.21 0.45 -9999 0 -0.91 45 45
EGLN1 -0.21 0.44 -9999 0 -0.91 44 44
CREB1 0.041 0.019 -9999 0 -10000 0 0
PGM1 -0.22 0.46 -9999 0 -0.92 48 48
SMAD3 0.029 0.054 -9999 0 -0.39 3 3
EDN1 -0.24 0.43 -9999 0 -1.2 30 30
IGFBP1 -0.22 0.44 -9999 0 -0.92 45 45
VEGFA -0.16 0.31 -9999 0 -0.66 37 37
HIF1A/JAB1 0.004 0.083 -9999 0 -0.25 6 6
CP -0.22 0.45 -9999 0 -0.91 46 46
CXCL12 -0.23 0.47 -9999 0 -0.96 46 46
COPS5 0.029 0.038 -9999 0 -0.48 1 1
SMAD3/SMAD4 0.026 0.065 -9999 0 -0.35 5 5
BNIP3 -0.26 0.47 -9999 0 -0.91 54 54
EGLN3 -0.24 0.47 -9999 0 -0.94 49 49
CA9 -0.27 0.48 -9999 0 -0.95 52 52
TERT -0.21 0.44 -9999 0 -0.9 46 46
ENO1 -0.21 0.44 -9999 0 -0.9 45 45
PFKL -0.21 0.44 -9999 0 -0.91 44 44
NCOA1 0.026 0.071 -9999 0 -0.48 4 4
ADM -0.22 0.46 -9999 0 -0.93 47 47
ARNT -0.019 0.096 -9999 0 -0.55 1 1
HNF4A 0.009 0.072 -9999 0 -0.48 4 4
ADFP -0.23 0.46 -9999 0 -0.93 45 45
SLC2A1 -0.17 0.34 -9999 0 -0.7 37 37
LEP -0.22 0.44 -9999 0 -0.91 45 45
HIF1A/ARNT/Cbp/p300 -0.16 0.39 -9999 0 -0.79 35 35
EPO -0.1 0.28 -9999 0 -0.87 8 8
CREBBP -0.021 0.11 -9999 0 -0.29 8 8
HIF1A/ARNT/Cbp/p300/HDAC7 -0.16 0.38 -9999 0 -0.78 36 36
PFKFB3 -0.21 0.44 -9999 0 -0.91 45 45
NT5E -0.25 0.47 -9999 0 -0.95 48 48
Ephrin B reverse signaling

Figure S4.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S4.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
EFNB2 -0.004 0.12 -10000 0 -0.46 13 13
EPHB2 0.005 0.12 -10000 0 -0.48 12 12
EFNB1 0.012 0.047 -10000 0 -0.36 2 2
mol:GTP 0 0 -10000 0 -10000 0 0
Rac1/GDP -0.007 0.13 -10000 0 -0.3 19 19
Ephrin B2/EPHB1-2 -0.038 0.13 -10000 0 -0.3 32 32
neuron projection morphogenesis -0.022 0.12 -10000 0 -0.28 21 21
Ephrin B1/EPHB1-2/Tiam1 -0.016 0.14 -10000 0 -0.3 24 24
DNM1 0.031 0.036 -10000 0 -0.2 5 5
cell-cell signaling 0.001 0.004 -10000 0 -10000 0 0
MAP2K4 -0.16 0.25 -10000 0 -0.53 62 62
YES1 -0.24 0.37 -10000 0 -0.78 64 64
Ephrin B1/EPHB1-2/NCK2 -0.011 0.13 -10000 0 -0.3 24 24
PI3K -0.14 0.27 -10000 0 -0.52 68 68
mol:GDP -0.017 0.13 -10000 0 -0.3 24 24
ITGA2B 0.035 0.006 -10000 0 -10000 0 0
endothelial cell proliferation 0.01 0.084 -10000 0 -0.29 13 13
FYN -0.24 0.37 -10000 0 -0.78 65 65
MAP3K7 -0.18 0.26 -10000 0 -0.55 65 65
FGR -0.24 0.36 -10000 0 -0.77 65 65
TIAM1 0.028 0.054 -10000 0 -0.39 3 3
PIK3R1 0.028 0.062 -10000 0 -0.48 3 3
RGS3 0.035 0.005 -10000 0 -10000 0 0
cell adhesion -0.14 0.25 -10000 0 -0.49 64 64
LYN -0.22 0.36 -10000 0 -0.76 63 63
Ephrin B1/EPHB1-2/Src Family Kinases -0.22 0.33 -10000 0 -0.69 65 65
Ephrin B1/EPHB1-2 -0.18 0.28 -10000 0 -0.61 61 61
SRC -0.22 0.35 -10000 0 -0.74 63 63
ITGB3 0.033 0.018 -10000 0 -0.2 1 1
EPHB1 -0.061 0.16 -10000 0 -0.26 67 67
EPHB4 0.022 0.07 -10000 0 -0.32 7 7
RAC1 0.033 0.011 -10000 0 -10000 0 0
Ephrin B2/EPHB4 0.01 0.085 -10000 0 -0.3 13 13
alphaIIb/beta3 Integrin 0.05 0.018 -10000 0 -10000 0 0
BLK -0.24 0.37 -10000 0 -0.78 65 65
HCK -0.23 0.35 -10000 0 -0.75 63 63
regulation of stress fiber formation 0.012 0.13 0.3 24 -10000 0 24
MAPK8 -0.16 0.24 -10000 0 -0.5 63 63
Ephrin B1/EPHB1-2/RGS3 -0.011 0.13 -10000 0 -0.29 26 26
endothelial cell migration -0.11 0.23 0.24 5 -0.47 52 57
NCK2 0.035 0.017 -10000 0 -0.2 1 1
PTPN13 -0.19 0.27 -10000 0 -0.45 96 96
regulation of focal adhesion formation 0.012 0.13 0.3 24 -10000 0 24
chemotaxis 0.012 0.13 0.29 26 -10000 0 26
PIK3CA 0.035 0.006 -10000 0 -10000 0 0
Rac1/GTP -0.012 0.12 -10000 0 -0.29 19 19
angiogenesis -0.18 0.28 -10000 0 -0.6 63 63
LCK -0.25 0.37 -10000 0 -0.78 65 65
IL4-mediated signaling events

Figure S5.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S5.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BCL2L1 -0.34 0.64 -10000 0 -1.4 45 45
STAT6 (cleaved dimer) -0.44 0.63 -10000 0 -1.4 55 55
IGHG1 -0.11 0.24 -10000 0 -0.48 18 18
IGHG3 -0.41 0.58 -10000 0 -1.2 55 55
AKT1 -0.19 0.36 -10000 0 -0.88 29 29
IL4/IL4R/JAK1/IL2R gamma/JAK3/SHP1 -0.16 0.37 -10000 0 -1.1 20 20
IL4/IL4R/JAK1/IL2R gamma/JAK3/IRS1 -0.22 0.41 -10000 0 -1.2 22 22
THY1 -0.43 0.62 -10000 0 -1.4 52 52
MYB 0 0.13 -10000 0 -0.48 14 14
HMGA1 0.036 0.004 -10000 0 -10000 0 0
IL4/IL4R/JAK1/IL2R gamma/JAK3 -0.24 0.4 -10000 0 -0.86 42 42
IL4/IL4R/JAK1/IL2R gamma/JAK3/SHIP -0.21 0.4 -10000 0 -1.1 23 23
SP1 0.023 0.048 -10000 0 -0.19 2 2
INPP5D 0 0 -10000 0 -10000 0 0
SOCS5 0.035 0.034 -10000 0 -10000 0 0
STAT6 (dimer)/ETS1 -0.43 0.64 -10000 0 -1.4 54 54
SOCS1 -0.25 0.39 -10000 0 -0.8 47 47
SOCS3 -0.22 0.38 -10000 0 -1 27 27
FCER2 -0.3 0.48 -10000 0 -1 44 44
PARP14 0.031 0.037 -10000 0 -0.2 5 5
CCL17 -0.46 0.66 -10000 0 -1.4 51 51
GRB2 0.034 0.008 -10000 0 -10000 0 0
IL4/IL4R/JAK1/IL2R gamma/JAK3/SHC/SHIP -0.15 0.28 -10000 0 -0.77 19 19
T cell proliferation -0.43 0.63 -10000 0 -1.4 51 51
IL4R/JAK1 -0.43 0.62 -10000 0 -1.3 53 53
EGR2 -0.5 0.7 -10000 0 -1.5 56 56
JAK2 -0.026 0.095 -10000 0 -0.32 11 11
JAK3 0.037 0.016 -10000 0 -10000 0 0
PIK3R1 0.028 0.062 -10000 0 -0.48 3 3
JAK1 0.014 0.047 -10000 0 -0.49 1 1
COL1A2 -0.19 0.44 -10000 0 -1.5 18 18
CCL26 -0.49 0.67 -10000 0 -1.4 60 60
IL4R -0.45 0.66 -10000 0 -1.4 53 53
PTPN6 0.037 0.026 -10000 0 -10000 0 0
IL13RA2 -0.54 0.71 -10000 0 -1.5 60 60
IL13RA1 -0.02 0.08 -10000 0 -0.33 5 5
IRF4 -0.098 0.33 -10000 0 -1.2 13 13
ARG1 -0.085 0.33 -10000 0 -1.3 10 10
CBL -0.23 0.38 -10000 0 -0.82 42 42
GTF3A -0.013 0.12 -10000 0 -0.4 14 14
PIK3CA 0.035 0.006 -10000 0 -10000 0 0
IL13RA1/JAK2 -0.025 0.11 -10000 0 -0.32 8 8
IRF4/BCL6 -0.098 0.32 -10000 0 -1.2 13 13
CD40LG 0.023 0.077 -10000 0 -0.33 7 7
MAPK14 -0.24 0.4 -10000 0 -0.92 36 36
mitosis -0.17 0.34 -10000 0 -0.82 29 29
STAT6 -0.52 0.82 -10000 0 -1.7 54 54
SPI1 0.016 0.075 -10000 0 -0.22 16 16
RPS6KB1 -0.16 0.33 -10000 0 -0.78 29 29
STAT6 (dimer) -0.52 0.82 -10000 0 -1.7 54 54
STAT6 (dimer)/PARP14 -0.47 0.69 -10000 0 -1.5 54 54
mast cell activation 0.007 0.016 -10000 0 -10000 0 0
IL4/IL4R/JAK1/IL2R gamma/JAK3/DOK2 -0.24 0.41 -10000 0 -0.99 32 32
FRAP1 -0.19 0.36 -10000 0 -0.88 29 29
LTA -0.43 0.62 -10000 0 -1.4 46 46
FES 0.017 0.081 -10000 0 -0.32 10 10
T-helper 1 cell differentiation 0.49 0.73 1.5 54 -10000 0 54
CCL11 -0.5 0.69 -10000 0 -1.5 59 59
IL4/IL4R/JAK1/IL2R gamma/JAK3/FES -0.21 0.4 -10000 0 -0.98 30 30
IL2RG -0.019 0.16 -10000 0 -0.43 25 25
IL10 -0.42 0.61 -10000 0 -1.3 51 51
IRS1 0.013 0.098 -10000 0 -0.38 11 11
IRS2 -0.008 0.13 -10000 0 -0.45 15 15
IL4 -0.063 0.2 -10000 0 -1.2 3 3
IL5 -0.43 0.61 -10000 0 -1.3 50 50
IL4/IL4R/JAK1/IL13RA1/JAK2 -0.3 0.47 -10000 0 -0.98 44 44
COL1A1 -0.29 0.56 -10000 0 -1.5 30 30
positive regulation of NF-kappaB transcription factor activity 0 0 -10000 0 -10000 0 0
IL4/IL4R/JAK1 -0.44 0.65 -10000 0 -1.5 46 46
IL2R gamma/JAK3 0.009 0.12 -10000 0 -0.34 21 21
TFF3 -0.45 0.65 -10000 0 -1.4 54 54
ALOX15 -0.43 0.62 -10000 0 -1.3 55 55
MYBL1 0.025 0.044 -10000 0 -0.3 3 3
T-helper 2 cell differentiation -0.33 0.52 -10000 0 -1.1 48 48
SHC1 0.035 0.007 -10000 0 -10000 0 0
CEBPB 0.013 0.045 -10000 0 -0.5 1 1
IL4/IL4R/JAK1/IL2R gamma/JAK3/FES/IRS2 -0.2 0.4 -10000 0 -1.1 23 23
mol:PI-3-4-5-P3 -0.19 0.36 -10000 0 -0.89 28 28
PI3K -0.2 0.4 -10000 0 -1 27 27
DOK2 0.011 0.066 -10000 0 -0.22 13 13
ETS1 0.027 0.057 -10000 0 -0.21 7 7
IL4/IL4R/JAK1/IL2R gamma/JAK3/SHC/SHIP/GRB2 -0.14 0.27 -10000 0 -0.72 21 21
ITGB3 -0.42 0.61 -10000 0 -1.3 53 53
PIGR -0.48 0.69 -10000 0 -1.5 57 57
IGHE 0.062 0.087 0.18 37 -0.32 1 38
MAPKKK cascade -0.14 0.27 -10000 0 -0.7 21 21
BCL6 0.007 0.1 -10000 0 -0.33 16 16
OPRM1 -0.43 0.62 -10000 0 -1.4 45 45
RETNLB -0.61 0.74 -10000 0 -1.5 82 82
SELP -0.5 0.71 -10000 0 -1.5 56 56
AICDA -0.42 0.6 -10000 0 -1.3 50 50
Fc-epsilon receptor I signaling in mast cells

Figure S6.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S6.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PPAP2A 0.029 0.056 -10000 0 -0.34 4 4
LAT2 -0.08 0.16 -10000 0 -0.4 34 34
AP1 -0.13 0.24 0.33 1 -0.54 40 41
mol:PIP3 -0.11 0.24 0.44 3 -0.52 39 42
IKBKB -0.036 0.14 0.23 16 -0.28 31 47
AKT1 -0.11 0.17 0.31 7 -0.43 29 36
IKBKG -0.053 0.13 0.24 7 -0.28 36 43
MS4A2 -0.069 0.19 -10000 0 -0.38 52 52
mol:Sphingosine-1-phosphate 0 0 -10000 0 -10000 0 0
PIK3CA 0.035 0.006 -10000 0 -10000 0 0
MAP3K1 -0.076 0.18 0.3 3 -0.43 34 37
mol:Ca2+ -0.078 0.18 0.32 5 -0.39 37 42
LYN 0.028 0.015 -10000 0 -10000 0 0
CBLB -0.078 0.17 -10000 0 -0.4 34 34
SHC1 0.035 0.007 -10000 0 -10000 0 0
RasGAP/p62DOK 0.033 0.086 -10000 0 -0.26 11 11
positive regulation of cell migration -0.011 0.079 -10000 0 -0.35 10 10
INPP5D 0 0 -10000 0 -10000 0 0
PLD2 -0.11 0.19 0.32 6 -0.37 55 61
PTPN13 -0.14 0.22 -10000 0 -0.59 24 24
PTPN11 0.016 0.062 -10000 0 -0.42 3 3
GO:0007205 0 0 -10000 0 -10000 0 0
regulation of mast cell degranulation -0.07 0.14 0.32 4 -0.35 26 30
SYK 0.027 0.056 -10000 0 -0.4 3 3
GRB2 0.034 0.008 -10000 0 -10000 0 0
LAT/PLCgamma1/GRB2/SLP76/GADs -0.098 0.25 -10000 0 -0.51 43 43
LAT -0.081 0.17 0.19 1 -0.4 36 37
PAK2 -0.082 0.2 0.31 3 -0.47 35 38
NFATC2 -0.02 0.048 -10000 0 -10000 0 0
HRAS -0.093 0.22 0.36 2 -0.5 38 40
GAB2 0.036 0.004 -10000 0 -10000 0 0
PLA2G1B 0.029 0.12 -10000 0 -0.81 4 4
Fc epsilon R1 -0.11 0.21 -10000 0 -0.37 73 73
Antigen/IgE/Fc epsilon R1 -0.096 0.2 -10000 0 -0.33 73 73
mol:GDP -0.1 0.24 0.33 2 -0.54 39 41
JUN -0.017 0.15 -10000 0 -0.4 25 25
mol:Ca++ 0 0 -10000 0 -10000 0 0
PIK3R1 0.027 0.062 -10000 0 -0.49 3 3
FOS -0.063 0.17 -10000 0 -0.32 56 56
Antigen/IgE/Fc epsilon R1/LYN/SYK -0.077 0.17 -10000 0 -0.39 37 37
CHUK -0.055 0.13 0.25 6 -0.28 37 43
KLRG1 -0.074 0.15 -10000 0 -0.36 34 34
VAV1 -0.097 0.19 -10000 0 -0.42 42 42
calcium-dependent protein kinase C activity 0 0 -10000 0 -10000 0 0
CBL -0.078 0.16 -10000 0 -0.39 35 35
negative regulation of mast cell degranulation -0.072 0.14 -10000 0 -0.35 32 32
BTK -0.1 0.25 -10000 0 -0.6 34 34
Fc epsilon R1/FcgammaRIIB/SHIP/RasGAP/p62DOK -0.16 0.26 -10000 0 -0.49 66 66
GAB2/PI3K/SHP2 -0.12 0.17 -10000 0 -0.37 53 53
Antigen/IgE/Fc epsilon R1/LYN/SYK/WIP -0.084 0.16 -10000 0 -0.31 57 57
RAF1 0.029 0.14 -10000 0 -0.93 4 4
Fc epsilon R1/FcgammaRIIB/SHIP -0.14 0.24 -10000 0 -0.38 84 84
FCER1G 0.027 0.06 -10000 0 -0.32 5 5
FCER1A -0.13 0.23 -10000 0 -0.4 76 76
Antigen/IgE/Fc epsilon R1/Fyn -0.095 0.21 -10000 0 -0.34 74 74
MAPK3 0.028 0.12 -10000 0 -0.82 4 4
MAPK1 0.025 0.13 -10000 0 -0.82 4 4
NFKB1 0.035 0.006 -10000 0 -10000 0 0
MAPK8 -0.11 0.27 -10000 0 -0.71 25 25
DUSP1 0 0.1 -10000 0 -0.26 25 25
NF-kappa-B/RelA -0.02 0.087 0.16 6 -0.18 25 31
actin cytoskeleton reorganization -0.062 0.19 -10000 0 -0.5 20 20
mol:Glucocorticoid Dexamethasone 0 0 -10000 0 -10000 0 0
PI3K -0.074 0.21 0.32 3 -0.47 36 39
FER -0.082 0.16 -10000 0 -0.4 34 34
RELA 0.035 0.004 -10000 0 -10000 0 0
ITK -0.023 0.088 -10000 0 -0.43 7 7
SOS1 0.036 0.002 -10000 0 -10000 0 0
PLCG1 -0.045 0.25 0.37 4 -0.51 34 38
cytokine secretion -0.022 0.054 -10000 0 -0.15 2 2
SPHK1 -0.1 0.19 -10000 0 -0.44 41 41
PTK2 -0.065 0.2 -10000 0 -0.58 13 13
NTAL/PLCgamma1/GRB2/SLP76/GADs -0.1 0.26 0.23 1 -0.54 43 44
EDG1 -0.011 0.079 -10000 0 -0.35 10 10
mol:DAG -0.1 0.23 0.41 3 -0.52 38 41
MAP2K2 0.025 0.12 -10000 0 -0.83 4 4
MAP2K1 0.02 0.13 -10000 0 -0.87 4 4
MAP2K7 0.03 0.043 -10000 0 -0.3 3 3
KLRG1/SHP2 -0.063 0.15 -10000 0 -0.35 30 30
MAP2K4 -0.18 0.41 -10000 0 -0.9 49 49
Fc epsilon R1/FcgammaRIIB -0.15 0.25 -10000 0 -0.41 84 84
mol:Choline -0.11 0.18 0.32 6 -0.36 55 61
SHC/Grb2/SOS1 -0.035 0.18 -10000 0 -0.42 24 24
FYN 0.006 0.11 -10000 0 -0.34 16 16
DOK1 0.032 0.039 -10000 0 -0.34 2 2
PXN -0.06 0.18 -10000 0 -0.55 11 11
HCLS1 -0.085 0.18 -10000 0 -0.42 35 35
PRKCB -0.075 0.18 0.28 7 -0.38 37 44
FCGR2B -0.085 0.2 -10000 0 -0.37 61 61
IGHE -0.004 0.007 -10000 0 -10000 0 0
KLRG1/SHIP -0.073 0.14 -10000 0 -0.35 32 32
LCP2 -0.028 0.16 -10000 0 -0.37 32 32
PLA2G4A -0.16 0.2 -10000 0 -0.39 72 72
RASA1 0.024 0.073 -10000 0 -0.43 5 5
mol:Phosphatidic acid -0.11 0.18 0.32 6 -0.36 55 61
IKK complex -0.026 0.11 0.24 10 -0.22 24 34
WIPF1 0 0 -10000 0 -10000 0 0
Wnt signaling

Figure S7.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S7.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Noncanonical Wnts/FZD -0.12 0.21 -9999 0 -0.48 36 36
FZD6 0.021 0.065 -9999 0 -0.41 4 4
WNT6 0.031 0.033 -9999 0 -0.2 4 4
WNT4 -0.037 0.16 -9999 0 -0.37 36 36
FZD3 -0.038 0.16 -9999 0 -0.38 33 33
WNT5A -0.011 0.14 -9999 0 -0.39 23 23
WNT11 -0.068 0.18 -9999 0 -0.35 56 56
Syndecan-1-mediated signaling events

Figure S8.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S8.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TGFB1 0.034 0.017 -10000 0 -0.2 1 1
CCL5 -0.04 0.16 -10000 0 -0.35 40 40
SDCBP 0.03 0.02 -10000 0 -0.2 1 1
FGFR/FGF2/Syndecan-1 -0.08 0.18 0.25 5 -0.35 39 44
mol:PI-4-5-P2 0 0 -10000 0 -10000 0 0
RP11-540L11.1 0 0 -10000 0 -10000 0 0
Syndecan-1/Laminin-5 -0.082 0.13 -10000 0 -0.37 22 22
Syndecan-1/Syntenin -0.068 0.16 0.28 2 -0.35 31 33
MAPK3 -0.077 0.16 0.32 1 -0.34 33 34
HGF/MET 0.042 0.057 -10000 0 -0.38 3 3
TGFB1/TGF beta receptor Type II 0.034 0.017 -10000 0 -0.2 1 1
BSG 0.035 0.007 -10000 0 -10000 0 0
keratinocyte migration -0.081 0.13 -10000 0 -0.36 22 22
Syndecan-1/RANTES -0.1 0.2 0.34 1 -0.38 50 51
Syndecan-1/CD147 -0.065 0.18 0.34 1 -0.35 33 34
Syndecan-1/Syntenin/PIP2 -0.067 0.16 0.32 1 -0.34 30 31
LAMA5 0.013 0.047 -10000 0 -0.27 4 4
positive regulation of cell-cell adhesion -0.066 0.15 0.31 1 -0.33 31 32
MMP7 -0.12 0.22 -10000 0 -0.39 77 77
HGF 0.03 0.043 -10000 0 -0.3 3 3
Syndecan-1/CASK -0.088 0.16 -10000 0 -0.33 40 40
Syndecan-1/HGF/MET -0.064 0.18 0.34 1 -0.35 32 33
regulation of cell adhesion -0.073 0.16 0.34 4 -0.38 19 23
HPSE -0.016 0.13 -10000 0 -0.32 30 30
positive regulation of cell migration -0.08 0.18 0.25 5 -0.35 39 44
SDC1 -0.074 0.17 -10000 0 -0.35 39 39
Syndecan-1/Collagen -0.08 0.18 0.25 5 -0.35 39 44
PPIB 0.028 0.046 -10000 0 -0.27 4 4
MET 0.027 0.056 -10000 0 -0.34 4 4
PRKACA 0.035 0.006 -10000 0 -10000 0 0
MMP9 -0.006 0.09 -10000 0 -0.3 15 15
MAPK1 -0.073 0.16 0.32 1 -0.33 32 33
homophilic cell adhesion -0.081 0.17 0.25 5 -0.35 37 42
MMP1 -0.13 0.21 -10000 0 -0.35 92 92
Endothelins

Figure S9.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S9.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
AKT1 -0.019 0.18 0.27 21 -0.36 20 41
PTK2B 0.028 0.015 -10000 0 -10000 0 0
mol:Ca2+ -0.062 0.24 -10000 0 -0.71 14 14
EDN1 -0.03 0.22 0.24 18 -0.45 35 53
EDN3 -0.098 0.2 -10000 0 -0.41 55 55
EDN2 -0.089 0.2 -10000 0 -0.34 68 68
HRAS/GDP -0.074 0.21 0.29 3 -0.46 28 31
ETA receptor/Endothelin-1/Gq/GTP/PLC beta -0.055 0.16 0.26 1 -0.35 31 32
ADCY4 -0.036 0.15 0.35 1 -0.38 17 18
ADCY5 -0.022 0.14 0.35 1 -0.34 13 14
ADCY6 -0.02 0.14 0.35 1 -0.34 13 14
ADCY7 -0.025 0.14 0.35 1 -0.35 15 16
ADCY1 -0.018 0.14 0.35 1 -0.36 10 11
ADCY2 -0.021 0.14 0.35 1 -0.35 12 13
ADCY3 -0.033 0.15 0.35 1 -0.37 15 16
ADCY8 -0.024 0.13 -10000 0 -0.33 14 14
ADCY9 -0.024 0.14 0.35 1 -0.35 13 14
arachidonic acid secretion -0.17 0.27 -10000 0 -0.6 44 44
ETB receptor/Endothelin-1/Gq/GTP -0.053 0.15 -10000 0 -0.35 29 29
GNAO1 0.036 0.002 -10000 0 -10000 0 0
HRAS 0.031 0.04 -10000 0 -0.34 2 2
ETA receptor/Endothelin-1/G12/GTP 0.041 0.2 0.37 28 -0.37 13 41
ETA receptor/Endothelin-1/Gs/GTP 0.013 0.18 0.34 22 -0.33 16 38
mol:GTP -0.002 0.006 -10000 0 -10000 0 0
COL3A1 -0.033 0.22 0.28 18 -0.55 17 35
EDNRB -0.017 0.13 -10000 0 -0.43 16 16
response to oxidative stress 0 0 -10000 0 -10000 0 0
CYSLTR2 -0.003 0.17 0.32 21 -0.42 8 29
CYSLTR1 -0.025 0.2 0.28 18 -0.5 15 33
SLC9A1 -0.006 0.14 0.2 18 -0.37 11 29
mol:GDP -0.086 0.21 0.29 3 -0.47 31 34
SLC9A3 -0.099 0.32 -10000 0 -0.7 35 35
RAF1 -0.1 0.22 0.27 1 -0.53 29 30
JUN -0.11 0.35 -10000 0 -1 22 22
JAK2 -0.023 0.19 0.28 22 -0.36 29 51
mol:IP3 -0.064 0.18 0.28 2 -0.38 34 36
ETA receptor/Endothelin-1 0.026 0.25 0.43 30 -0.38 34 64
PLCB1 -0.037 0.16 -10000 0 -0.41 30 30
PLCB2 0.03 0.02 -10000 0 -0.21 1 1
ETA receptor/Endothelin-3 -0.062 0.16 -10000 0 -0.36 43 43
FOS -0.18 0.36 -10000 0 -0.95 34 34
Gai/GDP -0.007 0.2 -10000 0 -0.9 8 8
CRK 0.03 0.014 -10000 0 -10000 0 0
mol:Ca ++ -0.079 0.22 0.36 2 -0.47 33 35
BCAR1 0.034 0.017 -10000 0 -0.2 1 1
PRKCB1 -0.065 0.18 0.25 4 -0.43 25 29
GNAQ -0.002 0.008 -10000 0 -10000 0 0
GNAZ 0.022 0.064 -10000 0 -0.27 8 8
GNAL 0.022 0.035 -10000 0 -0.2 4 4
Gs family/GDP -0.077 0.19 0.27 2 -0.43 29 31
ETA receptor/Endothelin-1/Gq/GTP -0.038 0.16 0.22 3 -0.35 21 24
MAPK14 -0.067 0.15 -10000 0 -0.4 24 24
TRPC6 -0.067 0.26 -10000 0 -0.8 12 12
GNAI2 0.024 0.073 -10000 0 -0.43 5 5
GNAI3 0.03 0.051 -10000 0 -0.48 2 2
GNAI1 -0.013 0.14 -10000 0 -0.4 23 23
ETB receptor/Endothelin-1/Gq/GTP/PLC beta -0.071 0.16 -10000 0 -0.39 30 30
ETB receptor/Endothelin-2 -0.064 0.16 -10000 0 -0.4 32 32
ETB receptor/Endothelin-3 -0.078 0.17 -10000 0 -0.39 40 40
ETB receptor/Endothelin-1 -0.035 0.19 -10000 0 -0.38 37 37
MAPK3 -0.16 0.32 -10000 0 -0.79 36 36
MAPK1 -0.16 0.33 -10000 0 -0.8 36 36
Rac1/GDP -0.074 0.2 0.29 3 -0.45 29 32
cAMP biosynthetic process -0.015 0.14 0.35 2 -0.37 11 13
MAPK8 -0.062 0.23 -10000 0 -0.58 19 19
SRC 0.011 0.063 -10000 0 -0.48 3 3
ETB receptor/Endothelin-1/Gi/GTP -0.035 0.14 0.18 2 -0.36 24 26
p130Cas/CRK/Src/PYK2 -0.065 0.24 0.35 5 -0.51 27 32
mol:K + 0 0 -10000 0 -10000 0 0
G12/GDP -0.072 0.2 0.29 3 -0.45 28 31
COL1A2 -0.033 0.28 0.38 8 -0.62 25 33
EntrezGene:2778 0 0 -10000 0 -10000 0 0
ETA receptor/Endothelin-2 -0.039 0.18 -10000 0 -0.36 39 39
mol:DAG -0.065 0.18 0.28 2 -0.38 34 36
MAP2K2 -0.13 0.26 0.39 1 -0.59 37 38
MAP2K1 -0.14 0.27 -10000 0 -0.61 38 38
EDNRA 0.035 0.13 0.24 21 -0.3 12 33
positive regulation of muscle contraction -0.001 0.16 0.25 24 -0.37 11 35
Gq family/GDP -0.079 0.19 -10000 0 -0.45 28 28
HRAS/GTP -0.083 0.2 0.26 3 -0.45 29 32
PRKCH -0.066 0.18 0.31 2 -0.42 28 30
RAC1 0.033 0.011 -10000 0 -10000 0 0
PRKCA -0.058 0.18 0.25 3 -0.4 29 32
PRKCB -0.06 0.18 0.24 3 -0.38 33 36
PRKCE -0.061 0.18 0.26 2 -0.4 28 30
PRKCD -0.059 0.18 0.26 2 -0.41 26 28
PRKCG -0.065 0.18 0.26 2 -0.41 28 30
regulation of vascular smooth muscle contraction -0.22 0.43 -10000 0 -1.1 34 34
PRKCQ -0.08 0.19 0.26 2 -0.4 36 38
PLA2G4A -0.19 0.3 -10000 0 -0.67 44 44
GNA14 -0.027 0.15 -10000 0 -0.37 29 29
GNA15 0.015 0.069 -10000 0 -0.26 10 10
GNA12 0.033 0.01 -10000 0 -10000 0 0
GNA11 0.023 0.056 -10000 0 -0.4 3 3
Rac1/GTP 0.039 0.2 0.37 28 -0.37 13 41
MMP1 -0.23 0.38 0.44 1 -0.88 49 50
Signaling mediated by p38-alpha and p38-beta

Figure S10.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S10.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PTGS2 -0.16 0.38 -10000 0 -1.1 28 28
MKNK1 0.035 0.005 -10000 0 -10000 0 0
MAPK14 -0.035 0.12 -10000 0 -0.3 28 28
ATF2/c-Jun -0.08 0.2 -10000 0 -0.61 20 20
MAPK11 -0.034 0.12 -10000 0 -0.31 26 26
MITF -0.052 0.15 -10000 0 -0.37 31 31
MAPKAPK5 -0.041 0.13 -10000 0 -0.35 28 28
KRT8 -0.047 0.14 -10000 0 -0.36 30 30
MAPKAPK3 0.035 0.005 -10000 0 -10000 0 0
MAPKAPK2 0.035 0.006 -10000 0 -10000 0 0
p38alpha-beta/CK2 -0.051 0.17 -10000 0 -0.43 29 29
CEBPB -0.025 0.094 -10000 0 -0.34 14 14
SLC9A1 -0.042 0.14 -10000 0 -0.36 27 27
mol:GDP 0 0 -10000 0 -10000 0 0
ATF2 -0.048 0.14 -10000 0 -0.32 38 38
p38alpha-beta/MNK1 -0.023 0.15 -10000 0 -0.36 27 27
JUN -0.082 0.19 -10000 0 -0.61 20 20
PPARGC1A -0.083 0.18 -10000 0 -0.39 45 45
USF1 -0.062 0.15 -10000 0 -0.34 40 40
RAB5/GDP/GDI1 -0.027 0.1 -10000 0 -0.26 28 28
NOS2 -0.048 0.13 -10000 0 -0.36 28 28
DDIT3 -0.05 0.14 -10000 0 -0.34 33 33
RAB5A 0.035 0.005 -10000 0 -10000 0 0
HSPB1 -0.033 0.13 0.29 8 -0.29 30 38
p38alpha-beta/HBP1 -0.028 0.15 -10000 0 -0.36 28 28
CREB1 -0.046 0.14 -10000 0 -0.37 29 29
RAB5/GDP 0.026 0.004 -10000 0 -10000 0 0
EIF4E -0.044 0.12 -10000 0 -0.33 25 25
RPS6KA4 -0.041 0.13 -10000 0 -0.35 28 28
PLA2G4A -0.15 0.17 -10000 0 -0.35 72 72
GDI1 -0.041 0.13 -10000 0 -0.35 28 28
TP53 -0.1 0.17 -10000 0 -0.42 37 37
RPS6KA5 -0.053 0.14 -10000 0 -0.36 32 32
ESR1 -0.049 0.15 -10000 0 -0.38 30 30
HBP1 0.03 0.051 -10000 0 -0.48 2 2
MEF2C -0.064 0.15 -10000 0 -0.36 38 38
MEF2A -0.042 0.14 -10000 0 -0.37 26 26
EIF4EBP1 -0.055 0.15 -10000 0 -0.4 29 29
KRT19 -0.055 0.14 -10000 0 -0.34 35 35
ELK4 -0.044 0.13 -10000 0 -0.35 29 29
ATF6 -0.04 0.13 -10000 0 -0.35 27 27
ATF1 -0.047 0.14 -10000 0 -0.37 29 29
p38alpha-beta/MAPKAPK2 -0.024 0.15 -10000 0 -0.36 27 27
p38alpha-beta/MAPKAPK3 -0.024 0.15 -10000 0 -0.36 27 27
Osteopontin-mediated events

Figure S11.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S11.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
IKK alpha homodimer -0.083 0.14 -10000 0 -0.27 57 57
NF kappa B1 p50/RelA/I kappa B alpha -0.084 0.15 0.33 2 -0.42 12 14
alphaV/beta3 Integrin/Osteopontin/Src -0.12 0.18 -10000 0 -0.36 64 64
AP1 -0.15 0.18 -10000 0 -0.44 30 30
ILK -0.092 0.14 -10000 0 -0.36 11 11
bone resorption -0.093 0.13 -10000 0 -0.35 13 13
PTK2B 0.028 0.015 -10000 0 -10000 0 0
PYK2/p130Cas -0.067 0.15 -10000 0 -0.32 14 14
ITGAV 0.02 0.083 -10000 0 -0.4 7 7
mol:GTP 0 0 -10000 0 -10000 0 0
CD44/Rho Family GTPase/ROCK2 0.026 0.098 -10000 0 -0.35 13 13
alphaV/beta3 Integrin/Osteopontin -0.087 0.16 -10000 0 -0.3 65 65
MAP3K1 -0.095 0.14 -10000 0 -0.28 63 63
JUN -0.017 0.15 -10000 0 -0.4 25 25
MAPK3 -0.1 0.13 -10000 0 -0.37 14 14
MAPK1 -0.096 0.13 -10000 0 -0.38 12 12
Rac1/GDP 0.024 0.008 -10000 0 -10000 0 0
NFKB1 0.035 0.006 -10000 0 -10000 0 0
MAPK8 -0.094 0.13 -10000 0 -0.35 12 12
ITGB3 0.032 0.024 -10000 0 -0.21 1 1
NFKBIA -0.1 0.14 0.34 1 -0.39 18 19
FOS -0.063 0.17 -10000 0 -0.32 56 56
CD44 0.03 0.051 -10000 0 -0.48 2 2
CHUK 0.027 0.062 -10000 0 -0.48 3 3
PLAU -0.15 0.3 -10000 0 -1.1 15 15
NF kappa B1 p50/RelA -0.084 0.16 -10000 0 -0.44 15 15
BCAR1 0.034 0.017 -10000 0 -0.2 1 1
RELA 0.035 0.004 -10000 0 -10000 0 0
alphaV beta3 Integrin 0.04 0.064 -10000 0 -0.34 4 4
mol:GDP 0 0 -10000 0 -10000 0 0
SYK -0.095 0.14 -10000 0 -0.28 64 64
VAV3 -0.14 0.16 -10000 0 -0.3 94 94
MAP3K14 -0.093 0.14 -10000 0 -0.28 60 60
ROCK2 0.007 0.12 -10000 0 -0.46 12 12
SPP1 -0.17 0.22 -10000 0 -0.36 109 109
RAC1 0.033 0.011 -10000 0 -10000 0 0
Rac1/GTP -0.12 0.14 -10000 0 -0.34 38 38
MMP2 -0.15 0.16 -10000 0 -0.42 30 30
IL12-mediated signaling events

Figure S12.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S12.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
IL12/IL12R/TYK2/JAK2/SOCS1 -0.025 0.12 -10000 0 -0.37 12 12
TBX21 -0.26 0.51 -10000 0 -1.3 35 35
B2M 0.016 0.087 -10000 0 -0.34 10 10
TYK2 0.012 0.038 -10000 0 -10000 0 0
IL12RB1 0.011 0.042 -10000 0 -0.23 1 1
GADD45B -0.18 0.38 -10000 0 -1 26 26
IL12RB2 -0.005 0.087 -10000 0 -0.28 14 14
GADD45G -0.18 0.38 -10000 0 -0.98 29 29
natural killer cell activation -0.008 0.02 -10000 0 -0.043 28 28
RELB 0.033 0.036 -10000 0 -0.48 1 1
RELA 0.035 0.004 -10000 0 -10000 0 0
IL18 -0.023 0.16 -10000 0 -0.42 26 26
IL2RA -0.039 0.16 -10000 0 -0.35 40 40
IFNG -0.11 0.2 -10000 0 -0.33 80 80
STAT3 (dimer) -0.16 0.34 -10000 0 -0.78 38 38
HLA-DRB5 -0.034 0.15 -10000 0 -0.46 22 22
FASLG -0.23 0.46 -10000 0 -1.2 29 29
NF kappa B2 p52/RelB -0.18 0.39 -10000 0 -0.89 38 38
CD4 0.028 0.018 -10000 0 -10000 0 0
SOCS1 0.027 0.064 -10000 0 -0.41 4 4
EntrezGene:6955 -0.003 0.008 -10000 0 -0.026 16 16
CD3D -0.009 0.13 -10000 0 -0.39 19 19
CD3E 0.028 0.026 -10000 0 -0.21 1 1
CD3G -0.032 0.15 -10000 0 -0.35 33 33
IL12Rbeta2/JAK2 -0.003 0.1 -10000 0 -0.33 10 10
CCL3 -0.21 0.43 -10000 0 -1.1 32 32
CCL4 -0.22 0.45 -10000 0 -1.1 33 33
HLA-A 0 0.12 -10000 0 -0.39 17 17
IL18/IL18R -0.051 0.19 -10000 0 -0.35 51 51
NOS2 -0.19 0.37 -10000 0 -0.82 41 41
IL12/IL12R/TYK2/JAK2/SPHK2 -0.028 0.12 -10000 0 -0.36 11 11
IL1R1 -0.2 0.39 -10000 0 -1 30 30
IL4 0.039 0.046 -10000 0 -0.34 2 2
JAK2 -0.004 0.085 -10000 0 -0.29 12 12
EntrezGene:6957 -0.002 0.008 -10000 0 -0.025 15 15
TCR/CD3/MHC I/CD8 -0.054 0.2 -10000 0 -0.65 15 15
RAB7A -0.15 0.3 -10000 0 -0.69 38 38
lysosomal transport -0.14 0.29 -10000 0 -0.65 38 38
FOS -0.33 0.56 -10000 0 -1.3 45 45
STAT4 (dimer) -0.17 0.37 -10000 0 -0.86 34 34
STAT5A (dimer) -0.23 0.41 -10000 0 -0.92 42 42
GZMA -0.19 0.38 -10000 0 -0.86 40 40
GZMB -0.28 0.51 -10000 0 -1.2 41 41
HLX 0 0 -10000 0 -10000 0 0
LCK -0.23 0.44 -10000 0 -0.97 41 41
TCR/CD3/MHC II/CD4 -0.089 0.23 -10000 0 -0.52 34 34
IL2/IL2R -0.012 0.18 -10000 0 -0.36 35 35
MAPK14 -0.19 0.39 -10000 0 -0.88 38 38
CCR5 -0.18 0.35 -10000 0 -0.78 39 39
IL1B -0.077 0.19 -10000 0 -0.4 47 47
STAT6 -0.053 0.17 -10000 0 -0.74 7 7
STAT4 0.02 0.079 -10000 0 -0.33 9 9
STAT3 0.034 0.007 -10000 0 -10000 0 0
STAT1 0.015 0.067 -10000 0 -0.2 18 18
NFKB1 0.035 0.006 -10000 0 -10000 0 0
NFKB2 0.033 0.018 -10000 0 -0.2 1 1
IL12B 0.006 0.068 -10000 0 -0.36 4 4
CD8A 0.001 0.004 -10000 0 -0.025 2 2
CD8B 0 0.005 -10000 0 -0.039 2 2
T-helper 1 cell differentiation 0 0 -10000 0 -10000 0 0
natural killer cell mediated cytotoxicity 0.024 0.12 0.36 12 -10000 0 12
IL2RB 0.018 0.084 -10000 0 -0.38 8 8
proteasomal ubiquitin-dependent protein catabolic process -0.15 0.33 -10000 0 -0.77 34 34
IL2RG -0.021 0.16 -10000 0 -0.44 25 25
IL12 -0.02 0.12 -10000 0 -0.36 15 15
STAT5A 0.027 0.049 -10000 0 -0.26 5 5
CD247 -0.002 0.008 -10000 0 -0.023 15 15
IL2 0.035 0.005 -10000 0 -10000 0 0
SPHK2 0.021 0.081 -10000 0 -0.44 6 6
FRAP1 0.031 0.037 -10000 0 -0.48 1 1
IL12A -0.033 0.13 -10000 0 -0.34 27 27
IL12/IL12R/TYK2/JAK2 -0.23 0.47 -10000 0 -1 40 40
MAP2K3 -0.21 0.41 -10000 0 -0.92 39 39
RIPK2 0.022 0.063 -10000 0 -0.48 3 3
MAP2K6 -0.2 0.4 -10000 0 -0.92 37 37
regulation of dendritic cell antigen processing and presentation 0 0 -10000 0 -10000 0 0
HLA-DRA -0.036 0.16 -10000 0 -0.39 32 32
IL18RAP -0.063 0.19 -10000 0 -0.37 50 50
IL12Rbeta1/TYK2 0.021 0.054 -10000 0 -10000 0 0
EOMES -0.001 0.18 -10000 0 -1.3 3 3
STAT1 (dimer) -0.22 0.38 -10000 0 -0.86 42 42
T cell proliferation -0.14 0.27 -10000 0 -0.58 41 41
T-helper 1 cell lineage commitment 0 0 -10000 0 -10000 0 0
IL18R1 0.007 0.098 -10000 0 -0.29 18 18
CD8-positive alpha-beta T cell lineage commitment 0 0 -10000 0 -10000 0 0
NF kappa B1 p50/RelA -0.15 0.3 -10000 0 -0.66 39 39
ATF2 -0.18 0.35 -10000 0 -0.8 38 38
Glypican 1 network

Figure S13.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S13.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
GPC1/FGF2 dimer/FGFR1 dimer 0.012 0.12 -10000 0 -0.33 18 18
fibroblast growth factor receptor signaling pathway 0.011 0.12 -10000 0 -0.33 18 18
LAMA1 0.026 0.016 -10000 0 -10000 0 0
PRNP 0.014 0.081 -10000 0 -0.44 6 6
GPC1/SLIT2 -0.04 0.16 -10000 0 -0.38 32 32
SMAD2 -0.002 0.065 -10000 0 -0.26 10 10
GPC1/PrPc/Cu2+ 0.014 0.078 -10000 0 -0.29 10 10
GPC1/Laminin alpha1 0.018 0.078 -10000 0 -0.34 7 7
TDGF1 -0.065 0.2 -10000 0 -0.46 42 42
CRIPTO/GPC1 -0.048 0.17 -10000 0 -0.35 46 46
APP/GPC1 0.011 0.1 -10000 0 -0.35 13 13
mol:NO 0 0 -10000 0 -10000 0 0
YES1 -0.059 0.13 -10000 0 -0.3 47 47
FLT1 0.009 0.076 -10000 0 -0.28 11 11
GPC1/TGFB/TGFBR1/TGFBR2 0.044 0.084 -10000 0 -0.3 9 9
SERPINC1 0.025 0.06 -10000 0 -0.3 6 6
FYN -0.072 0.15 -10000 0 -0.31 53 53
FGR -0.059 0.14 -10000 0 -0.31 46 46
positive regulation of MAPKKK cascade -0.042 0.21 0.27 7 -0.41 39 46
SLIT2 -0.059 0.18 -10000 0 -0.36 50 50
GPC1/NRG 0.016 0.088 -10000 0 -0.34 9 9
NRG1 0.023 0.054 -10000 0 -0.39 3 3
GPC1/VEGF165 homodimer/VEGFR1 homodimer 0.014 0.073 -10000 0 -0.32 6 6
LYN -0.05 0.13 -10000 0 -0.3 42 42
mol:Spermine -0.008 0.069 -10000 0 -0.35 7 7
cell growth 0.011 0.12 -10000 0 -0.33 18 18
BMP signaling pathway -0.008 0.1 0.33 15 -10000 0 15
SRC -0.052 0.13 -10000 0 -0.31 37 37
TGFBR1 0.031 0.04 -10000 0 -0.34 2 2
mol:Cu2+ 0 0 -10000 0 -10000 0 0
PLA2G2A -0.13 0.22 -10000 0 -0.4 78 78
GPC1 0.008 0.1 -10000 0 -0.33 15 15
TGFBR1 (dimer) 0.031 0.04 -10000 0 -0.34 2 2
VEGFA 0 0 -10000 0 -10000 0 0
BLK -0.069 0.14 -10000 0 -0.31 50 50
HCK -0.066 0.14 -10000 0 -0.32 45 45
FGF2 -0.003 0.12 -10000 0 -0.3 24 24
FGFR1 0.022 0.06 -10000 0 -0.3 6 6
VEGFR1 homodimer 0.009 0.076 -10000 0 -0.28 11 11
TGFBR2 0.03 0.051 -10000 0 -0.48 2 2
cell death 0.011 0.1 -10000 0 -0.35 13 13
ATIII/GPC1 0.022 0.091 -10000 0 -0.35 9 9
PLA2G2A/GPC1 -0.099 0.18 -10000 0 -0.36 61 61
LCK -0.082 0.15 -10000 0 -0.32 57 57
neuron differentiation 0.016 0.088 -10000 0 -0.34 9 9
PrPc/Cu2+ 0.011 0.058 -10000 0 -0.35 5 5
APP 0.013 0.093 -10000 0 -0.36 11 11
TGFBR2 (dimer) 0.03 0.051 -10000 0 -0.48 2 2
TCGA08_retinoblastoma

Figure S14.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S14.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CDKN2B 0.004 0.084 -10000 0 -0.26 15 15
CDKN2C 0.036 0.055 -10000 0 -0.37 3 3
CDKN2A -0.03 0.15 -10000 0 -0.31 40 40
CCND2 0.003 0.08 0.18 20 -0.51 1 21
RB1 0.004 0.079 0.18 7 -0.2 15 22
CDK4 0.015 0.072 0.2 21 -10000 0 21
CDK6 0.012 0.074 0.2 20 -0.17 2 22
G1/S progression -0.005 0.089 0.2 17 -0.22 8 25
EGFR-dependent Endothelin signaling events

Figure S15.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S15.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
HRAS 0.032 0.04 -10000 0 -0.34 2 2
EGFR 0.016 0.09 -10000 0 -0.41 8 8
EGF/EGFR -0.082 0.15 -10000 0 -0.29 57 57
EGF/EGFR dimer/SHC/GRB2/SOS1 -0.002 0.14 -10000 0 -0.26 32 32
mol:GTP 0 0 -10000 0 -10000 0 0
EDNRA 0.009 0.091 -10000 0 -0.27 18 18
response to oxidative stress 0 0 -10000 0 -10000 0 0
EGF -0.088 0.19 -10000 0 -0.32 72 72
EGF/EGFR dimer/SHC -0.029 0.14 -10000 0 -0.3 33 33
mol:GDP -0.007 0.13 -10000 0 -0.26 32 32
mol:Ca2+ 0 0 -10000 0 -10000 0 0
EDN1 -0.061 0.18 -10000 0 -0.36 51 51
GRB2/SOS1 0.051 0.012 -10000 0 -10000 0 0
HRAS/GTP -0.02 0.11 -10000 0 -0.24 33 33
SHC1 0.035 0.007 -10000 0 -10000 0 0
HRAS/GDP -0.008 0.13 -10000 0 -0.24 33 33
FRAP1 -0.03 0.12 0.3 3 -0.48 1 4
EGF/EGFR dimer -0.054 0.15 -10000 0 -0.35 34 34
SOS1 0.036 0.002 -10000 0 -10000 0 0
GRB2 0.034 0.008 -10000 0 -10000 0 0
ETA receptor/Endothelin-1 -0.043 0.15 -10000 0 -0.35 33 33
Noncanonical Wnt signaling pathway

Figure S16.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S16.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
NFATC2 0.018 0.018 -10000 0 -10000 0 0
GNB1/GNG2 -0.091 0.21 -10000 0 -0.49 29 29
mol:DAG -0.079 0.16 -10000 0 -0.47 23 23
PLCG1 -0.082 0.17 -10000 0 -0.48 23 23
YES1 -0.1 0.2 -10000 0 -0.48 32 32
FZD3 -0.038 0.16 -10000 0 -0.38 33 33
FZD6 0.021 0.065 -10000 0 -0.41 4 4
G protein -0.032 0.22 0.29 5 -0.51 22 27
MAP3K7 -0.074 0.14 0.23 1 -0.44 18 19
mol:Ca2+ -0.077 0.16 -10000 0 -0.45 23 23
mol:IP3 -0.079 0.16 -10000 0 -0.47 23 23
NLK -0.012 0.2 -10000 0 -0.79 13 13
GNB1 0.034 0.008 -10000 0 -10000 0 0
CAMK2A -0.075 0.15 -10000 0 -0.45 20 20
MAP3K7IP1 0.034 0.009 -10000 0 -10000 0 0
Noncanonical Wnts/FZD -0.12 0.21 -10000 0 -0.48 36 36
CSNK1A1 0.035 0.006 -10000 0 -10000 0 0
GNAS -0.082 0.19 -10000 0 -0.49 28 28
GO:0007205 -0.08 0.16 -10000 0 -0.47 22 22
WNT6 0.031 0.033 -10000 0 -0.2 4 4
WNT4 -0.037 0.16 -10000 0 -0.37 36 36
NFAT1/CK1 alpha -0.076 0.17 -10000 0 -0.52 20 20
GNG2 0.033 0.01 -10000 0 -10000 0 0
WNT5A -0.011 0.14 -10000 0 -0.39 23 23
WNT11 -0.068 0.18 -10000 0 -0.35 56 56
CDC42 -0.1 0.19 -10000 0 -0.49 28 28
IL27-mediated signaling events

Figure S17.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S17.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TGFB1 0.034 0.017 -10000 0 -0.2 1 1
CD4-positive alpha-beta T cell lineage commitment 0 0 -10000 0 -10000 0 0
cytokine production during immune response 0.12 0.21 0.61 22 -10000 0 22
IL27/IL27R/JAK1 -0.14 0.33 -10000 0 -1.2 15 15
TBX21 -0.19 0.25 0.38 1 -0.6 42 43
IL12B 0.018 0.06 -10000 0 -0.32 5 5
IL12A -0.027 0.088 -10000 0 -0.23 27 27
IL6ST 0.017 0.028 -10000 0 -10000 0 0
IL27RA/JAK1 -0.098 0.34 -10000 0 -1.3 15 15
IL27 -0.098 0.2 -10000 0 -0.41 55 55
TYK2 0.013 0.031 -10000 0 -10000 0 0
T-helper cell lineage commitment -0.041 0.12 0.2 15 -0.27 39 54
T-helper 2 cell differentiation 0.12 0.21 0.61 22 -10000 0 22
T cell proliferation during immune response 0.12 0.21 0.61 22 -10000 0 22
MAPKKK cascade -0.12 0.21 -10000 0 -0.61 22 22
STAT3 0.034 0.007 -10000 0 -10000 0 0
STAT2 0.032 0.04 -10000 0 -0.34 2 2
STAT1 0.014 0.068 -10000 0 -0.21 18 18
IL12RB1 0.032 0.018 -10000 0 -0.21 1 1
positive regulation of tyrosine phosphorylation of STAT protein 0 0 -10000 0 -10000 0 0
IL12RB2 -0.17 0.23 0.38 1 -0.57 35 36
IL27/IL27R/JAK2/TYK2 -0.13 0.21 -10000 0 -0.62 22 22
positive regulation of T cell mediated cytotoxicity -0.12 0.21 -10000 0 -0.61 22 22
STAT1 (dimer) -0.19 0.35 0.52 1 -0.94 24 25
JAK2 -0.002 0.081 -10000 0 -0.28 12 12
JAK1 0.032 0.036 -10000 0 -0.48 1 1
STAT2 (dimer) -0.11 0.21 -10000 0 -0.59 22 22
T cell proliferation -0.18 0.23 -10000 0 -0.55 38 38
IL12/IL12R/TYK2/JAK2 -0.061 0.2 -10000 0 -0.86 7 7
IL17A -0.042 0.12 0.2 14 -0.27 39 53
mast cell activation 0.12 0.21 0.61 22 -10000 0 22
IFNG -0.033 0.056 -10000 0 -0.13 41 41
T cell differentiation -0.01 0.01 -10000 0 -0.024 59 59
STAT3 (dimer) -0.11 0.21 -10000 0 -0.59 21 21
STAT5A (dimer) -0.11 0.21 -10000 0 -0.6 21 21
STAT4 (dimer) -0.12 0.22 -10000 0 -0.61 23 23
STAT4 0.02 0.079 -10000 0 -0.33 9 9
T cell activation 0.001 0.034 0.12 15 -10000 0 15
IL27R/JAK2/TYK2 -0.1 0.33 -10000 0 -1.2 15 15
GATA3 0.015 0.15 0.56 1 -1.4 2 3
IL18 -0.031 0.11 -10000 0 -0.3 26 26
positive regulation of mast cell cytokine production -0.1 0.2 -10000 0 -0.57 21 21
IL27/EBI3 -0.062 0.15 -10000 0 -0.34 43 43
IL27RA -0.11 0.36 -10000 0 -1.4 15 15
IL6 -0.12 0.2 -10000 0 -0.34 82 82
STAT5A 0.027 0.049 -10000 0 -0.26 5 5
monocyte differentiation -0.002 0.003 -10000 0 -10000 0 0
IL2 0.036 0.12 0.46 15 -10000 0 15
IL1B -0.055 0.13 -10000 0 -0.27 47 47
EBI3 0.017 0.027 -10000 0 -10000 0 0
TNF -0.001 0.043 -10000 0 -0.18 9 9
Thromboxane A2 receptor signaling

Figure S18.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S18.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TGM2 -0.015 0.12 -10000 0 -0.4 16 16
GNB1/GNG2 -0.064 0.079 -10000 0 -0.18 51 51
AKT1 -0.06 0.14 0.28 3 -0.34 12 15
EGF -0.088 0.19 -10000 0 -0.32 72 72
mol:TXA2 0 0.001 -10000 0 -10000 0 0
FGR -0.019 0.081 0.28 4 -0.25 1 5
mol:Ca2+ -0.081 0.16 0.28 3 -0.32 30 33
LYN -0.016 0.072 0.32 2 -0.24 2 4
RhoA/GTP -0.034 0.068 -10000 0 -0.15 4 4
mol:PGI2 0 0 -10000 0 -10000 0 0
SYK -0.094 0.18 0.29 2 -0.35 51 53
GNG2 0.033 0.01 -10000 0 -10000 0 0
ARRB2 0.027 0.038 -10000 0 -0.48 1 1
TP alpha/Gq family/GDP/G beta5/gamma2 -0.052 0.16 -10000 0 -0.46 22 22
G beta5/gamma2 -0.082 0.1 -10000 0 -0.25 40 40
PRKCH -0.098 0.19 0.3 1 -0.37 52 53
DNM1 0.029 0.037 -10000 0 -0.2 5 5
TXA2/TP beta/beta Arrestin3 0.019 0.023 -10000 0 -10000 0 0
mol:GTP 0 0.001 -10000 0 -10000 0 0
PTGDR -0.057 0.16 -10000 0 -0.29 57 57
G12 family/GTP -0.089 0.15 -10000 0 -0.31 47 47
ADRBK1 0.036 0.004 -10000 0 -10000 0 0
ADRBK2 0.029 0.043 -10000 0 -0.3 3 3
RhoA/GTP/ROCK1 0.036 0.021 -10000 0 -10000 0 0
mol:GDP 0.051 0.13 0.34 17 -0.25 4 21
mol:NADP 0.029 0.053 -10000 0 -0.39 3 3
RAB11A 0.03 0.04 -10000 0 -0.34 2 2
PRKG1 0.034 0.007 -10000 0 -10000 0 0
mol:IP3 -0.1 0.2 0.31 2 -0.4 36 38
cell morphogenesis 0.036 0.02 -10000 0 -10000 0 0
PLCB2 -0.16 0.26 -10000 0 -0.54 42 42
mol:cGMP 0 0.001 -10000 0 -10000 0 0
BLK -0.025 0.086 0.28 4 -0.26 4 8
mol:PDG2 0 0 -10000 0 -10000 0 0
HCK -0.023 0.077 0.26 1 -0.31 7 8
RHOA 0.035 0.004 -10000 0 -10000 0 0
PTGIR 0.034 0.017 -10000 0 -0.2 1 1
PRKCB1 -0.11 0.2 0.34 1 -0.39 52 53
GNAQ 0 0 -10000 0 -10000 0 0
mol:L-citrulline 0.029 0.053 -10000 0 -0.39 3 3
TXA2/TXA2-R family -0.15 0.26 -10000 0 -0.54 53 53
LCK -0.038 0.098 0.28 3 -0.28 10 13
TXA2/TP beta/beta Arrestin3/RAB11/GDP -0.002 0.083 -10000 0 -0.29 1 1
TXA2-R family/G12 family/GDP/G beta/gamma 0 0.12 -10000 0 -0.45 11 11
TXA2/TP beta/beta Arrestin2/RAB11/GDP -0.005 0.081 -10000 0 -0.28 1 1
MAPK14 -0.06 0.12 0.22 4 -0.24 24 28
TGM2/GTP -0.13 0.2 -10000 0 -0.49 20 20
MAPK11 -0.061 0.12 0.22 4 -0.24 25 29
ARHGEF1 -0.042 0.1 0.21 5 -0.2 10 15
GNAI2 0.024 0.073 -10000 0 -0.43 5 5
JNK cascade -0.1 0.2 0.31 2 -0.39 53 55
RAB11/GDP 0.031 0.04 -10000 0 -0.34 2 2
ICAM1 -0.076 0.15 0.26 2 -0.32 17 19
cAMP biosynthetic process -0.1 0.19 0.31 2 -0.38 31 33
Gq family/GTP/EBP50 -0.007 0.073 -10000 0 -0.21 20 20
actin cytoskeleton reorganization 0.036 0.02 -10000 0 -10000 0 0
SRC -0.013 0.055 0.26 1 -0.25 1 2
GNB5 -0.004 0.13 -10000 0 -0.38 19 19
GNB1 0.034 0.008 -10000 0 -10000 0 0
EGF/EGFR -0.023 0.13 0.38 4 -0.31 11 15
VCAM1 -0.079 0.16 0.28 1 -0.3 51 52
TP beta/Gq family/GDP/G beta5/gamma2 -0.052 0.16 -10000 0 -0.46 22 22
platelet activation -0.079 0.17 0.32 3 -0.32 28 31
PGI2/IP 0.025 0.012 -10000 0 -0.13 1 1
PRKACA -0.016 0.078 -10000 0 -0.25 17 17
Gq family/GDP/G beta5/gamma2 -0.049 0.15 -10000 0 -0.42 23 23
TXA2/TP beta/beta Arrestin2 -0.009 0.063 -10000 0 -0.33 2 2
positive regulation of NF-kappaB transcription factor activity 0 0 -10000 0 -10000 0 0
TBXA2R -0.022 0.068 -10000 0 -0.23 16 16
mol:DAG -0.12 0.22 0.32 1 -0.43 54 55
EGFR 0.016 0.09 -10000 0 -0.41 8 8
TXA2/TP alpha -0.14 0.25 0.36 1 -0.52 34 35
Gq family/GTP -0.019 0.081 -10000 0 -0.24 22 22
YES1 -0.015 0.075 0.28 3 -0.24 2 5
GNAI2/GTP -0.016 0.079 -10000 0 -0.25 4 4
PGD2/DP -0.039 0.11 -10000 0 -0.2 58 58
SLC9A3R1 0.025 0.064 -10000 0 -0.41 4 4
FYN -0.029 0.096 0.28 4 -0.33 6 10
mol:NO 0.029 0.053 -10000 0 -0.39 3 3
GNA15 0.02 0.068 -10000 0 -0.26 10 10
PGK/cGMP 0.041 0.037 -10000 0 -0.3 2 2
RhoA/GDP 0.036 0.005 -10000 0 -10000 0 0
TP alpha/TGM2/GDP/G beta/gamma -0.008 0.087 0.29 1 -0.31 4 5
NOS3 0.029 0.053 -10000 0 -0.39 3 3
RAC1 0.033 0.011 -10000 0 -10000 0 0
PRKCA -0.092 0.19 0.32 2 -0.37 39 41
PRKCB -0.095 0.18 0.28 2 -0.36 53 55
PRKCE -0.096 0.19 0.29 1 -0.36 50 51
PRKCD -0.1 0.19 0.3 1 -0.39 53 54
PRKCG -0.11 0.2 0.31 3 -0.39 53 56
muscle contraction -0.14 0.24 0.35 1 -0.49 54 55
PRKCZ -0.092 0.18 0.28 3 -0.35 53 56
ARR3 0.036 0 -10000 0 -10000 0 0
TXA2/TP beta -0.002 0.085 -10000 0 -0.29 1 1
PRKCQ -0.11 0.19 0.38 1 -0.37 54 55
MAPKKK cascade -0.13 0.23 0.33 1 -0.46 53 54
SELE -0.1 0.19 0.28 1 -0.39 55 56
TP beta/GNAI2/GDP/G beta/gamma 0.01 0.097 0.29 1 -0.28 2 3
ROCK1 0.028 0.015 -10000 0 -10000 0 0
GNA14 -0.021 0.15 -10000 0 -0.37 29 29
chemotaxis -0.17 0.29 -10000 0 -0.62 53 53
GNA12 0.033 0.01 -10000 0 -10000 0 0
GNA13 0.034 0.009 -10000 0 -10000 0 0
GNA11 0.028 0.054 -10000 0 -0.39 3 3
Rac1/GTP 0.023 0.008 -10000 0 -10000 0 0
Calcineurin-regulated NFAT-dependent transcription in lymphocytes

Figure S19.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S19.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
FOXP3 0.031 0.034 -10000 0 -0.22 2 2
NFATC2 -0.046 0.17 -10000 0 -0.58 10 10
NFATC3 -0.048 0.11 -10000 0 -0.33 13 13
CD40LG -0.32 0.39 -10000 0 -0.86 50 50
ITCH 0.006 0.059 -10000 0 -10000 0 0
CBLB 0.017 0.082 -10000 0 -0.51 2 2
CD4-positive CD25-positive alpha-beta regulatory T cell lineage commitment -0.25 0.37 -10000 0 -1.1 26 26
JUNB 0.015 0.081 -10000 0 -0.26 14 14
CaM/Ca2+/Calcineurin A alpha-beta B1 0.025 0.083 -10000 0 -0.27 13 13
T cell anergy 0.019 0.12 -10000 0 -0.38 10 10
TLE4 -0.037 0.14 -10000 0 -0.61 7 7
Jun/NFAT1-c-4/p21SNFT -0.22 0.32 -10000 0 -0.86 26 26
AP-1/NFAT1-c-4 -0.36 0.44 -10000 0 -0.99 48 48
IKZF1 -0.033 0.11 -10000 0 -0.4 10 10
T-helper 2 cell differentiation -0.086 0.2 -10000 0 -0.7 7 7
AP-1/NFAT1 -0.098 0.18 -10000 0 -0.47 25 25
CALM1 0.028 0.055 -10000 0 -10000 0 0
EGR2 -0.24 0.49 -10000 0 -1.4 29 29
EGR3 -0.23 0.44 -10000 0 -1.2 28 28
NFAT1/FOXP3 -0.023 0.13 -10000 0 -0.46 7 7
EGR1 -0.053 0.17 -10000 0 -0.31 53 53
JUN -0.052 0.15 -10000 0 -0.43 25 25
EGR4 0.001 0.002 -10000 0 -10000 0 0
mol:Ca2+ 0 0.044 -10000 0 -10000 0 0
GBP3 -0.077 0.23 -10000 0 -0.74 20 20
FOSL1 0.029 0.04 -10000 0 -0.2 6 6
NFAT1-c-4/MAF/IRF4 -0.18 0.32 -10000 0 -0.92 23 23
DGKA -0.035 0.13 -10000 0 -0.54 6 6
CREM 0.031 0.04 -10000 0 -0.34 2 2
NFAT1-c-4/PPARG -0.19 0.32 -10000 0 -0.89 24 24
CTLA4 -0.002 0.14 -10000 0 -0.44 6 6
NFAT1-c-4 (dimer)/EGR1 -0.2 0.33 -10000 0 -0.88 27 27
NFAT1-c-4 (dimer)/EGR4 -0.18 0.3 -10000 0 -0.89 22 22
FOS -0.096 0.17 -10000 0 -0.36 49 49
IFNG -0.34 0.54 -10000 0 -1.2 48 48
T cell activation -0.1 0.22 -10000 0 -0.71 7 7
MAF -0.004 0.12 -10000 0 -0.34 22 22
T-helper 2 cell lineage commitment 0 0 -10000 0 -10000 0 0
activation-induced cell death of T cells 0.17 0.28 0.74 33 -10000 0 33
TNF -0.18 0.31 -10000 0 -0.83 26 26
FASLG -0.36 0.61 -10000 0 -1.5 42 42
TBX21 -0.082 0.18 -10000 0 -0.35 52 52
BATF3 0 0 -10000 0 -10000 0 0
PRKCQ -0.022 0.14 -10000 0 -0.38 24 24
PTPN1 -0.033 0.13 -10000 0 -0.53 6 6
NFAT1-c-4/ICER1 -0.17 0.31 -10000 0 -0.9 22 22
GATA3 0.031 0.054 -10000 0 -0.39 3 3
T-helper 1 cell differentiation -0.32 0.51 -10000 0 -1.2 48 48
IL2RA -0.26 0.38 -10000 0 -1 29 29
T-helper 1 cell lineage commitment 0 0 -10000 0 -10000 0 0
CASP3 -0.034 0.13 -10000 0 -0.5 8 8
E2F1 0.017 0.053 -10000 0 -0.48 2 2
PPARG -0.021 0.16 -10000 0 -0.45 24 24
SLC3A2 -0.034 0.13 -10000 0 -0.55 6 6
IRF4 0.006 0.11 -10000 0 -0.34 16 16
PTGS2 -0.35 0.42 -10000 0 -0.88 58 58
CSF2 -0.35 0.42 -10000 0 -0.88 59 59
JunB/Fra1/NFAT1-c-4 -0.17 0.3 -10000 0 -0.87 21 21
IL4 -0.09 0.2 -10000 0 -0.76 6 6
IL5 -0.32 0.39 -10000 0 -0.86 48 48
IL2 -0.1 0.22 -10000 0 -0.74 6 6
IL3 -0.044 0.15 -10000 0 -0.76 7 7
RNF128 -0.005 0.15 -10000 0 -0.58 12 12
NFATC1 -0.17 0.29 -10000 0 -0.74 33 33
CDK4 0.09 0.17 0.55 13 -10000 0 13
PTPRK -0.039 0.14 -10000 0 -0.59 8 8
IL8 -0.38 0.43 -10000 0 -0.91 61 61
POU2F1 0.032 0.067 -10000 0 -0.37 5 5
Glucocorticoid receptor regulatory network

Figure S20.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S20.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PCK2 0.062 0.12 -10000 0 -0.74 2 2
SMARCC2 0.035 0.004 -10000 0 -10000 0 0
SMARCC1 0.035 0.005 -10000 0 -10000 0 0
TBX21 -0.15 0.26 -10000 0 -0.76 26 26
SUMO2 0.031 0.017 -10000 0 -10000 0 0
STAT1 (dimer) 0.005 0.1 -10000 0 -0.26 25 25
FKBP4 0.032 0.037 -10000 0 -0.48 1 1
FKBP5 0.026 0.066 -10000 0 -0.37 5 5
GR alpha/HSP90/FKBP51/HSP90 0.098 0.1 0.27 31 -0.23 2 33
PRL -0.05 0.1 -10000 0 -10000 0 0
cortisol/GR alpha (dimer)/TIF2 0.17 0.22 0.53 41 -10000 0 41
RELA -0.084 0.12 -10000 0 -0.28 28 28
FGG 0.14 0.2 0.45 38 -0.52 2 40
GR beta/TIF2 0.093 0.12 0.31 23 -0.34 1 24
IFNG -0.35 0.44 -10000 0 -1.1 45 45
apoptosis -0.015 0.23 0.62 4 -0.59 14 18
CREB1 0.041 0.042 -10000 0 -0.38 2 2
histone acetylation -0.076 0.12 -10000 0 -0.34 20 20
BGLAP -0.064 0.12 -10000 0 -0.41 3 3
GR/PKAc 0.091 0.15 0.32 19 -0.26 12 31
NF kappa B1 p50/RelA -0.16 0.22 -10000 0 -0.44 55 55
SMARCD1 0.035 0.005 -10000 0 -10000 0 0
MDM2 0.078 0.086 0.22 38 -10000 0 38
GATA3 0.036 0.058 -10000 0 -0.38 3 3
AKT1 0.025 0.035 0.24 2 -0.19 3 5
CSF2 -0.23 0.43 -10000 0 -1.3 27 27
GSK3B 0.03 0.039 -10000 0 -0.48 1 1
NR1I3 -0.002 0.21 0.63 4 -0.54 10 14
CSN2 0.12 0.16 0.37 34 -10000 0 34
BRG1/BAF155/BAF170/BAF60A 0.083 0.039 -10000 0 -0.27 1 1
NFATC1 0.007 0.067 -10000 0 -0.33 1 1
POU2F1 0.031 0.068 -10000 0 -0.42 4 4
CDKN1A -0.097 0.28 -10000 0 -1.7 5 5
response to stress 0 0 -10000 0 -10000 0 0
response to UV -0.001 0.007 -10000 0 -10000 0 0
SFN 0.02 0.071 -10000 0 -0.31 8 8
GR alpha/HSP90/FKBP51/HSP90/14-3-3 0.1 0.1 0.29 21 -0.24 2 23
prolactin receptor activity 0 0 -10000 0 -10000 0 0
EGR1 -0.072 0.32 0.56 4 -0.78 28 32
JUN -0.16 0.2 -10000 0 -0.48 38 38
IL4 -0.065 0.14 -10000 0 -0.66 5 5
CDK5R1 0.034 0.008 -10000 0 -10000 0 0
PRKACA 0.035 0.006 -10000 0 -10000 0 0
cortisol/GR alpha (monomer)/AP-1 -0.072 0.18 0.22 28 -0.37 30 58
GR alpha/HSP90/FKBP51/HSP90/PP5C 0.12 0.099 0.29 25 -0.22 1 26
cortisol/GR alpha (monomer) 0.21 0.26 0.61 46 -10000 0 46
NCOA2 0.025 0.052 -10000 0 -0.48 2 2
response to hypoxia 0 0 -10000 0 -10000 0 0
FOS -0.1 0.18 -10000 0 -0.39 46 46
AP-1/NFAT1-c-4 -0.25 0.26 -10000 0 -0.61 47 47
AFP -0.19 0.38 -10000 0 -1.6 13 13
SUV420H1 0.036 0.004 -10000 0 -10000 0 0
IRF1 0.079 0.21 0.45 7 -0.73 7 14
TP53 -0.046 0.2 -10000 0 -0.5 31 31
PPP5C 0.034 0.017 -10000 0 -0.2 1 1
KRT17 -0.21 0.27 -10000 0 -0.76 23 23
KRT14 -0.069 0.13 -10000 0 -10000 0 0
TBP 0.042 0.018 -10000 0 -10000 0 0
CREBBP 0.036 0.043 -10000 0 -0.44 1 1
HDAC1 0.032 0.014 -10000 0 -10000 0 0
HDAC2 0.042 0.045 -10000 0 -0.48 1 1
AP-1 -0.25 0.26 -10000 0 -0.62 47 47
MAPK14 0.034 0.01 -10000 0 -10000 0 0
MAPK10 0.009 0.1 -10000 0 -0.36 13 13
MAPK11 0.028 0.024 -10000 0 -0.2 1 1
KRT5 -0.21 0.28 -10000 0 -0.76 26 26
interleukin-1 receptor activity 0.01 0.025 -10000 0 -10000 0 0
NCOA1 0.027 0.073 -10000 0 -0.48 4 4
STAT1 0.005 0.1 -10000 0 -0.26 25 25
CGA -0.077 0.16 -10000 0 -0.65 6 6
NF kappa B1 p50/RelA/Cbp/cortisol/GR alpha (monomer)/HDAC2 0.084 0.18 0.47 29 -0.39 1 30
MAPK3 0.022 0.074 -10000 0 -0.43 5 5
MAPK1 0.033 0.012 -10000 0 -10000 0 0
ICAM1 -0.22 0.28 -10000 0 -0.73 31 31
NFKB1 -0.082 0.12 -10000 0 -0.26 38 38
MAPK8 -0.11 0.15 -10000 0 -0.41 26 26
MAPK9 0.031 0.038 -10000 0 -0.49 1 1
cortisol/GR alpha (dimer) -0.016 0.24 0.63 4 -0.63 14 18
BAX -0.068 0.18 -10000 0 -1.8 1 1
POMC -0.11 0.23 -10000 0 -1.6 3 3
EP300 0.023 0.096 -10000 0 -0.44 7 7
cortisol/GR alpha (dimer)/p53 0.11 0.25 0.54 33 -0.47 1 34
proteasomal ubiquitin-dependent protein catabolic process 0.049 0.085 0.25 15 -10000 0 15
SGK1 0.035 0.089 0.23 5 -0.24 8 13
IL13 -0.15 0.19 -10000 0 -0.65 11 11
IL6 -0.35 0.48 -10000 0 -1 58 58
PRKACG 0.035 0.006 -10000 0 -10000 0 0
IL5 -0.13 0.16 -10000 0 -0.81 1 1
IL2 -0.19 0.23 -10000 0 -0.68 21 21
CDK5 0.034 0.006 -10000 0 -10000 0 0
PRKACB -0.032 0.17 -10000 0 -0.41 31 31
HSP90AA1 0 0 -10000 0 -10000 0 0
IL8 -0.39 0.5 -10000 0 -1.1 64 64
CDK5R1/CDK5 0.049 0.014 -10000 0 -10000 0 0
NF kappa B1 p50/RelA/PKAc -0.12 0.21 -10000 0 -0.41 46 46
cortisol/GR alpha (dimer)/Hsp90/FKBP52/HSP90 0.18 0.21 0.5 46 -10000 0 46
SMARCA4 0.03 0.043 -10000 0 -0.3 3 3
chromatin remodeling 0.12 0.13 0.34 39 -10000 0 39
NF kappa B1 p50/RelA/Cbp -0.11 0.19 0.33 1 -0.43 32 33
JUN (dimer) -0.16 0.19 -10000 0 -0.48 37 37
YWHAH 0.031 0.037 -10000 0 -0.48 1 1
VIPR1 -0.13 0.24 -10000 0 -0.7 26 26
NR3C1 0.13 0.16 0.41 36 -10000 0 36
NR4A1 0.014 0.087 -10000 0 -0.42 4 4
TIF2/SUV420H1 0.04 0.044 -10000 0 -0.35 2 2
MAPKKK cascade -0.015 0.23 0.62 4 -0.59 14 18
cortisol/GR alpha (dimer)/Src-1 0.2 0.23 0.54 45 -10000 0 45
PBX1 0.021 0.097 -10000 0 -0.42 9 9
POU1F1 0.039 0.037 -10000 0 -0.48 1 1
SELE -0.38 0.48 -10000 0 -1 65 65
cortisol/GR alpha/BRG1/BAF155/BAF170/BAF60A 0.12 0.13 0.34 39 -10000 0 39
cortisol/GR alpha (monomer)/Hsp90/FKBP52/HSP90 0.18 0.21 0.5 46 -10000 0 46
mol:cortisol 0.12 0.16 0.35 50 -10000 0 50
MMP1 -0.35 0.51 -10000 0 -1.2 51 51
IL1-mediated signaling events

Figure S21.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S21.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
UBC13/UEV1A 0.026 0.004 -9999 0 -10000 0 0
PRKCZ 0 0 -9999 0 -10000 0 0
MAP3K7IP2 0.035 0.006 -9999 0 -10000 0 0
ERC1 0 0 -9999 0 -10000 0 0
IL1 beta fragment/IL1R1/IL1RAP/MYD88/IRAK4 -0.033 0.092 -9999 0 -0.25 12 12
IRAK/TOLLIP 0.04 0.018 -9999 0 -10000 0 0
IKBKB 0.031 0.012 -9999 0 -10000 0 0
IKBKG 0.035 0.017 -9999 0 -0.2 1 1
IL1 alpha/IL1R2 -0.12 0.19 -9999 0 -0.37 64 64
IL1A -0.08 0.18 -9999 0 -0.32 68 68
IL1B -0.12 0.18 -9999 0 -0.38 61 61
IRAK/TRAF6/p62/Atypical PKCs 0.063 0.043 -9999 0 -0.24 2 2
IL1R2 -0.079 0.19 -9999 0 -0.36 61 61
IL1R1 0.016 0.081 -9999 0 -0.26 14 14
IL1 beta fragment/IL1R1/IL1RAP/MYD88/IRAK4/IRAK/TOLLIP -0.02 0.087 -9999 0 -0.31 2 2
TOLLIP 0.036 0.002 -9999 0 -10000 0 0
TICAM2 0 0 -9999 0 -10000 0 0
MAP3K3 0.034 0.009 -9999 0 -10000 0 0
TAK1/TAB1/TAB2 0.066 0.032 -9999 0 -0.3 1 1
IKK complex/ELKS 0.023 0.066 -9999 0 -0.35 2 2
JUN -0.044 0.079 -9999 0 -0.43 2 2
MAP3K7 0.033 0.036 -9999 0 -0.48 1 1
IL1 beta fragment/IL1R1/IL1RAP/PI3K -0.06 0.18 -9999 0 -0.3 63 63
IL1 alpha/IL1R1/IL1RAP/MYD88 -0.006 0.14 -9999 0 -0.28 32 32
PIK3R1 0.028 0.062 -9999 0 -0.48 3 3
IL1 alpha/IL1R1/IL1RAP/MYD88/IRAK4 0.004 0.14 -9999 0 -0.26 33 33
IL1 beta fragment/IL1R1/IL1RAP -0.084 0.18 -9999 0 -0.32 65 65
NFKB1 0.035 0.006 -9999 0 -10000 0 0
MAPK8 -0.022 0.049 -9999 0 -10000 0 0
IRAK1 0.018 0.017 -9999 0 -0.18 1 1
IL1RN/IL1R1 -0.02 0.14 -9999 0 -0.34 26 26
IRAK4 0.033 0.036 -9999 0 -0.48 1 1
PRKCI 0.028 0.056 -9999 0 -0.34 4 4
TRAF6 0.036 0.004 -9999 0 -10000 0 0
PI3K 0.045 0.049 -9999 0 -0.35 3 3
IL1 beta fragment/IL1R1/IL1RAP/MYD88/IRAK4/TOLLIP -0.039 0.1 -9999 0 -0.3 12 12
CHUK 0.027 0.062 -9999 0 -0.48 3 3
IL1 beta fragment/IL1R1/IL1RAP/MYD88s -0.084 0.18 -9999 0 -0.32 65 65
IL1 beta/IL1R2 -0.15 0.22 -9999 0 -0.37 87 87
IRAK/TRAF6/TAK1/TAB1/TAB2 0.082 0.039 -9999 0 -10000 0 0
NF kappa B1 p50/RelA -0.064 0.16 -9999 0 -0.38 21 21
IRAK3 -0.012 0.13 -9999 0 -0.31 28 28
IL1 beta fragment/IL1R1/IL1RAP/TICAM2/IRAK4 -0.069 0.17 -9999 0 -0.3 62 62
IL1 alpha/IL1R1/IL1RAP/MYD88/IRAK4/TOLLIP -0.016 0.1 -9999 0 -0.24 30 30
IL1 alpha/IL1R1/IL1RAP -0.025 0.14 -9999 0 -0.3 36 36
RELA 0.035 0.004 -9999 0 -10000 0 0
MAP3K7IP1 0.034 0.009 -9999 0 -10000 0 0
SQSTM1 0.034 0.017 -9999 0 -0.2 1 1
MYD88 0.036 0.004 -9999 0 -10000 0 0
IRAK/TRAF6/MEKK3 0.057 0.025 -9999 0 -10000 0 0
IL1RAP 0.031 0.033 -9999 0 -0.2 4 4
UBE2N 0.035 0.005 -9999 0 -10000 0 0
IRAK/TRAF6 -0.075 0.14 -9999 0 -0.36 20 20
CASP1 -0.085 0.2 -9999 0 -0.37 62 62
IL1RN/IL1R2 -0.086 0.2 -9999 0 -0.37 56 56
IL1 beta fragment/IL1R1/IL1RAP/MYD88 -0.068 0.18 -9999 0 -0.31 61 61
TMEM189-UBE2V1 0 0 -9999 0 -10000 0 0
IL1 alpha/IL1R1/IL1RAP/MYD88/IRAK4/IRAK/TOLLIP -0.002 0.093 -9999 0 -0.37 5 5
PIK3CA 0.035 0.006 -9999 0 -10000 0 0
IL1RN -0.042 0.16 -9999 0 -0.31 47 47
TRAF6/TAK1/TAB1/TAB2 0.08 0.035 -9999 0 -0.25 1 1
MAP2K6 0.001 0.057 -9999 0 -10000 0 0
Glypican 2 network

Figure S22.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S22.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
MDK -0.01 0.13 -9999 0 -0.34 25 25
GPC2 0 0 -9999 0 -10000 0 0
GPC2/Midkine -0.005 0.093 -9999 0 -0.24 25 25
neuron projection morphogenesis -0.005 0.093 -9999 0 -0.24 25 25
FOXA2 and FOXA3 transcription factor networks

Figure S23.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S23.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
ACADVL -0.12 0.36 -10000 0 -0.99 20 20
PCK1 -0.25 0.55 -10000 0 -1.4 37 37
HNF4A -0.083 0.43 -10000 0 -1.2 17 17
KCNJ11 -0.096 0.36 -10000 0 -0.94 20 20
AKT1 -0.045 0.22 -10000 0 -0.53 18 18
response to starvation -0.006 0.036 -10000 0 -0.14 10 10
DLK1 -0.1 0.4 -10000 0 -1.1 20 20
NKX2-1 0.04 0.2 0.42 26 -0.4 7 33
ACADM -0.12 0.38 0.58 1 -0.98 23 24
TAT -0.076 0.24 -10000 0 -0.84 7 7
CEBPB 0.013 0.041 -10000 0 -0.48 1 1
CEBPA 0.007 0.096 -10000 0 -0.38 10 10
TTR -0.2 0.5 0.59 2 -1.2 35 37
PKLR -0.12 0.39 -10000 0 -1 22 22
APOA1 -0.12 0.54 -10000 0 -1.4 22 22
CPT1C -0.12 0.38 -10000 0 -0.97 25 25
ALAS1 -0.03 0.18 -10000 0 -0.77 1 1
TFRC -0.12 0.38 -10000 0 -0.99 22 22
FOXF1 0 0.13 -10000 0 -0.43 16 16
NF1 0.04 0.011 -10000 0 -10000 0 0
HNF1A (dimer) 0.002 0.033 -10000 0 -0.15 7 7
CPT1A -0.12 0.38 -10000 0 -0.94 25 25
HMGCS1 -0.12 0.38 0.58 1 -0.97 23 24
NR3C1 0.02 0.094 -10000 0 -0.48 6 6
CPT1B -0.12 0.36 -10000 0 -0.98 20 20
chromatin remodeling 0 0 -10000 0 -10000 0 0
SP1 0.034 0.017 -10000 0 -0.2 1 1
GCK -0.11 0.38 -10000 0 -1 19 19
CREB1 -0.008 0.09 -10000 0 -0.23 20 20
IGFBP1 -0.064 0.26 -10000 0 -1.2 5 5
PDX1 -0.03 0.18 -10000 0 -0.38 18 18
UCP2 -0.14 0.39 -10000 0 -0.93 29 29
ALDOB -0.21 0.49 -10000 0 -1 44 44
AFP -0.14 0.27 -10000 0 -0.94 17 17
BDH1 -0.13 0.4 -10000 0 -1 23 23
HADH -0.094 0.36 -10000 0 -0.88 22 22
F2 -0.083 0.47 -10000 0 -1.3 15 15
HNF1A 0.002 0.033 -10000 0 -0.15 7 7
G6PC 0.005 0.19 -10000 0 -1.1 3 3
SLC2A2 -0.07 0.31 -10000 0 -0.88 15 15
INS 0.025 0.029 0.22 1 -10000 0 1
FOXA1 -0.12 0.23 -10000 0 -0.46 60 60
FOXA3 -0.049 0.18 -10000 0 -0.45 23 23
FOXA2 -0.1 0.41 -10000 0 -1 22 22
ABCC8 -0.1 0.36 -10000 0 -0.96 19 19
ALB -0.12 0.21 -10000 0 -0.7 14 14
FAS signaling pathway (CD95)

Figure S24.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S24.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
SPTAN1 0.004 0.066 0.22 8 -0.26 3 11
RFC1 0.003 0.064 0.23 7 -0.28 2 9
PRKDC 0.018 0.079 0.22 20 -0.28 2 22
RIPK1 0.038 0.006 -10000 0 -10000 0 0
CASP7 -0.038 0.15 -10000 0 -0.62 11 11
FASLG/FAS/FADD/FAF1 0.01 0.14 0.21 33 -0.29 19 52
MAP2K4 -0.11 0.19 -10000 0 -0.44 36 36
mol:ceramide -0.076 0.16 -10000 0 -0.43 25 25
GSN -0.002 0.077 0.22 9 -0.27 5 14
FASLG/FAS/FADD/FAF1/Caspase 8 -0.008 0.14 -10000 0 -0.39 13 13
FAS -0.048 0.17 -10000 0 -0.4 34 34
BID -0.024 0.049 0.27 2 -0.34 3 5
MAP3K1 -0.048 0.14 0.25 2 -0.46 11 13
MAP3K7 0.03 0.036 -10000 0 -0.48 1 1
RB1 0.035 0.11 0.26 31 -0.31 1 32
CFLAR 0.038 0.007 -10000 0 -10000 0 0
HGF/MET -0.075 0.16 -10000 0 -0.3 63 63
ARHGDIB -0.006 0.071 0.22 6 -0.27 6 12
FADD 0.023 0.025 -10000 0 -10000 0 0
actin filament polymerization 0.002 0.077 0.26 5 -0.22 9 14
NFKB1 -0.055 0.15 -10000 0 -0.74 6 6
MAPK8 -0.15 0.24 -10000 0 -0.51 52 52
DFFA 0.004 0.065 0.23 7 -0.28 2 9
DNA fragmentation during apoptosis 0.003 0.063 0.23 6 -0.28 2 8
FAS/FADD/MET 0.005 0.12 -10000 0 -0.31 23 23
CFLAR/RIP1 0.057 0.012 -10000 0 -10000 0 0
FAIM3 0.028 0.058 -10000 0 -0.32 5 5
FAF1 0.021 0.027 -10000 0 -10000 0 0
PARP1 0.001 0.062 0.23 6 -0.28 2 8
DFFB 0.003 0.064 0.23 6 -0.28 2 8
CHUK -0.054 0.14 -10000 0 -0.64 7 7
FASLG -0.041 0.14 -10000 0 -0.32 37 37
FAS/FADD -0.021 0.13 -10000 0 -0.36 24 24
HGF 0.03 0.043 -10000 0 -0.3 3 3
LMNA -0.003 0.068 0.23 3 -0.26 5 8
CASP6 0.001 0.07 0.23 7 -0.28 4 11
CASP10 0.013 0.064 -10000 0 -0.3 6 6
CASP3 0.005 0.072 0.27 8 -0.25 6 14
PTPN13 -0.16 0.23 -10000 0 -0.39 96 96
CASP8 -0.026 0.057 0.36 2 -0.37 3 5
IL6 -0.31 0.55 -10000 0 -1.3 48 48
MET 0.027 0.056 -10000 0 -0.34 4 4
ICAD/CAD -0.003 0.053 0.27 1 -0.26 2 3
FASLG/FAS/FADD/FAF1/Caspase 10 -0.077 0.16 -10000 0 -0.44 25 25
activation of caspase activity by cytochrome c -0.023 0.049 0.27 2 -0.34 3 5
PAK2 0.006 0.071 0.23 10 -0.26 3 13
BCL2 -0.002 0.098 -10000 0 -0.31 16 16
Calcium signaling in the CD4+ TCR pathway

Figure S25.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S25.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
NFATC1 -0.021 0.047 -9999 0 -0.16 1 1
NFATC2 -0.008 0.028 -9999 0 -10000 0 0
NFATC3 -0.021 0.051 -9999 0 -0.35 1 1
CD40LG -0.15 0.27 -9999 0 -0.57 43 43
PTGS2 -0.19 0.3 -9999 0 -0.58 59 59
JUNB 0.015 0.081 -9999 0 -0.26 14 14
CaM/Ca2+/Calcineurin A alpha-beta B1 -0.005 0.035 -9999 0 -10000 0 0
CaM/Ca2+ -0.005 0.035 -9999 0 -10000 0 0
CALM1 0.013 0.031 -9999 0 -10000 0 0
JUN -0.037 0.15 -9999 0 -0.41 25 25
mol:Ca2+ -0.011 0.014 -9999 0 -10000 0 0
Calcineurin A alpha-beta B1/FKBP12/FK506 0.012 0.026 -9999 0 -0.29 1 1
FOSL1 0.029 0.04 -9999 0 -0.2 6 6
CREM 0.031 0.04 -9999 0 -0.34 2 2
Jun/NFAT1-c-4/p21SNFT -0.069 0.14 -9999 0 -0.4 18 18
FOS -0.08 0.17 -9999 0 -0.33 56 56
IFNG -0.2 0.31 -9999 0 -0.63 57 57
AP-1/NFAT1-c-4 -0.18 0.31 -9999 0 -0.64 48 48
FASLG -0.17 0.29 -9999 0 -0.61 47 47
NFAT1-c-4/ICER1 -0.025 0.083 -9999 0 -0.38 1 1
IL2RA -0.17 0.3 -9999 0 -0.62 50 50
FKBP12/FK506 0.019 0.028 -9999 0 -0.35 1 1
CSF2 -0.18 0.3 -9999 0 -0.6 54 54
JunB/Fra1/NFAT1-c-4 -0.004 0.11 -9999 0 -0.37 2 2
IL4 -0.15 0.26 -9999 0 -0.55 44 44
IL2 0 0.14 -9999 0 -0.96 4 4
IL3 0 0.16 -9999 0 -0.8 7 7
FKBP1A 0.026 0.038 -9999 0 -0.48 1 1
BATF3 0 0 -9999 0 -10000 0 0
mol:FK506 0 0 -9999 0 -10000 0 0
POU2F1 0.032 0.067 -9999 0 -0.37 5 5
Presenilin action in Notch and Wnt signaling

Figure S26.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S26.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Delta 1/NOTCH/NOTCH(cleaved) -0.001 0.18 -10000 0 -0.48 24 24
HDAC1 0.033 0.013 -10000 0 -10000 0 0
AES 0.031 0.037 -10000 0 -0.48 1 1
FBXW11 0.036 0.004 -10000 0 -10000 0 0
DTX1 0.036 0.004 -10000 0 -10000 0 0
LRP6/FZD1 0.049 0.019 -10000 0 -10000 0 0
TLE1 0.005 0.12 -10000 0 -0.48 12 12
AP1 -0.13 0.17 -10000 0 -0.33 69 69
NCSTN 0.034 0.007 -10000 0 -10000 0 0
ADAM10 0.024 0.066 -10000 0 -0.37 5 5
Beta Catenin/TCF1/CtBP/CBP/TLE1/AES/SMAD4 0.016 0.11 -10000 0 -0.5 4 4
NICD/RBPSUH -0.029 0.16 -10000 0 -0.46 24 24
WIF1 -0.023 0.1 -10000 0 -0.2 51 51
NOTCH1 -0.029 0.18 -10000 0 -0.49 24 24
PSENEN 0.031 0.04 -10000 0 -0.34 2 2
KREMEN2 -0.071 0.18 -10000 0 -0.31 64 64
DKK1 -0.099 0.19 -10000 0 -0.32 79 79
beta catenin/beta TrCP1 0.07 0.11 0.29 5 -0.31 4 9
APH1B 0.02 0.073 -10000 0 -0.3 9 9
APH1A 0.003 0.11 -10000 0 -0.31 19 19
AXIN1 -0.028 0.11 -10000 0 -0.63 4 4
CtBP/CBP/TCF1/TLE1/AES 0.006 0.077 0.2 2 -0.26 10 12
PSEN1 0.032 0.019 -10000 0 -0.2 1 1
FOS -0.063 0.17 -10000 0 -0.32 56 56
JUN -0.017 0.15 -10000 0 -0.4 25 25
MAP3K7 0.032 0.037 -10000 0 -0.48 1 1
CTNNB1 0.056 0.11 0.29 5 -0.32 4 9
MAPK3 0.024 0.073 -10000 0 -0.43 5 5
DKK2/LRP6/Kremen 2 -0.053 0.15 -10000 0 -0.31 44 44
HNF1A 0 0.003 -10000 0 -10000 0 0
CTBP1 0.034 0.008 -10000 0 -10000 0 0
MYC -0.039 0.31 -10000 0 -1.4 10 10
NKD1 -0.14 0.22 -10000 0 -0.35 97 97
FZD1 0.035 0.006 -10000 0 -10000 0 0
NOTCH1 precursor/Deltex homolog 1 -0.003 0.18 -10000 0 -0.47 24 24
apoptosis -0.13 0.17 -10000 0 -0.33 69 69
Delta 1/NOTCHprecursor -0.005 0.18 -10000 0 -0.48 24 24
DLL1 0.031 0.04 -10000 0 -0.34 2 2
PPARD 0.032 0.06 -10000 0 -0.74 1 1
Gamma Secretase 0.05 0.099 -10000 0 -0.26 10 10
APC -0.058 0.15 -10000 0 -0.45 20 20
DVL1 0.002 0.1 -10000 0 -0.59 5 5
CSNK2A1 0.028 0.015 -10000 0 -10000 0 0
MAP3K7IP1 0.033 0.01 -10000 0 -10000 0 0
DKK1/LRP6/Kremen 2 -0.094 0.17 -10000 0 -0.33 57 57
LRP6 0.033 0.018 -10000 0 -0.2 1 1
CSNK1A1 0.035 0.006 -10000 0 -10000 0 0
NLK 0.025 0.028 -10000 0 -0.31 1 1
CCND1 0.006 0.21 -10000 0 -1.4 4 4
WNT1 0.035 0.005 -10000 0 -10000 0 0
Axin1/APC/beta catenin 0.01 0.14 0.42 1 -0.45 6 7
DKK2 -0.031 0.15 -10000 0 -0.31 40 40
NOTCH1 precursor/DVL1 -0.02 0.2 -10000 0 -0.58 17 17
GSK3B 0.033 0.036 -10000 0 -0.48 1 1
FRAT1 0.029 0.051 -10000 0 -0.48 2 2
NOTCH/Deltex homolog 1 0 0.18 -10000 0 -0.47 24 24
PPP2R5D 0.1 0.11 0.28 48 -0.24 1 49
MAPK1 0.034 0.008 -10000 0 -10000 0 0
WNT1/LRP6/FZD1 0.038 0.083 -10000 0 -10000 0 0
RBPJ 0 0 -10000 0 -10000 0 0
CREBBP 0.033 0.038 -10000 0 -0.49 1 1
BMP receptor signaling

Figure S27.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S27.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BMP7/BMPR2/BMPR1A-1B/FS -0.035 0.12 -9999 0 -0.26 31 31
SMAD6-7/SMURF1 0.044 0.046 -9999 0 -0.3 1 1
NOG 0.029 0.051 -9999 0 -0.48 2 2
SMAD9 -0.077 0.2 -9999 0 -0.52 32 32
SMAD4 0.017 0.063 -9999 0 -0.48 3 3
SMAD5 -0.038 0.12 -9999 0 -0.38 14 14
BMP7/USAG1 -0.14 0.2 -9999 0 -0.43 59 59
SMAD5/SKI -0.035 0.14 -9999 0 -0.42 12 12
SMAD1 0.007 0.11 -9999 0 -0.5 6 6
BMP2 -0.023 0.15 -9999 0 -0.44 22 22
SMAD1/SMAD1/SMAD4 0.012 0.097 -9999 0 -0.52 3 3
BMPR1A 0.032 0.037 -9999 0 -0.48 1 1
BMPR1B 0.032 0.029 -9999 0 -0.2 3 3
BMPR1A-1B/BAMBI -0.012 0.13 -9999 0 -0.3 30 30
AHSG 0.011 0.11 -9999 0 -0.48 10 10
CER1 0.031 0.04 -9999 0 -0.34 2 2
BMP2-4/CER1 -0.035 0.14 -9999 0 -0.31 38 38
BMP2-4/BMPR2/BMPR1A-1B/RGM/ENDOFIN/GADD34/PP1CA -0.037 0.13 -9999 0 -0.36 17 17
BMP2-4 (homodimer) -0.052 0.16 -9999 0 -0.37 37 37
RGMB -0.014 0.12 -9999 0 -0.26 34 34
BMP6/BMPR2/BMPR1A-1B 0.064 0.078 -9999 0 -0.27 7 7
RGMA 0.017 0.084 -9999 0 -0.38 8 8
SMURF1 0.034 0.008 -9999 0 -10000 0 0
BMP2-4/BMPR2/BMPR1A-1B/RGM/XIAP -0.055 0.13 -9999 0 -0.34 24 24
BMP2-4/USAG1 -0.14 0.19 -9999 0 -0.37 69 69
SMAD6/SMURF1/SMAD5 -0.033 0.14 -9999 0 -0.43 11 11
SOSTDC1 -0.16 0.22 -9999 0 -0.38 93 93
BMP7/BMPR2/BMPR1A-1B -0.036 0.11 -9999 0 -0.27 29 29
SKI 0.034 0.009 -9999 0 -10000 0 0
BMP6 (homodimer) 0.013 0.096 -9999 0 -0.33 13 13
HFE2 0.029 0.053 -9999 0 -0.39 3 3
ZFYVE16 0.035 0.006 -9999 0 -10000 0 0
MAP3K7 0.033 0.036 -9999 0 -0.48 1 1
BMP2-4/CHRD -0.03 0.14 -9999 0 -0.31 36 36
SMAD5/SMAD5/SMAD4 -0.037 0.14 -9999 0 -0.4 14 14
MAPK1 0.034 0.008 -9999 0 -10000 0 0
TAK1/TAB family -0.008 0.14 -9999 0 -0.34 14 14
BMP7 (homodimer) -0.091 0.18 -9999 0 -0.33 62 62
NUP214 0.034 0.017 -9999 0 -0.2 1 1
BMP6/FETUA 0.016 0.11 -9999 0 -0.37 15 15
SMAD1/SKI 0.017 0.11 -9999 0 -0.48 6 6
SMAD6 0.03 0.03 -9999 0 -0.2 3 3
CTDSP2 0.025 0.066 -9999 0 -0.37 5 5
BMP2-4/FETUA -0.044 0.16 -9999 0 -0.33 42 42
MAP3K7IP1 0.034 0.009 -9999 0 -10000 0 0
GREM1 -0.055 0.18 -9999 0 -0.39 43 43
BMPR2 (homodimer) 0.035 0.004 -9999 0 -10000 0 0
GADD34/PP1CA 0.062 0.039 -9999 0 -10000 0 0
BMPR1A-1B (homodimer) 0.045 0.039 -9999 0 -0.35 1 1
CHRDL1 0.022 0.073 -9999 0 -0.3 9 9
ENDOFIN/SMAD1 0.018 0.11 -9999 0 -0.48 6 6
SMAD6-7/SMURF1/SMAD1 0.03 0.11 -9999 0 -0.52 4 4
SMAD6/SMURF1 0.034 0.008 -9999 0 -10000 0 0
BAMBI -0.068 0.18 -9999 0 -0.35 56 56
SMURF2 0.021 0.066 -9999 0 -0.27 9 9
BMP2-4/CHRDL1 -0.04 0.15 -9999 0 -0.33 39 39
BMP2-4/GREM1 -0.087 0.17 -9999 0 -0.33 61 61
SMAD7 0.022 0.039 -9999 0 -0.48 1 1
SMAD8A/SMAD8A/SMAD4 -0.078 0.2 -9999 0 -0.48 35 35
SMAD1/SMAD6 0.018 0.11 -9999 0 -0.48 6 6
TAK1/SMAD6 0.047 0.031 -9999 0 -0.35 1 1
BMP7 -0.091 0.18 -9999 0 -0.33 62 62
BMP6 0.013 0.096 -9999 0 -0.33 13 13
MAP3K7IP2 0.035 0.006 -9999 0 -10000 0 0
BMP2-4/BMPR2/BMPR1A-1B/RGM/SMAD7/SMURF1 -0.054 0.14 -9999 0 -0.39 21 21
PPM1A 0.032 0.011 -9999 0 -10000 0 0
SMAD1/SMURF2 0.013 0.11 -9999 0 -0.49 6 6
SMAD7/SMURF1 0.033 0.037 -9999 0 -0.35 1 1
CTDSPL 0.016 0.091 -9999 0 -0.39 9 9
PPP1CA 0.03 0.037 -9999 0 -0.2 5 5
XIAP 0 0 -9999 0 -10000 0 0
CTDSP1 0.036 0.002 -9999 0 -10000 0 0
PPP1R15A 0.032 0.029 -9999 0 -0.2 3 3
BMP2-4/BMPR2/BMPR1A-1B/RGM/FS -0.056 0.14 -9999 0 -0.36 24 24
CHRD 0.036 0.004 -9999 0 -10000 0 0
BMPR2 0.035 0.004 -9999 0 -10000 0 0
BMP2-4/BMPR2/BMPR1A-1B/RGM -0.049 0.14 -9999 0 -0.36 21 21
BMP4 -0.047 0.17 -9999 0 -0.38 40 40
FST 0.016 0.096 -9999 0 -0.42 9 9
BMP2-4/NOG -0.034 0.14 -9999 0 -0.31 38 38
BMP7/BMPR2/BMPR1A-1B/SMAD6/SMURF1 -0.029 0.11 -9999 0 -0.26 28 28
amb2 Integrin signaling

Figure S28.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S28.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
alphaM/beta2 Integrin/proMMP-2 -0.036 0.16 -10000 0 -0.37 29 29
alphaM/beta2 Integrin/GPIbA -0.024 0.14 -10000 0 -0.34 23 23
alphaM/beta2 Integrin/proMMP-9 -0.031 0.12 -10000 0 -0.35 20 20
PLAUR 0.013 0.095 -10000 0 -0.34 12 12
HMGB1 0.008 0.049 -10000 0 -0.5 1 1
alphaM/beta2 Integrin/Talin -0.019 0.14 -10000 0 -0.34 23 23
AGER 0.01 0.042 -10000 0 -10000 0 0
RAP1A 0.034 0.008 -10000 0 -10000 0 0
SELPLG 0.013 0.096 -10000 0 -0.33 13 13
mol:LDL 0 0 -10000 0 -10000 0 0
alphaM/beta2 Integrin/RAGE/HMGB1 -0.04 0.15 -10000 0 -0.35 22 22
mol:GTP 0 0 -10000 0 -10000 0 0
MMP9 -0.006 0.09 -10000 0 -0.3 15 15
CYR61 -0.008 0.12 -10000 0 -0.31 26 26
TLN1 0.035 0.006 -10000 0 -10000 0 0
Rap1/GTP -0.011 0.14 -10000 0 -0.46 11 11
RHOA 0.035 0.004 -10000 0 -10000 0 0
P-selectin oligomer -0.057 0.18 -10000 0 -0.38 46 46
MYH2 -0.034 0.15 -10000 0 -0.55 12 12
MST1R 0.028 0.062 -10000 0 -0.48 3 3
leukocyte activation during inflammatory response -0.028 0.14 -10000 0 -0.3 30 30
APOB 0.002 0.13 -10000 0 -0.46 14 14
mol:GDP 0 0 -10000 0 -10000 0 0
complement component iC3b receptor activity 0 0 -10000 0 -10000 0 0
MMP2 0.005 0.11 -10000 0 -0.31 19 19
JAM3 0.027 0.043 -10000 0 -0.2 7 7
GP1BA 0.027 0.027 -10000 0 -0.2 2 2
alphaM/beta2 Integrin/CTGF -0.022 0.14 -10000 0 -0.35 23 23
alphaM/beta2 Integrin -0.035 0.15 -10000 0 -0.48 14 14
JAM3 homodimer 0.027 0.043 -10000 0 -0.2 7 7
ICAM2 0.011 0.099 -10000 0 -0.37 12 12
ICAM1 0.007 0.094 -10000 0 -0.26 20 20
phagocytosis triggered by activation of immune response cell surface activating receptor -0.035 0.15 -10000 0 -0.48 14 14
cell adhesion -0.024 0.14 -10000 0 -0.34 23 23
NFKB1 -0.071 0.22 0.3 1 -0.41 45 46
THY1 0.012 0.1 -10000 0 -0.37 12 12
RhoA/GDP 0.026 0.003 -10000 0 -10000 0 0
Lipoprotein(a) 0.02 0.081 -10000 0 -0.3 12 12
alphaM/beta2 Integrin/LRP/tPA -0.018 0.15 -10000 0 -0.33 27 27
IL6 -0.16 0.32 -10000 0 -0.67 52 52
ITGB2 -0.039 0.14 -10000 0 -0.34 29 29
elevation of cytosolic calcium ion concentration -0.037 0.18 -10000 0 -0.38 32 32
alphaM/beta2 Integrin/JAM2/JAM3 -0.033 0.18 -10000 0 -0.39 29 29
JAM2 -0.013 0.14 -10000 0 -0.39 23 23
alphaM/beta2 Integrin/ICAM1 -0.011 0.16 -10000 0 -0.33 30 30
alphaM/beta2 Integrin/uPA/Plg -0.031 0.17 -10000 0 -0.37 31 31
RhoA/GTP -0.026 0.15 -10000 0 -0.63 9 9
positive regulation of phagocytosis -0.042 0.14 -10000 0 -0.46 15 15
Ron/MSP 0.031 0.075 -10000 0 -0.35 5 5
alphaM/beta2 Integrin/uPAR/uPA -0.036 0.18 -10000 0 -0.39 32 32
alphaM/beta2 Integrin/uPAR -0.028 0.15 -10000 0 -0.32 31 31
PLAU -0.014 0.14 -10000 0 -0.35 26 26
PLAT 0.008 0.1 -10000 0 -0.41 11 11
actin filament polymerization -0.032 0.14 -10000 0 -0.52 12 12
MST1 0.015 0.076 -10000 0 -0.24 15 15
alphaM/beta2 Integrin/lipoprotein(a) -0.025 0.14 -10000 0 -0.31 30 30
TNF -0.074 0.21 0.29 1 -0.53 19 20
RAP1B 0.035 0.004 -10000 0 -10000 0 0
alphaM/beta2 Integrin/uPA -0.045 0.18 -10000 0 -0.39 33 33
fibrinolysis -0.032 0.17 -10000 0 -0.37 31 31
HCK -0.013 0.11 -10000 0 -0.35 17 17
dendritic cell antigen processing and presentation -0.035 0.15 -10000 0 -0.48 14 14
VTN 0.034 0.008 -10000 0 -10000 0 0
alphaM/beta2 Integrin/CYR61 -0.044 0.16 -10000 0 -0.36 33 33
LPA 0.031 0.013 -10000 0 -10000 0 0
LRP1 0.035 0.005 -10000 0 -10000 0 0
cell migration -0.041 0.13 -10000 0 -0.33 26 26
FN1 -0.016 0.13 -10000 0 -0.48 11 11
alphaM/beta2 Integrin/Thy1 -0.031 0.16 -10000 0 -0.39 25 25
MPO 0.021 0.056 -10000 0 -0.2 12 12
KNG1 0.003 0.11 -10000 0 -0.3 20 20
RAP1/GDP 0.045 0.014 -10000 0 -10000 0 0
ROCK1 -0.024 0.14 0.34 1 -0.58 9 10
ELA2 0.031 0.04 -10000 0 -0.34 2 2
PLG 0.032 0.036 -10000 0 -0.48 1 1
CTGF 0.029 0.037 -10000 0 -0.2 5 5
alphaM/beta2 Integrin/Hck -0.034 0.14 -10000 0 -0.36 23 23
ITGAM -0.016 0.11 -10000 0 -0.33 16 16
alphaM/beta2 Integrin/P-Selectin/PSGL1 -0.063 0.19 -10000 0 -0.36 46 46
HP 0.03 0.051 -10000 0 -0.48 2 2
leukocyte adhesion -0.043 0.2 -10000 0 -0.52 20 20
SELP -0.057 0.18 -10000 0 -0.38 46 46
TCR signaling in naïve CD8+ T cells

Figure S29.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S29.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
GRB2/SOS1/SHC -0.024 0.15 0.24 3 -0.43 16 19
FYN -0.064 0.19 0.38 1 -0.54 20 21
LAT/GRAP2/SLP76 -0.056 0.18 -10000 0 -0.45 25 25
IKBKB 0.031 0.012 -10000 0 -10000 0 0
AKT1 -0.062 0.15 0.24 3 -0.37 28 31
B2M 0.014 0.088 -10000 0 -0.35 10 10
IKBKG -0.019 0.05 0.13 2 -0.14 8 10
MAP3K8 0.005 0.11 -10000 0 -0.31 18 18
mol:Ca2+ -0.011 0.021 0.09 3 -0.061 9 12
integrin-mediated signaling pathway 0.036 0.048 -10000 0 -0.29 3 3
LAT/GRAP2/SLP76/VAV1/PI3K Class IA -0.084 0.21 0.27 3 -0.53 27 30
TRPV6 0.024 0.22 1.2 7 -10000 0 7
CD28 -0.001 0.12 -10000 0 -0.35 20 20
SHC1 -0.052 0.17 0.24 3 -0.44 24 27
receptor internalization -0.053 0.18 0.18 1 -0.52 21 22
PRF1 -0.065 0.22 -10000 0 -0.78 13 13
KRAS 0.033 0.018 -10000 0 -0.2 1 1
GRB2 0.034 0.008 -10000 0 -10000 0 0
COT/AKT1 -0.051 0.13 0.23 3 -0.31 29 32
LAT -0.059 0.18 0.24 1 -0.44 26 27
EntrezGene:6955 -0.001 0.003 -10000 0 -0.013 4 4
CD3D -0.004 0.13 -10000 0 -0.38 19 19
CD3E 0.033 0.019 -10000 0 -0.21 1 1
CD3G -0.026 0.15 -10000 0 -0.35 33 33
RASGRP2 0.002 0.033 0.073 1 -0.17 5 6
RASGRP1 -0.037 0.16 0.3 3 -0.4 21 24
HLA-A -0.001 0.12 -10000 0 -0.39 17 17
RASSF5 0.022 0.071 -10000 0 -0.31 8 8
RAP1A/GTP/RAPL 0.036 0.048 -10000 0 -0.3 3 3
mol:GTP 0 0 -10000 0 -10000 0 0
mol:GDP 0.01 0.062 0.19 4 -0.12 12 16
PDK1/CARD11/BCL10/MALT1/TRAF6 -0.042 0.07 -10000 0 -0.2 24 24
PRKCA 0 0.11 0.19 8 -0.26 16 24
GRAP2 0.019 0.083 -10000 0 -0.4 7 7
mol:IP3 -0.052 0.13 -10000 0 -0.37 21 21
EntrezGene:6957 -0.001 0.004 0.01 1 -0.011 9 10
TCR/CD3/MHC I/CD8 -0.044 0.16 -10000 0 -0.4 24 24
ORAI1 -0.022 0.19 0.36 3 -0.99 7 10
CSK -0.053 0.17 0.25 1 -0.44 24 25
B7 family/CD28 -0.062 0.23 -10000 0 -0.53 26 26
CHUK 0.027 0.062 -10000 0 -0.48 3 3
TCR/CD3/MHC I/CD8/LCK/ZAP-70 -0.064 0.2 -10000 0 -0.47 27 27
PTPN6 -0.062 0.18 0.2 1 -0.44 25 26
VAV1 -0.07 0.2 0.3 3 -0.48 29 32
Monovalent TCR/CD3 -0.033 0.15 -10000 0 -0.46 20 20
CBL 0.035 0.005 -10000 0 -10000 0 0
LCK -0.07 0.21 0.36 1 -0.5 27 28
PAG1 -0.047 0.18 0.2 10 -0.43 26 36
RAP1A 0.034 0.008 -10000 0 -10000 0 0
TCR/CD3/MHC I/CD8/LCK -0.064 0.2 0.26 1 -0.48 27 28
CD80 0.026 0.047 -10000 0 -0.21 8 8
CD86 -0.048 0.18 -10000 0 -0.38 42 42
PDK1/CARD11/BCL10/MALT1 -0.044 0.088 -10000 0 -0.23 25 25
HRAS 0.032 0.04 -10000 0 -0.34 2 2
GO:0035030 -0.078 0.17 -10000 0 -0.44 26 26
CD8A -0.001 0.004 0.01 1 -0.011 9 10
CD8B -0.001 0.004 0.012 1 -0.011 13 14
PTPRC -0.026 0.15 -10000 0 -0.37 31 31
PDK1/PKC theta -0.068 0.18 0.26 4 -0.45 25 29
CSK/PAG1 -0.044 0.17 0.2 1 -0.41 25 26
SOS1 0.036 0.002 -10000 0 -10000 0 0
peptide-MHC class I 0.007 0.12 -10000 0 -0.37 16 16
GRAP2/SLP76 -0.059 0.21 -10000 0 -0.49 27 27
STIM1 0.012 0.14 1.2 3 -10000 0 3
RAS family/GTP 0.006 0.076 0.21 3 -0.17 9 12
TCR/CD3/MHC I/CD8/LCK/ZAP-70/CBL/ubiquitin -0.055 0.19 0.18 1 -0.55 21 22
mol:DAG -0.054 0.11 -10000 0 -0.32 23 23
RAP1A/GDP 0.008 0.031 0.11 3 -0.066 3 6
PLCG1 0.019 0.018 -10000 0 -10000 0 0
CD247 -0.001 0.003 -10000 0 -0.013 4 4
cytotoxic T cell degranulation -0.062 0.21 -10000 0 -0.74 13 13
RAP1A/GTP 0.002 0.013 -10000 0 -0.065 5 5
mol:PI-3-4-5-P3 -0.069 0.17 0.26 3 -0.44 27 30
LAT/GRAP2/SLP76/VAV1/PLCgamma1 -0.064 0.16 -10000 0 -0.48 20 20
NRAS 0.019 0.079 -10000 0 -0.33 9 9
ZAP70 0.03 0.053 -10000 0 -0.39 3 3
GRB2/SOS1 0.051 0.012 -10000 0 -10000 0 0
LAT/GRAP2/SLP76/VAV1 -0.066 0.19 0.23 2 -0.47 25 27
MALT1 0.021 0.039 -10000 0 -0.48 1 1
TRAF6 0.036 0.004 -10000 0 -10000 0 0
CD8 heterodimer -0.001 0.006 0.021 1 -0.015 11 12
CARD11 -0.013 0.1 -10000 0 -0.22 37 37
PRKCB -0.041 0.076 -10000 0 -0.22 24 24
PRKCE 0.003 0.11 0.2 9 -0.26 16 25
PRKCQ -0.074 0.2 0.29 3 -0.5 27 30
LCP2 -0.027 0.16 -10000 0 -0.37 32 32
BCL10 0.033 0.036 -10000 0 -0.48 1 1
regulation of survival gene product expression -0.052 0.13 0.23 3 -0.32 28 31
IKK complex 0.019 0.068 0.14 20 -0.11 6 26
RAS family/GDP -0.005 0.014 -10000 0 -0.056 6 6
MAP3K14 -0.041 0.1 0.2 3 -0.24 28 31
PDPK1 -0.056 0.14 0.24 3 -0.35 26 29
TCR/CD3/MHC I/CD8/Fyn -0.055 0.18 -10000 0 -0.49 22 22
EPHB forward signaling

Figure S30.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S30.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Ephrin A5/EPHB2 0.019 0.088 -10000 0 -0.3 14 14
cell-cell adhesion 0.054 0.11 0.39 12 -10000 0 12
Ephrin B/EPHB2/RasGAP 0.014 0.13 -10000 0 -0.29 26 26
ITSN1 0.034 0.008 -10000 0 -10000 0 0
PIK3CA 0.035 0.006 -10000 0 -10000 0 0
SHC1 0.035 0.007 -10000 0 -10000 0 0
Ephrin B1/EPHB3 -0.007 0.13 -10000 0 -0.32 30 30
Ephrin B1/EPHB1 -0.022 0.11 -10000 0 -0.31 18 18
HRAS/GDP -0.031 0.13 -10000 0 -0.36 15 15
Ephrin B/EPHB1/GRB7 -0.011 0.12 -10000 0 -0.27 26 26
Endophilin/SYNJ1 0.02 0.12 0.2 1 -0.26 24 25
KRAS 0.033 0.018 -10000 0 -0.2 1 1
Ephrin B/EPHB1/Src -0.011 0.11 -10000 0 -0.31 16 16
endothelial cell migration 0.025 0.093 -10000 0 -0.27 15 15
GRB2 0.034 0.008 -10000 0 -10000 0 0
GRB7 0.028 0.051 -10000 0 -0.48 2 2
PAK1 0.023 0.13 0.36 1 -0.27 22 23
HRAS 0.032 0.04 -10000 0 -0.34 2 2
RRAS 0.023 0.13 0.2 3 -0.26 24 27
DNM1 0.029 0.037 -10000 0 -0.2 5 5
cell-cell signaling 0 0 -10000 0 -10000 0 0
CRK -0.013 0.12 -10000 0 -0.27 24 24
lamellipodium assembly -0.054 0.11 -10000 0 -0.39 12 12
Ephrin B/EPHB1/Src/p52 SHC/GRB2 -0.004 0.11 -10000 0 -0.5 4 4
PIK3R1 0.028 0.062 -10000 0 -0.48 3 3
EPHB2 0.004 0.12 -10000 0 -0.48 12 12
EPHB3 -0.043 0.18 -10000 0 -0.46 33 33
EPHB1 -0.064 0.16 -10000 0 -0.27 68 68
EPHB4 0.022 0.07 -10000 0 -0.32 7 7
mol:GDP -0.012 0.13 0.25 8 -0.38 15 23
Ephrin B/EPHB2 0.011 0.11 -10000 0 -0.27 24 24
Ephrin B/EPHB3 -0.008 0.13 -10000 0 -0.27 34 34
JNK cascade -0.056 0.13 0.31 2 -0.31 32 34
Ephrin B/EPHB1 -0.016 0.12 -10000 0 -0.28 24 24
RAP1/GDP -0.002 0.14 0.31 6 -0.35 14 20
EFNB2 -0.004 0.12 -10000 0 -0.46 13 13
EFNB3 0.029 0.014 -10000 0 -10000 0 0
EFNB1 0.028 0.058 -10000 0 -0.32 5 5
Ephrin B2/EPHB1-2 -0.04 0.13 -10000 0 -0.31 32 32
RAP1B 0.035 0.004 -10000 0 -10000 0 0
RAP1A 0.034 0.008 -10000 0 -10000 0 0
CDC42/GTP -0.042 0.14 -10000 0 -0.36 24 24
Rap1/GTP -0.047 0.12 -10000 0 -0.4 12 12
axon guidance 0.019 0.088 -10000 0 -0.3 14 14
MAPK3 -0.001 0.11 -10000 0 -0.49 4 4
MAPK1 0.003 0.1 -10000 0 -0.46 4 4
Rac1/GDP -0.015 0.13 0.28 5 -0.36 13 18
actin cytoskeleton reorganization -0.056 0.099 -10000 0 -0.33 13 13
CDC42/GDP -0.008 0.14 0.3 9 -0.35 15 24
PI3K 0.029 0.096 -10000 0 -0.27 15 15
EFNA5 0.028 0.054 -10000 0 -0.39 3 3
Ephrin B2/EPHB4 0.01 0.085 -10000 0 -0.3 13 13
Ephrin B/EPHB2/Intersectin/N-WASP -0.014 0.11 -10000 0 -0.27 23 23
CDC42 0.032 0.019 -10000 0 -0.2 1 1
RAS family/GTP -0.055 0.12 -10000 0 -0.38 14 14
PTK2 0.095 0.21 0.59 31 -10000 0 31
MAP4K4 -0.057 0.13 0.31 2 -0.31 32 34
SRC 0.011 0.062 -10000 0 -0.48 3 3
KALRN 0.035 0.004 -10000 0 -10000 0 0
Intersectin/N-WASP 0.047 0.031 -10000 0 -0.35 1 1
neuron projection morphogenesis -0.02 0.15 0.37 8 -0.38 10 18
MAP2K1 -0.005 0.1 -10000 0 -0.48 4 4
WASL 0.032 0.036 -10000 0 -0.48 1 1
Ephrin B1/EPHB1-2/NCK1 -0.02 0.15 -10000 0 -0.31 30 30
cell migration 0.022 0.14 0.26 9 -0.59 3 12
NRAS 0.019 0.079 -10000 0 -0.33 9 9
SYNJ1 0.02 0.12 0.2 1 -0.26 24 25
PXN 0.036 0.004 -10000 0 -10000 0 0
TF 0.001 0.12 0.18 43 -0.27 20 63
HRAS/GTP -0.037 0.13 -10000 0 -0.41 12 12
Ephrin B1/EPHB1-2 -0.025 0.13 -10000 0 -0.31 27 27
cell adhesion mediated by integrin -0.011 0.12 0.26 14 -0.2 40 54
RAC1 0.033 0.011 -10000 0 -10000 0 0
mol:GTP -0.037 0.14 -10000 0 -0.31 33 33
RAC1-CDC42/GTP -0.078 0.14 -10000 0 -0.4 25 25
RASA1 0.024 0.073 -10000 0 -0.43 5 5
RAC1-CDC42/GDP -0.008 0.13 0.28 5 -0.35 13 18
ruffle organization -0.025 0.16 0.33 11 -0.42 11 22
NCK1 0.026 0.071 -10000 0 -0.48 4 4
receptor internalization 0.002 0.12 0.18 39 -0.26 20 59
Ephrin B/EPHB2/KALRN 0.022 0.12 -10000 0 -0.28 24 24
ROCK1 -0.028 0.11 -10000 0 -0.29 30 30
RAS family/GDP -0.056 0.099 -10000 0 -0.35 12 12
Rac1/GTP -0.053 0.12 -10000 0 -0.41 12 12
Ephrin B/EPHB1/Src/Paxillin -0.018 0.1 -10000 0 -0.31 16 16
Signaling events mediated by Stem cell factor receptor (c-Kit)

Figure S31.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S31.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
MAP4K1 -0.05 0.15 -10000 0 -0.42 22 22
CRKL -0.053 0.15 -10000 0 -0.44 23 23
HRAS -0.035 0.16 -10000 0 -0.4 22 22
mol:PIP3 -0.049 0.15 -10000 0 -0.4 25 25
SPRED1 0.014 0.1 -10000 0 -0.48 8 8
SPRED2 0.031 0.051 -10000 0 -0.48 2 2
GAB1 -0.055 0.16 -10000 0 -0.46 23 23
FOXO3 -0.071 0.19 -10000 0 -0.44 33 33
AKT1 -0.078 0.2 -10000 0 -0.48 33 33
BAD -0.074 0.19 -10000 0 -0.44 34 34
megakaryocyte differentiation -0.099 0.18 -10000 0 -0.46 31 31
GSK3B -0.073 0.19 -10000 0 -0.46 27 27
RAF1 -0.029 0.13 0.25 1 -0.37 12 13
SHC1 0.035 0.007 -10000 0 -10000 0 0
STAT3 -0.05 0.15 -10000 0 -0.44 22 22
STAT1 -0.14 0.37 -10000 0 -1.1 25 25
HRAS/SPRED1 -0.026 0.14 -10000 0 -0.4 13 13
cell proliferation -0.049 0.15 -10000 0 -0.44 22 22
PIK3CA 0.035 0.006 -10000 0 -10000 0 0
TEC 0.035 0.006 -10000 0 -10000 0 0
RPS6KB1 -0.056 0.17 -10000 0 -0.45 28 28
HRAS/SPRED2 -0.02 0.14 -10000 0 -0.37 14 14
LYN/TEC/p62DOK -0.018 0.17 -10000 0 -0.42 22 22
MAPK3 -0.018 0.1 0.27 2 -0.29 12 14
STAP1 -0.051 0.16 -10000 0 -0.45 24 24
GRAP2 0.019 0.083 -10000 0 -0.4 7 7
JAK2 -0.1 0.31 -10000 0 -0.86 25 25
STAT1 (dimer) -0.13 0.37 -10000 0 -1 25 25
mol:Gleevec 0.002 0.007 -10000 0 -10000 0 0
GRB2/SOCS1/VAV1 -0.033 0.19 -10000 0 -0.49 23 23
actin filament polymerization -0.05 0.16 -10000 0 -0.44 24 24
LYN 0.03 0.013 -10000 0 -10000 0 0
STAP1/STAT5A (dimer) -0.074 0.22 -10000 0 -0.62 25 25
PIK3R1 0.028 0.062 -10000 0 -0.48 3 3
CBL/CRKL/GRB2 -0.024 0.16 -10000 0 -0.41 21 21
PI3K -0.031 0.18 -10000 0 -0.42 25 25
PTEN 0.026 0.062 -10000 0 -0.48 3 3
SCF/KIT/EPO/EPOR -0.13 0.44 -10000 0 -1.3 23 23
MAPK8 -0.05 0.16 -10000 0 -0.45 22 22
STAT3 (dimer) -0.049 0.15 -10000 0 -0.43 22 22
positive regulation of transcription -0.013 0.086 0.25 2 -0.24 10 12
mol:GDP -0.037 0.17 -10000 0 -0.44 21 21
PIK3C2B -0.054 0.16 -10000 0 -0.45 24 24
CBL/CRKL -0.038 0.16 -10000 0 -0.42 23 23
FER -0.058 0.16 -10000 0 -0.46 23 23
SH2B3 -0.051 0.16 -10000 0 -0.45 24 24
PDPK1 -0.045 0.14 -10000 0 -0.36 25 25
SNAI2 -0.062 0.17 -10000 0 -0.46 25 25
positive regulation of cell proliferation -0.091 0.27 -10000 0 -0.75 25 25
KITLG 0.009 0.084 -10000 0 -0.28 13 13
cell motility -0.091 0.27 -10000 0 -0.75 25 25
PTPN6 0.037 0.012 -10000 0 -10000 0 0
EPOR -0.005 0.13 -10000 0 -0.67 1 1
STAT5A (dimer) -0.073 0.23 -10000 0 -0.64 24 24
SOCS1 0.027 0.064 -10000 0 -0.41 4 4
cell migration 0.052 0.15 0.43 24 -10000 0 24
SOS1 0.036 0.002 -10000 0 -10000 0 0
EPO 0.025 0.032 -10000 0 -0.21 2 2
VAV1 -0.004 0.13 -10000 0 -0.42 18 18
GRB10 -0.066 0.16 -10000 0 -0.45 23 23
PTPN11 0.031 0.053 -10000 0 -0.38 3 3
SCF/KIT -0.052 0.17 -10000 0 -0.47 24 24
GO:0007205 0.003 0.009 -10000 0 -10000 0 0
MAP2K1 -0.024 0.1 0.23 1 -0.31 9 10
CBL 0.035 0.005 -10000 0 -10000 0 0
KIT -0.14 0.45 -10000 0 -1.4 24 24
MAP2K2 -0.022 0.11 0.29 3 -0.31 8 11
SHC/Grb2/SOS1 -0.01 0.17 -10000 0 -0.44 19 19
STAT5A -0.078 0.23 -10000 0 -0.66 24 24
GRB2 0.034 0.008 -10000 0 -10000 0 0
response to radiation -0.06 0.16 -10000 0 -0.46 24 24
SHC/GRAP2 0.038 0.064 -10000 0 -0.35 5 5
PTPRO -0.1 0.18 -10000 0 -0.47 31 31
SH2B2 -0.051 0.16 -10000 0 -0.45 24 24
DOK1 0.032 0.039 -10000 0 -0.34 2 2
MATK -0.053 0.16 -10000 0 -0.44 24 24
CREBBP 0.016 0.07 -10000 0 -0.28 3 3
BCL2 -0.24 0.47 -10000 0 -1.4 24 24
Canonical Wnt signaling pathway

Figure S32.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S32.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
HDAC1 0.05 0.041 0.21 5 -10000 0 5
AES 0.044 0.051 0.2 1 -0.49 1 2
FBXW11 0.036 0.004 -10000 0 -10000 0 0
mol:GTP 0.001 0.001 -10000 0 -10000 0 0
LRP6/FZD1 0.049 0.019 -10000 0 -10000 0 0
SMAD4 0.017 0.063 -10000 0 -0.48 3 3
DKK2 -0.031 0.15 -10000 0 -0.31 40 40
TLE1 0.019 0.13 0.2 2 -0.47 12 14
MACF1 0.036 0.004 -10000 0 -10000 0 0
CTNNB1 0.038 0.093 0.36 2 -10000 0 2
WIF1 -0.023 0.1 -10000 0 -0.2 51 51
beta catenin/RanBP3 0.086 0.18 0.42 42 -10000 0 42
KREMEN2 -0.071 0.18 -10000 0 -0.31 64 64
DKK1 -0.099 0.19 -10000 0 -0.32 79 79
beta catenin/beta TrCP1 0.054 0.094 0.36 2 -10000 0 2
FZD1 0.035 0.007 -10000 0 -10000 0 0
AXIN2 -0.26 0.63 0.64 8 -1.5 40 48
AXIN1 0.031 0.051 -10000 0 -0.48 2 2
RAN 0.036 0.004 -10000 0 -10000 0 0
Axin1/APC/GSK3/beta catenin 0.04 0.088 -10000 0 -0.62 2 2
beta catenin/TCF/CtBP/CBP/TLE1/AES/SMAD4 -0.053 0.19 0.29 1 -0.52 14 15
Axin1/APC/GSK3 0.062 0.08 0.27 2 -0.37 1 3
Axin1/APC/GSK3/beta catenin/Macf1 0.025 0.088 -10000 0 -0.42 1 1
HNF1A 0.014 0.036 0.16 6 -10000 0 6
CTBP1 0.048 0.037 0.2 5 -10000 0 5
MYC 0.012 0.44 0.63 28 -1.6 10 38
RANBP3 0.033 0.036 -10000 0 -0.47 1 1
DKK2/LRP6/Kremen 2 -0.052 0.15 -10000 0 -0.31 44 44
NKD1 -0.14 0.22 -10000 0 -0.35 97 97
TCF4 0.033 0.048 0.2 4 -0.19 2 6
TCF3 0.04 0.069 0.2 5 -0.44 3 8
WNT1/LRP6/FZD1/Axin1 0.08 0.047 -10000 0 -0.27 2 2
Ran/GTP 0.028 0.004 -10000 0 -10000 0 0
CtBP/CBP/TCF/TLE1/AES 0.048 0.24 0.48 41 -0.51 3 44
LEF1 0.016 0.12 0.21 1 -0.3 19 20
DVL1 0.029 0.08 0.23 1 -0.52 2 3
CSNK2A1 0.028 0.015 -10000 0 -10000 0 0
beta catenin/TCF/CtBP/CBP/TLE1/AES -0.04 0.15 0.31 1 -0.54 8 9
DKK1/LRP6/Kremen 2 -0.093 0.17 -10000 0 -0.33 57 57
LRP6 0.034 0.018 -10000 0 -0.2 1 1
CSNK1A1 0.051 0.04 0.21 5 -10000 0 5
NLK 0.029 0.021 -10000 0 -0.2 1 1
CCND1 -0.057 0.21 -10000 0 -1.3 4 4
WNT1 0.035 0.005 -10000 0 -10000 0 0
GSK3A 0.035 0.005 -10000 0 -10000 0 0
GSK3B 0.033 0.036 -10000 0 -0.48 1 1
FRAT1 0.029 0.051 -10000 0 -0.48 2 2
PPP2R5D 0.11 0.11 0.29 51 -0.24 1 52
APC 0.016 0.081 0.54 1 -0.26 9 10
WNT1/LRP6/FZD1 0.045 0.041 -10000 0 -10000 0 0
CREBBP 0.046 0.053 0.2 5 -0.49 1 6
PLK2 and PLK4 events

Figure S33.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S33.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PLK2 -0.013 0.14 -9999 0 -0.34 27 27
PLK4 0.029 0.053 -9999 0 -0.39 3 3
regulation of centriole replication -0.016 0.099 -9999 0 -0.36 14 14
Syndecan-2-mediated signaling events

Figure S34.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S34.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Syndecan-2/Fibronectin -0.013 0.12 -10000 0 -0.39 14 14
EPHB2 0.004 0.12 -10000 0 -0.48 12 12
Syndecan-2/TACI 0.008 0.07 -10000 0 -0.28 10 10
LAMA1 0.026 0.016 -10000 0 -10000 0 0
Syndecan-2/alpha2 ITGB1 0.007 0.1 -10000 0 -0.26 18 18
HRAS 0.032 0.04 -10000 0 -0.34 2 2
Syndecan-2/CASK -0.006 0.063 -10000 0 -0.28 10 10
ITGA5 0.025 0.049 -10000 0 -0.2 9 9
BAX -0.011 0.097 -10000 0 -1.1 1 1
EPB41 0.028 0.046 -10000 0 -0.27 4 4
positive regulation of cell-cell adhesion 0.012 0.064 -10000 0 -0.25 10 10
LAMA3 0.004 0.087 -10000 0 -0.28 15 15
EZR 0 0 -10000 0 -10000 0 0
mol:PI-4-5-P2 0 0 -10000 0 -10000 0 0
CAV2 -0.01 0.13 -10000 0 -0.32 26 26
Syndecan-2/MMP2 0.001 0.1 -10000 0 -0.32 15 15
RP11-540L11.1 0 0 -10000 0 -10000 0 0
alpha2 ITGB1 0.034 0.078 -10000 0 -0.35 7 7
dendrite morphogenesis -0.005 0.096 -10000 0 -0.28 21 21
Syndecan-2/GM-CSF -0.04 0.13 -10000 0 -0.3 32 32
determination of left/right symmetry -0.006 0.076 -10000 0 -0.33 10 10
Syndecan-2/PKC delta 0.014 0.071 -10000 0 -0.28 10 10
GNB2L1 0.035 0.006 -10000 0 -10000 0 0
MAPK3 -0.026 0.14 0.2 24 -0.29 32 56
MAPK1 -0.02 0.13 0.2 23 -0.28 30 53
Syndecan-2/RACK1 0.026 0.074 -10000 0 -0.27 9 9
NF1 0.034 0.008 -10000 0 -10000 0 0
FGFR/FGF/Syndecan-2 -0.006 0.076 -10000 0 -0.33 10 10
ITGA2 0.012 0.1 -10000 0 -0.41 11 11
MAPK8 -0.005 0.07 -10000 0 -0.3 10 10
Syndecan-2/alpha2/beta1 Integrin 0.021 0.089 -10000 0 -0.25 15 15
Syndecan-2/Kininogen -0.003 0.091 -10000 0 -0.29 16 16
ITGB1 0.034 0.017 -10000 0 -0.2 1 1
SRC 0.009 0.063 -10000 0 -0.26 6 6
Syndecan-2/CASK/Protein 4.1 0.009 0.067 -10000 0 -0.25 11 11
extracellular matrix organization 0.013 0.07 -10000 0 -0.28 10 10
actin cytoskeleton reorganization -0.012 0.12 -10000 0 -0.38 14 14
Syndecan-2/Caveolin-2/Ras 0.004 0.11 -10000 0 -0.33 15 15
Syndecan-2/Laminin alpha3 -0.005 0.082 -10000 0 -0.28 13 13
Syndecan-2/RasGAP 0.034 0.083 -10000 0 -0.26 11 11
alpha5/beta1 Integrin 0.043 0.041 -10000 0 -10000 0 0
PRKCD 0.035 0.004 -10000 0 -10000 0 0
Syndecan-2 dimer -0.005 0.097 -10000 0 -0.28 21 21
GO:0007205 0.002 0.012 -10000 0 -10000 0 0
DNA mediated transformation 0 0 -10000 0 -10000 0 0
Syndecan-2/RasGAP/Src 0.01 0.058 -10000 0 -0.26 6 6
RHOA 0.035 0.004 -10000 0 -10000 0 0
SDCBP 0.03 0.02 -10000 0 -0.2 1 1
TNFRSF13B 0.028 0.022 -10000 0 -0.2 1 1
RASA1 0.024 0.073 -10000 0 -0.43 5 5
alpha2/beta1 Integrin 0.034 0.078 -10000 0 -0.35 7 7
Syndecan-2/Synbindin 0.013 0.07 -10000 0 -0.28 10 10
TGFB1 0.034 0.017 -10000 0 -0.2 1 1
CASP3 0.024 0.09 0.2 25 -0.26 10 35
FN1 -0.016 0.13 -10000 0 -0.48 11 11
Syndecan-2/IL8 -0.073 0.15 -10000 0 -0.32 47 47
SDC2 -0.006 0.076 -10000 0 -0.33 10 10
KNG1 0.003 0.11 -10000 0 -0.3 20 20
Syndecan-2/Neurofibromin 0.014 0.067 -10000 0 -0.28 9 9
TRAPPC4 0.035 0.005 -10000 0 -10000 0 0
CSF2 -0.068 0.18 -10000 0 -0.32 60 60
Syndecan-2/TGFB1 0.013 0.071 -10000 0 -0.28 10 10
Syndecan-2/Syntenin/PI-4-5-P2 0.012 0.064 -10000 0 -0.25 10 10
Syndecan-2/Ezrin 0.013 0.064 -10000 0 -0.25 10 10
PRKACA 0.032 0.091 0.2 31 -0.26 8 39
angiogenesis -0.073 0.15 -10000 0 -0.32 47 47
MMP2 0.005 0.11 -10000 0 -0.31 19 19
IL8 -0.14 0.22 -10000 0 -0.36 90 90
calcineurin-NFAT signaling pathway 0.008 0.069 -10000 0 -0.27 10 10
Visual signal transduction: Rods

Figure S35.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S35.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
mol:K + 0.03 0.04 -10000 0 -0.34 2 2
GNAT1/GTP 0.022 0.025 -10000 0 -10000 0 0
Metarhodopsin II/Arrestin 0.039 0.044 -10000 0 -0.3 2 2
PDE6G/GNAT1/GTP 0.042 0.028 -10000 0 -10000 0 0
mol:GTP 0 0 -10000 0 -10000 0 0
absorption of light 0 0 -10000 0 -10000 0 0
GNAT1 0.03 0.037 -10000 0 -0.2 5 5
GRK1 0 0 -10000 0 -10000 0 0
CNG Channel -0.054 0.15 -10000 0 -0.4 10 10
mol:Na + -0.036 0.15 -10000 0 -0.38 13 13
mol:ADP 0 0 -10000 0 -10000 0 0
RGS9-1/Gbeta5/R9AP 0.01 0.12 -10000 0 -0.3 20 20
mol:GDP 0 0 -10000 0 -10000 0 0
cGMP/CNG Channel -0.029 0.16 -10000 0 -0.38 13 13
CNGB1 0.036 0.002 -10000 0 -10000 0 0
RDH5 0.017 0.091 -10000 0 -0.39 9 9
SAG 0.021 0.068 -10000 0 -0.26 10 10
mol:Ca2+ -0.071 0.13 0.33 5 -0.37 13 18
Na + (4 Units) -0.04 0.14 -10000 0 -0.36 13 13
RGS9 0.025 0.051 -10000 0 -0.25 6 6
GNB1/GNGT1 -0.11 0.17 -10000 0 -0.35 64 64
GNAT1/GDP 0.019 0.11 -10000 0 -0.26 19 19
GUCY2D 0.028 0.021 -10000 0 -0.2 1 1
GNGT1 -0.17 0.23 -10000 0 -0.38 103 103
GUCY2F 0.015 0.1 -10000 0 -0.45 9 9
GNB5 -0.004 0.13 -10000 0 -0.38 19 19
mol:GMP (4 units) -0.012 0.099 -10000 0 -0.27 22 22
mol:11-cis-retinal 0.017 0.091 -10000 0 -0.39 9 9
mol:cGMP 0.031 0.1 -10000 0 -0.28 17 17
GNB1 0.034 0.008 -10000 0 -10000 0 0
Rhodopsin 0.037 0.071 -10000 0 -0.35 6 6
SLC24A1 0.03 0.04 -10000 0 -0.34 2 2
CNGA1 -0.085 0.2 -10000 0 -0.37 62 62
Metarhodopsin II 0.023 0.002 -10000 0 -10000 0 0
mol:Ca ++ 0 0 -10000 0 -10000 0 0
GC1/GCAP Family 0.05 0.087 -10000 0 -0.28 9 9
RGS9BP 0.007 0.1 -10000 0 -0.3 17 17
Metarhodopsin II/Transducin -0.072 0.12 -10000 0 -0.24 64 64
GCAP Family/Ca ++ 0.045 0.077 -10000 0 -0.28 9 9
PDE6A/B -0.014 0.13 -10000 0 -0.34 23 23
mol:Pi 0.009 0.12 -10000 0 -0.3 20 20
mol:all-trans-retinal 0 0 -10000 0 -10000 0 0
Transducin -0.073 0.15 -10000 0 -0.27 65 65
PDE6B 0.019 0.075 -10000 0 -0.29 10 10
PDE6A -0.031 0.16 -10000 0 -0.36 35 35
PDE6G 0.034 0.018 -10000 0 -0.2 1 1
RHO 0.036 0.004 -10000 0 -10000 0 0
PDE6 -0.016 0.15 -10000 0 -0.36 6 6
GUCA1A 0.033 0.024 -10000 0 -0.2 2 2
GC2/GCAP Family 0.052 0.11 -10000 0 -0.29 17 17
GUCA1C 0.011 0.1 -10000 0 -0.39 12 12
GUCA1B 0.029 0.046 -10000 0 -0.27 4 4
Signaling events mediated by the Hedgehog family

Figure S36.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S36.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TGFB2 0.015 0.12 -10000 0 -0.55 6 6
IHH 0.025 0.095 -10000 0 -0.53 5 5
SHH Np/Cholesterol/GAS1 -0.071 0.14 -10000 0 -0.31 42 42
LRPAP1 0.035 0.007 -10000 0 -10000 0 0
dorsoventral neural tube patterning 0.071 0.14 0.31 42 -10000 0 42
SMO/beta Arrestin2 0.003 0.12 -10000 0 -0.37 12 12
SMO -0.007 0.12 -10000 0 -0.4 11 11
AKT1 -0.013 0.15 -10000 0 -0.4 21 21
ARRB2 0.027 0.038 -10000 0 -0.48 1 1
BOC 0.026 0.054 -10000 0 -0.24 7 7
ADRBK1 0.036 0.004 -10000 0 -10000 0 0
heart looping -0.008 0.12 -10000 0 -0.39 12 12
STIL -0.003 0.1 -10000 0 -0.28 10 10
DHH N/PTCH2 0.051 0.01 -10000 0 -10000 0 0
DHH N/PTCH1 0.028 0.076 -10000 0 -0.3 9 9
PIK3CA 0.035 0.006 -10000 0 -10000 0 0
DHH 0.035 0.005 -10000 0 -10000 0 0
PTHLH 0.004 0.17 -10000 0 -0.86 6 6
determination of left/right symmetry -0.008 0.12 -10000 0 -0.39 12 12
PIK3R1 0.028 0.062 -10000 0 -0.48 3 3
skeletal system development 0.004 0.16 -10000 0 -0.85 6 6
IHH N/Hhip -0.017 0.16 -10000 0 -0.4 28 28
DHH N/Hhip -0.008 0.13 -10000 0 -0.35 25 25
mol:Cholesterol 0 0 -10000 0 -10000 0 0
heart development -0.008 0.12 -10000 0 -0.39 12 12
pancreas development -0.039 0.17 -10000 0 -0.4 35 35
HHAT -0.001 0.12 -10000 0 -0.4 17 17
PI3K 0.045 0.049 -10000 0 -0.35 3 3
EntrezGene:84976 0 0 -10000 0 -10000 0 0
GAS1 -0.12 0.2 -10000 0 -0.33 87 87
somite specification -0.008 0.12 -10000 0 -0.39 12 12
SHH Np/Cholesterol/PTCH1 -0.004 0.091 -10000 0 -0.25 22 22
SHH Np/Cholesterol/PTCH2 0.01 0.079 -10000 0 -0.28 13 13
SHH Np/Cholesterol/Megalin 0.009 0.08 -10000 0 -0.28 13 13
SHH -0.01 0.094 -10000 0 -0.36 13 13
catabolic process 0.008 0.079 -10000 0 -0.33 9 9
SMO/Vitamin D3 -0.012 0.11 -10000 0 -0.33 13 13
SHH Np/Cholesterol/Hhip -0.032 0.13 -10000 0 -0.31 33 33
LRP2 0.033 0.024 -10000 0 -0.2 2 2
receptor-mediated endocytosis -0.011 0.11 -10000 0 -0.32 13 13
SHH Np/Cholesterol/BOC 0.005 0.081 -10000 0 -0.28 13 13
SHH Np/Cholesterol/CDO 0.008 0.079 -10000 0 -0.28 13 13
mesenchymal cell differentiation 0.032 0.13 0.31 33 -10000 0 33
mol:Vitamin D3 0.005 0.1 0.21 3 -0.25 22 25
IHH N/PTCH2 0.044 0.063 -10000 0 -0.32 5 5
CDON 0.033 0.024 -10000 0 -0.2 2 2
IHH N/PTCH1 0.027 0.084 -10000 0 -0.33 9 9
Megalin/LRPAP1 0.049 0.022 -10000 0 -10000 0 0
PTCH2 0.035 0.005 -10000 0 -10000 0 0
SHH Np/Cholesterol -0.003 0.074 -10000 0 -0.27 13 13
PTCH1 0.008 0.079 -10000 0 -0.33 9 9
HHIP -0.039 0.17 -10000 0 -0.4 35 35
Cellular roles of Anthrax toxin

Figure S37.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S37.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
ANTXR1 -0.016 0.14 -10000 0 -0.35 28 28
ANTXR2 0.014 0.086 -10000 0 -0.28 14 14
negative regulation of myeloid dendritic cell antigen processing and presentation -0.009 0.02 -10000 0 -0.067 18 18
monocyte activation -0.006 0.12 -10000 0 -0.4 15 15
MAP2K2 0.003 0.094 -10000 0 -0.59 5 5
MAP2K1 -0.009 0.017 -10000 0 -10000 0 0
MAP2K7 -0.012 0.027 -10000 0 -0.14 4 4
MAP2K6 -0.021 0.056 0.13 1 -0.24 11 12
CYAA -0.036 0.076 -10000 0 -0.26 18 18
MAP2K4 -0.01 0.028 -10000 0 -0.25 2 2
IL1B -0.062 0.094 -10000 0 -0.24 38 38
Channel 0.001 0.099 -10000 0 -0.28 18 18
NLRP1 -0.008 0.018 -10000 0 -0.062 18 18
CALM1 0.032 0.011 -10000 0 -10000 0 0
negative regulation of phagocytosis -0.038 0.14 -10000 0 -0.42 22 22
mol:Ca2+ 0 0 -10000 0 -10000 0 0
regulation of endothelial cell proliferation 0.009 0.02 0.067 18 -10000 0 18
MAPK3 -0.015 0.041 0.13 1 -0.23 5 6
MAPK1 -0.01 0.019 -10000 0 -0.11 2 2
PGR -0.012 0.026 -10000 0 -0.18 2 2
PA/Cellular Receptors -0.001 0.11 -10000 0 -0.31 18 18
apoptosis -0.009 0.02 -10000 0 -0.067 18 18
LOC728358 0 0 -10000 0 -10000 0 0
Lethal toxin (unfolded) 0.003 0.093 -10000 0 -0.27 18 18
macrophage activation -0.012 0.047 0.16 5 -0.26 4 9
TNF 0.023 0.066 -10000 0 -0.27 9 9
VCAM1 -0.007 0.12 -10000 0 -0.41 15 15
platelet activation -0.038 0.14 -10000 0 -0.42 22 22
MAPKKK cascade 0.01 0.03 0.094 6 -0.1 2 8
IL18 -0.045 0.081 -10000 0 -0.25 23 23
negative regulation of macrophage activation -0.009 0.02 -10000 0 -0.067 18 18
LEF -0.009 0.02 -10000 0 -0.068 18 18
CASP1 -0.019 0.034 -10000 0 -0.077 50 50
mol:cAMP -0.038 0.14 -10000 0 -0.42 22 22
necrosis -0.009 0.02 -10000 0 -0.067 18 18
intracellular pH reduction 0 0 -10000 0 -10000 0 0
PAGA 0 0 -10000 0 -10000 0 0
Edema toxin (unfolded) 0.002 0.094 -10000 0 -0.26 18 18
mol:Epigallocatechin-3-gallate (EGCG) 0 0 -10000 0 -10000 0 0
Arf6 signaling events

Figure S38.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S38.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CENTA1/KIF3B 0.018 0.024 -10000 0 -0.29 1 1
ARNO/beta Arrestin1-2 -0.001 0.09 -10000 0 -0.24 21 21
EGFR 0.016 0.09 -10000 0 -0.41 8 8
EPHA2 0.011 0.088 -10000 0 -0.28 15 15
USP6 0.03 0.014 -10000 0 -10000 0 0
IQSEC1 0.034 0.017 -10000 0 -0.2 1 1
EGFR/EGFR/EGF/EGF -0.054 0.15 -10000 0 -0.35 34 34
ARRB2 0.009 0.049 -10000 0 -0.36 3 3
mol:GTP 0.006 0.022 0.11 6 -10000 0 6
ARRB1 0.015 0.1 -10000 0 -0.45 9 9
FBXO8 0.034 0.008 -10000 0 -10000 0 0
TSHR 0.03 0.037 -10000 0 -0.48 1 1
EGF -0.088 0.19 -10000 0 -0.32 72 72
somatostatin receptor activity 0 0 0.001 10 -0.001 16 26
ARAP2 0 0 0 10 0 13 23
mol:GDP 0.001 0.076 0.15 2 -0.25 10 12
mol:PI-3-4-5-P3 0 0 0 7 -0.001 14 21
ITGA2B 0.035 0.006 -10000 0 -10000 0 0
ARF6 0.028 0.051 -10000 0 -0.48 2 2
Ephrin A1/EPHA2/NCK1/GIT1 0.047 0.097 -10000 0 -0.29 11 11
ADAP1 0 0 0 6 0 3 9
KIF13B 0.026 0.038 -10000 0 -0.48 1 1
HGF/MET 0.042 0.057 -10000 0 -0.38 3 3
PXN 0.036 0.004 -10000 0 -10000 0 0
ARF6/GTP -0.003 0.1 0.2 7 -0.23 17 24
EGFR/EGFR/EGF/EGF/ARFGEP100 -0.031 0.14 -10000 0 -0.3 34 34
ADRB2 -0.002 0.13 -10000 0 -0.39 18 18
receptor agonist activity 0 0 0 5 0 8 13
actin filament binding 0 0 0 10 0 16 26
SRC 0.011 0.062 -10000 0 -0.48 3 3
ITGB3 0.033 0.018 -10000 0 -0.2 1 1
GNAQ 0 0 0.001 12 -0.001 8 20
EFA6/PI-4-5-P2 0 0 0.001 13 -0.001 7 20
ARF6/GDP -0.018 0.11 0.2 1 -0.28 22 23
ARF6/GDP/GULP/ACAP1 -0.013 0.12 -10000 0 -0.27 21 21
alphaIIb/beta3 Integrin/paxillin/GIT1 0.083 0.031 -10000 0 -10000 0 0
ACAP1 0 0 0 1 -10000 0 1
ACAP2 0 0 0 8 0 14 22
LHCGR/beta Arrestin2 0.011 0.06 -10000 0 -0.36 3 3
EFNA1 0.021 0.076 -10000 0 -0.36 7 7
HGF 0.03 0.043 -10000 0 -0.3 3 3
CYTH3 0 0 0.001 10 -0.001 10 20
CYTH2 -0.001 0.001 -10000 0 -0.004 21 21
NCK1 0.026 0.071 -10000 0 -0.48 4 4
fibronectin binding 0 0 0 7 0 16 23
endosomal lumen acidification 0 0 0 12 0 11 23
microtubule-based process 0 0 -10000 0 -10000 0 0
GULP1 -0.046 0.17 -10000 0 -0.34 45 45
GNAQ/ARNO 0 0.003 0.008 12 -0.006 8 20
mol:Phosphatidic acid 0 0 0 8 0 14 22
PIP3-E 0.011 0.11 -10000 0 -0.46 10 10
MET 0.027 0.056 -10000 0 -0.34 4 4
GNA14 -0.021 0.15 -10000 0 -0.37 29 29
GNA15 0.02 0.068 -10000 0 -0.26 10 10
GIT1 0.033 0.018 -10000 0 -0.2 1 1
mol:PI-4-5-P2 0 0 0.001 12 -0.001 9 21
GNA11 0.028 0.054 -10000 0 -0.39 3 3
LHCGR 0.025 0.062 -10000 0 -0.28 7 7
AGTR1 0.013 0.071 -10000 0 -0.2 20 20
desensitization of G-protein coupled receptor protein signaling pathway 0.011 0.059 -10000 0 -0.36 3 3
IPCEF1/ARNO -0.03 0.12 -10000 0 -0.23 41 41
alphaIIb/beta3 Integrin 0.05 0.018 -10000 0 -10000 0 0
IFN-gamma pathway

Figure S39.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S39.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
IFN-gamma/IFN-gammaR/JAK1/JAK1/JAK2/JAK2 -0.026 0.14 -10000 0 -0.25 41 41
positive regulation of NF-kappaB transcription factor activity 0 0 -10000 0 -10000 0 0
CRKL 0.029 0.051 -10000 0 -0.48 2 2
STAT1 (dimer)/Cbp/p300 -0.049 0.16 -10000 0 -0.38 21 21
IFN-gammaR/JAK1/JAK1/JAK2/JAK2 0.021 0.082 -10000 0 -0.31 4 4
antigen processing and presentation of peptide antigen via MHC class I -0.066 0.12 -10000 0 -0.29 22 22
CaM/Ca2+ -0.026 0.13 -10000 0 -0.25 30 30
RAP1A 0.034 0.008 -10000 0 -10000 0 0
STAT1 (dimer)/SHP2 -0.049 0.13 -10000 0 -0.26 45 45
AKT1 -0.054 0.11 -10000 0 -0.36 6 6
MAP2K1 -0.06 0.1 -10000 0 -0.29 7 7
MAP3K11 -0.051 0.12 -10000 0 -0.24 37 37
IFNGR1 0.016 0.046 -10000 0 -0.45 1 1
mol:GTP 0 0 -10000 0 -10000 0 0
CaM/Ca2+/CAMKII -0.009 0.11 -10000 0 -0.42 6 6
Rap1/GTP -0.043 0.096 -10000 0 -0.32 4 4
CRKL/C3G 0.046 0.041 -10000 0 -0.35 2 2
IFN-gamma/IFN-gammaR/JAK1/JAK1/JAK2/JAK2 /TC-PTP -0.028 0.14 -10000 0 -0.26 38 38
CEBPB -0.016 0.16 -10000 0 -0.54 6 6
STAT3 0.034 0.007 -10000 0 -10000 0 0
IFN-gamma/IFN-gammaR/JAK1/JAK1/JAK2/JAK2/SOCS1 -0.007 0.22 -10000 0 -1.2 5 5
STAT1 -0.06 0.12 -10000 0 -0.27 31 31
CALM1 0.032 0.011 -10000 0 -10000 0 0
IFN-gamma (dimer) -0.11 0.2 -10000 0 -0.34 80 80
PIK3CA 0.035 0.006 -10000 0 -10000 0 0
STAT1 (dimer)/PIAS1 -0.048 0.13 -10000 0 -0.3 13 13
CEBPB/PTGES2/Cbp/p300 -0.012 0.12 -10000 0 -0.36 6 6
mol:Ca2+ -0.027 0.14 -10000 0 -0.25 41 41
MAPK3 -0.054 0.16 -10000 0 -0.8 5 5
STAT1 (dimer) -0.084 0.16 -10000 0 -0.42 21 21
MAPK1 -0.069 0.19 -10000 0 -0.77 10 10
JAK2 0.001 0.083 -10000 0 -0.29 12 12
PIK3R1 0.028 0.062 -10000 0 -0.48 3 3
JAK1 0.016 0.047 -10000 0 -0.48 1 1
CAMK2D 0.033 0.036 -10000 0 -0.48 1 1
DAPK1 -0.01 0.14 -10000 0 -0.54 5 5
SMAD7 -0.03 0.063 -10000 0 -0.19 5 5
CBL/CRKL/C3G -0.025 0.13 -10000 0 -0.36 4 4
PI3K -0.023 0.14 -10000 0 -0.29 17 17
IFNG -0.11 0.2 -10000 0 -0.34 80 80
apoptosis -0.029 0.14 -10000 0 -0.42 12 12
CAMK2G 0.035 0.007 -10000 0 -10000 0 0
STAT3 (dimer) 0.034 0.007 -10000 0 -10000 0 0
CAMK2A 0.034 0.017 -10000 0 -0.2 1 1
CAMK2B 0.026 0.049 -10000 0 -0.26 5 5
FRAP1 -0.056 0.1 -10000 0 -0.35 7 7
PRKCD -0.054 0.11 -10000 0 -0.36 6 6
RAP1B 0.035 0.004 -10000 0 -10000 0 0
negative regulation of cell growth -0.066 0.12 -10000 0 -0.29 22 22
PTPN2 0.027 0.015 -10000 0 -10000 0 0
EP300 0.018 0.088 -10000 0 -0.44 7 7
IRF1 -0.073 0.17 0.28 1 -0.48 18 19
STAT1 (dimer)/PIASy -0.05 0.13 -10000 0 -0.3 13 13
SOCS1 0.007 0.2 -10000 0 -1.3 5 5
mol:GDP -0.026 0.12 -10000 0 -0.35 4 4
CASP1 -0.068 0.11 -10000 0 -0.26 43 43
PTGES2 0.035 0.005 -10000 0 -10000 0 0
IRF9 -0.003 0.057 -10000 0 -0.18 1 1
mol:PI-3-4-5-P3 -0.034 0.12 -10000 0 -0.27 20 20
RAP1/GDP -0.024 0.11 -10000 0 -0.39 2 2
CBL -0.05 0.12 -10000 0 -0.25 36 36
MAP3K1 -0.053 0.11 -10000 0 -0.24 36 36
PIAS1 0.034 0.009 -10000 0 -10000 0 0
PIAS4 0.031 0.04 -10000 0 -0.34 2 2
antigen processing and presentation of peptide antigen via MHC class II -0.066 0.12 -10000 0 -0.29 22 22
PTPN11 -0.053 0.12 -10000 0 -0.25 41 41
CREBBP 0.032 0.036 -10000 0 -0.48 1 1
RAPGEF1 0.035 0.004 -10000 0 -10000 0 0
S1P1 pathway

Figure S40.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S40.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
VEGFR2 homodimer/VEGFA homodimer 0.011 0.079 -10000 0 -0.29 12 12
PDGFRB 0.034 0.037 -10000 0 -0.48 1 1
SPHK1 -0.09 0.25 -10000 0 -0.74 25 25
mol:S1P -0.065 0.22 -10000 0 -0.63 25 25
S1P1/S1P/Gi -0.058 0.2 -10000 0 -0.46 28 28
GNAO1 0.031 0.018 -10000 0 -10000 0 0
PDGFB-D/PDGFRB/PLCgamma1 -0.002 0.19 0.28 3 -0.41 21 24
PLCG1 -0.018 0.19 -10000 0 -0.45 19 19
mol:GTP 0 0 -10000 0 -10000 0 0
PDGFB-D/PDGFRB 0.034 0.037 -10000 0 -0.48 1 1
GNAI2 0.019 0.075 -10000 0 -0.44 5 5
GNAI3 0.027 0.053 -10000 0 -0.48 2 2
GNAI1 -0.017 0.14 -10000 0 -0.4 23 23
mol:GDP 0 0 -10000 0 -10000 0 0
EDG1 -0.016 0.14 -10000 0 -0.54 12 12
S1P1/S1P -0.057 0.22 -10000 0 -0.58 23 23
negative regulation of cAMP metabolic process -0.056 0.19 -10000 0 -0.45 28 28
MAPK3 -0.094 0.25 0.27 1 -0.6 32 33
calcium-dependent phospholipase C activity -0.001 0.004 -10000 0 -10000 0 0
Rac1/GDP 0.024 0.008 -10000 0 -10000 0 0
RhoA/GDP 0.026 0.003 -10000 0 -10000 0 0
KDR 0.022 0.063 -10000 0 -0.21 12 12
PLCB2 -0.05 0.19 -10000 0 -0.5 23 23
RAC1 0.033 0.011 -10000 0 -10000 0 0
RhoA/GTP -0.05 0.18 -10000 0 -0.48 23 23
receptor internalization -0.052 0.2 -10000 0 -0.53 23 23
PTGS2 -0.15 0.38 -10000 0 -1 29 29
Rac1/GTP -0.051 0.17 -10000 0 -0.47 23 23
RHOA 0.035 0.004 -10000 0 -10000 0 0
VEGFA -0.007 0.039 -10000 0 -0.14 15 15
negative regulation of T cell proliferation -0.056 0.19 -10000 0 -0.45 28 28
GO:0007205 0 0 -10000 0 -10000 0 0
GNAZ 0.018 0.067 -10000 0 -0.28 8 8
MAPK1 -0.082 0.24 -10000 0 -0.6 28 28
S1P1/S1P/PDGFB-D/PDGFRB -0.035 0.22 0.31 2 -0.55 22 24
ABCC1 0.031 0.043 -10000 0 -0.3 3 3
IL6-mediated signaling events

Figure S41.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S41.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BCL2L1 0.002 0.28 -10000 0 -0.78 11 11
CRP -0.057 0.26 -10000 0 -0.79 12 12
cell cycle arrest -0.08 0.29 -10000 0 -0.85 16 16
TIMP1 -0.046 0.24 -10000 0 -0.72 13 13
IL6ST 0.032 0.024 -10000 0 -10000 0 0
Rac1/GDP -0.063 0.18 -10000 0 -0.54 16 16
AP1 0.009 0.15 -10000 0 -0.51 3 3
GAB2 0.037 0.007 -10000 0 -10000 0 0
TNFSF11 -0.11 0.41 -10000 0 -1 29 29
HSP90B1 -0.001 0.087 -10000 0 -1 1 1
GAB1 0.029 0.054 -10000 0 -0.4 3 3
MAPK14 -0.07 0.19 -10000 0 -0.66 12 12
AKT1 0.029 0.081 -10000 0 -0.42 4 4
FOXO1 0.031 0.079 -10000 0 -0.4 4 4
MAP2K6 -0.067 0.18 -10000 0 -0.52 16 16
mol:GTP 0 0.002 -10000 0 -10000 0 0
MAP2K4 -0.078 0.19 -10000 0 -0.58 15 15
MITF -0.06 0.17 -10000 0 -0.46 17 17
positive regulation of NF-kappaB transcription factor activity 0 0 -10000 0 -10000 0 0
TYK2 0.035 0.006 -10000 0 -10000 0 0
A2M -0.029 0.28 -10000 0 -1.3 9 9
CEBPB 0.016 0.039 -10000 0 -0.48 1 1
GRB2/SOS1/GAB family/SHP2 0.018 0.1 -10000 0 -0.44 3 3
STAT3 -0.087 0.31 -10000 0 -0.93 16 16
STAT1 0.016 0.03 -10000 0 -10000 0 0
CEBPD -0.047 0.26 -10000 0 -0.78 11 11
PIK3CA 0.036 0.008 -10000 0 -10000 0 0
PI3K 0.047 0.05 -10000 0 -0.35 3 3
JUN -0.017 0.15 -10000 0 -0.4 25 25
PIAS3/MITF -0.049 0.17 -10000 0 -0.49 14 14
MAPK11 -0.068 0.19 -10000 0 -0.65 12 12
STAT3 (dimer)/FOXO1 -0.04 0.24 -10000 0 -0.69 13 13
GRB2/SOS1/GAB family 0.004 0.17 -10000 0 -0.45 13 13
IL6/IL6RA/gp130 (dimer)/JAK1/JAK1/LMO4/HCK -0.067 0.14 -10000 0 -0.45 16 16
GRB2 0.035 0.009 -10000 0 -10000 0 0
JAK2 0.015 0.078 -10000 0 -0.27 12 12
LBP 0.042 0.23 -10000 0 -0.57 10 10
PIK3R1 0.029 0.062 -10000 0 -0.48 3 3
JAK1 0.031 0.038 -10000 0 -0.47 1 1
MYC -0.068 0.33 -10000 0 -0.96 18 18
FGG -0.073 0.27 -10000 0 -0.83 14 14
macrophage differentiation -0.08 0.29 -10000 0 -0.85 16 16
IL6/IL6RA/gp130 (dimer)/JAK2/JAK2/LMO4 -0.048 0.17 -10000 0 -0.29 55 55
JUNB -0.07 0.26 -10000 0 -0.81 14 14
FOS -0.063 0.17 -10000 0 -0.32 56 56
IL6/IL6RA/gp130 (dimer)/JAK1/JAK1/LMO4 -0.061 0.16 -10000 0 -0.48 15 15
STAT1/PIAS1 -0.033 0.17 -10000 0 -0.49 10 10
GRB2/SOS1/GAB family/SHP2/PI3K 0.038 0.075 -10000 0 -0.39 3 3
STAT3 (dimer) -0.084 0.31 -10000 0 -0.91 16 16
PRKCD -0.07 0.23 0.36 8 -0.62 17 25
IL6R 0.019 0.08 -10000 0 -0.34 8 8
SOCS3 -0.078 0.26 -10000 0 -1.1 9 9
gp130 (dimer)/JAK1/JAK1/LMO4 0.03 0.11 -10000 0 -0.29 13 13
Rac1/GTP -0.064 0.19 -10000 0 -0.55 16 16
HCK -0.013 0.11 -10000 0 -0.35 17 17
MAPKKK cascade 0.043 0.11 -10000 0 -0.54 3 3
bone resorption -0.094 0.38 -10000 0 -0.94 29 29
IRF1 -0.088 0.3 -10000 0 -0.96 15 15
mol:GDP -0.071 0.18 -10000 0 -0.51 19 19
SOS1 0.037 0.007 -10000 0 -10000 0 0
VAV1 -0.073 0.19 -10000 0 -0.52 19 19
IL6/IL6RA/gp130 (dimer)/JAK1/JAK1/LMO4/SOCS3 -0.069 0.21 -10000 0 -0.72 13 13
PTPN11 0.009 0.12 -10000 0 -0.92 3 3
IL6/IL6RA -0.077 0.17 -10000 0 -0.32 55 55
gp130 (dimer)/TYK2/TYK2/LMO4 0.035 0.098 -10000 0 -0.29 12 12
gp130 (dimer)/JAK2/JAK2/LMO4 0.023 0.11 -10000 0 -0.27 19 19
IL6 -0.12 0.2 -10000 0 -0.34 82 82
PIAS3 0.033 0.024 -10000 0 -0.2 2 2
PTPRE 0.019 0.069 -10000 0 -0.34 6 6
PIAS1 0.034 0.009 -10000 0 -10000 0 0
RAC1 0.033 0.011 -10000 0 -10000 0 0
IL6/IL6RA/gp130 (dimer)/TYK2/TYK2/LMO4 -0.057 0.13 -10000 0 -0.35 18 18
LMO4 -0.017 0.13 -10000 0 -0.32 28 28
STAT3 (dimer)/PIAS3 -0.077 0.29 -10000 0 -0.85 16 16
MCL1 0.034 0.14 -10000 0 -1.1 2 2
FOXM1 transcription factor network

Figure S42.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S42.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
NFATC3 -0.084 0.42 -9999 0 -1.2 14 14
PLK1 0.027 0.16 -9999 0 -1.3 3 3
BIRC5 -0.012 0.27 -9999 0 -1.2 9 9
HSPA1B -0.083 0.42 -9999 0 -1.1 18 18
MAP2K1 0.028 0.049 -9999 0 -10000 0 0
BRCA2 -0.057 0.45 -9999 0 -1.2 15 15
FOXM1 -0.14 0.6 -9999 0 -1.7 16 16
XRCC1 -0.078 0.42 -9999 0 -1.2 12 12
FOXM1B/p19 -0.14 0.46 -9999 0 -1.3 18 18
Cyclin D1/CDK4 -0.084 0.41 -9999 0 -1 17 17
CDC2 -0.091 0.44 -9999 0 -1.3 14 14
TGFA -0.11 0.41 -9999 0 -1 18 18
SKP2 -0.087 0.43 -9999 0 -1.2 16 16
CCNE1 0.027 0.059 -9999 0 -0.32 5 5
CKS1B -0.077 0.42 -9999 0 -1.2 14 14
RB1 -0.029 0.23 -9999 0 -1.1 4 4
FOXM1C/SP1 -0.1 0.48 -9999 0 -1.3 17 17
AURKB -0.14 0.41 -9999 0 -0.99 36 36
CENPF -0.088 0.44 -9999 0 -1.2 16 16
CDK4 0.029 0.029 -9999 0 -10000 0 0
MYC -0.095 0.38 -9999 0 -1 14 14
CHEK2 0.026 0.063 -9999 0 -0.53 1 1
ONECUT1 -0.099 0.42 -9999 0 -1.1 16 16
CDKN2A -0.039 0.15 -9999 0 -0.32 41 41
LAMA4 -0.084 0.42 -9999 0 -1.2 14 14
FOXM1B/HNF6 -0.13 0.48 -9999 0 -1.4 16 16
FOS -0.21 0.56 -9999 0 -1.2 41 41
SP1 0.033 0.022 -9999 0 -0.2 1 1
CDC25B -0.11 0.51 -9999 0 -1.2 27 27
response to radiation 0.004 0.029 -9999 0 -10000 0 0
CENPB -0.059 0.43 -9999 0 -1.2 12 12
CENPA -0.085 0.43 -9999 0 -1.3 12 12
NEK2 -0.084 0.43 -9999 0 -1.2 15 15
HIST1H2BA -0.084 0.42 -9999 0 -1.2 14 14
CCNA2 0.019 0.095 -9999 0 -0.49 7 7
EP300 0.018 0.088 -9999 0 -0.44 7 7
CCNB1/CDK1 -0.12 0.51 -9999 0 -1.7 12 12
CCNB2 -0.091 0.44 -9999 0 -1.3 13 13
CCNB1 -0.096 0.46 -9999 0 -1.4 14 14
ETV5 -0.11 0.46 -9999 0 -1.3 17 17
ESR1 -0.092 0.44 -9999 0 -1.3 15 15
CCND1 -0.1 0.41 -9999 0 -1 19 19
GSK3A 0.027 0.045 -9999 0 -10000 0 0
Cyclin A-E1/CDK1-2 0.031 0.1 -9999 0 -0.29 13 13
CDK2 0.021 0.075 -9999 0 -0.28 10 10
G2/M transition of mitotic cell cycle 0.005 0.034 -9999 0 -10000 0 0
FOXM1B/Cbp/p300 -0.097 0.46 -9999 0 -1.3 17 17
GAS1 -0.24 0.59 -9999 0 -1.2 48 48
MMP2 -0.1 0.46 -9999 0 -1.3 18 18
RB1/FOXM1C -0.11 0.39 -9999 0 -1.1 13 13
CREBBP 0.032 0.036 -9999 0 -0.48 1 1
Caspase cascade in apoptosis

Figure S43.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S43.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TOP1 -0.032 0.14 -10000 0 -0.5 11 11
ACTA1 -0.047 0.15 0.28 3 -0.39 22 25
NUMA1 -0.022 0.16 -10000 0 -0.5 11 11
SPTAN1 -0.046 0.15 0.42 1 -0.4 21 22
LIMK1 -0.058 0.17 0.26 4 -0.4 25 29
BIRC3 -0.011 0.13 -10000 0 -0.3 28 28
BIRC2 0.034 0.018 -10000 0 -0.2 1 1
BAX 0.029 0.046 -10000 0 -0.27 4 4
CASP10 -0.056 0.1 -10000 0 -0.31 26 26
CRMA 0 0 -10000 0 -10000 0 0
XIAP 0 0 -10000 0 -10000 0 0
PTK2 -0.023 0.14 -10000 0 -0.48 11 11
DIABLO 0.036 0.004 -10000 0 -10000 0 0
apoptotic nuclear changes -0.045 0.15 0.42 1 -0.39 21 22
response to UV 0 0 -10000 0 -10000 0 0
CRADD 0.025 0.071 -10000 0 -0.48 4 4
GSN -0.054 0.15 0.42 1 -0.39 23 24
MADD 0.036 0.002 -10000 0 -10000 0 0
TFAP2A 0.023 0.11 -10000 0 -0.67 4 4
BID -0.024 0.071 0.13 1 -0.19 28 29
MAP3K1 -0.006 0.079 -10000 0 -0.47 3 3
TRADD 0.036 0.004 -10000 0 -10000 0 0
mol:Ca2+ 0 0 -10000 0 -10000 0 0
APAF-1/Pro-Caspase 9 0.027 0.085 -10000 0 -0.34 9 9
mol:Activated DNA 0 0 -10000 0 -10000 0 0
ARHGDIB -0.057 0.16 0.29 4 -0.4 26 30
CASP9 0.033 0.009 -10000 0 -10000 0 0
DNA repair -0.004 0.065 0.29 3 -0.19 6 9
neuron apoptosis -0.037 0.22 -10000 0 -0.74 18 18
mol:NAD 0 0 -10000 0 -10000 0 0
DNA fragmentation during apoptosis -0.035 0.16 -10000 0 -0.44 16 16
APAF1 0.008 0.11 -10000 0 -0.35 15 15
CASP6 -0.013 0.18 -10000 0 -0.88 7 7
TRAF2 0.033 0.024 -10000 0 -0.2 2 2
ICAD/CAD -0.048 0.14 -10000 0 -0.39 19 19
CASP7 0.019 0.089 0.28 10 -0.36 3 13
KRT18 0.013 0.065 -10000 0 -0.43 3 3
apoptosis -0.046 0.15 0.3 1 -0.45 16 17
DFFA -0.046 0.14 -10000 0 -0.4 20 20
DFFB -0.048 0.14 0.22 1 -0.4 20 21
PARP1 0.003 0.065 0.19 6 -0.29 3 9
actin filament polymerization 0.063 0.16 0.4 25 -0.35 2 27
TNF 0.023 0.066 -10000 0 -0.27 9 9
CYCS -0.01 0.068 0.2 2 -0.26 5 7
SATB1 -0.062 0.19 -10000 0 -0.84 7 7
SLK -0.047 0.14 0.22 1 -0.4 20 21
p15 BID/BAX -0.017 0.086 -10000 0 -0.25 11 11
CASP2 0.019 0.067 0.22 5 -0.32 2 7
JNK cascade 0.006 0.079 0.46 3 -10000 0 3
CASP3 -0.047 0.15 0.23 2 -0.4 22 24
LMNB2 0.014 0.12 0.29 1 -0.49 6 7
RIPK1 0.036 0.004 -10000 0 -10000 0 0
CASP4 0.019 0.08 -10000 0 -0.33 9 9
Mammalian IAPs/DIABLO 0.035 0.085 -10000 0 -0.26 11 11
negative regulation of DNA binding 0.023 0.1 -10000 0 -0.66 4 4
stress fiber formation -0.047 0.14 0.22 1 -0.39 20 21
GZMB -0.042 0.12 -10000 0 -0.36 21 21
CASP1 -0.058 0.14 -10000 0 -0.34 38 38
LMNB1 -0.015 0.15 0.29 1 -0.63 6 7
APP -0.038 0.23 -10000 0 -0.75 18 18
TNFRSF1A 0.035 0.007 -10000 0 -10000 0 0
response to stress 0 0 -10000 0 -10000 0 0
CASP8 0.005 0.043 -10000 0 -0.35 3 3
VIM -0.043 0.15 0.28 2 -0.46 16 18
LMNA 0.022 0.088 0.29 1 -0.36 5 6
TNF-alpha/TNFR1A/TRADD/MADD/cIAP2/RIP1/TRAF2/RAIDD/PIDD 0.019 0.064 -10000 0 -0.3 3 3
LRDD 0.035 0.017 -10000 0 -0.2 1 1
SREBF1 -0.048 0.14 0.22 1 -0.4 20 21
APAF-1/Caspase 9 -0.028 0.18 -10000 0 -0.63 15 15
nuclear fragmentation during apoptosis -0.021 0.15 -10000 0 -0.48 11 11
CFL2 -0.065 0.17 0.35 2 -0.42 25 27
GAS2 -0.12 0.17 -10000 0 -0.38 43 43
positive regulation of apoptosis 0.009 0.12 0.3 1 -0.51 6 7
PRF1 0.003 0.089 -10000 0 -0.23 25 25
Nectin adhesion pathway

Figure S44.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S44.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PDGFRB 0.033 0.036 -10000 0 -0.48 1 1
alphaV beta3 Integrin 0.039 0.061 -10000 0 -0.35 4 4
PTK2 -0.023 0.15 -10000 0 -0.4 23 23
positive regulation of JNK cascade -0.001 0.13 -10000 0 -0.31 16 16
CDC42/GDP 0.01 0.18 -10000 0 -0.43 21 21
Rac1/GDP 0.003 0.18 -10000 0 -0.43 20 20
RAP1B 0.035 0.004 -10000 0 -10000 0 0
RAP1A 0.034 0.008 -10000 0 -10000 0 0
CTNNB1 0.011 0.093 -10000 0 -0.3 15 15
CDC42/GTP 0.012 0.16 -10000 0 -0.39 16 16
nectin-3/I-afadin -0.008 0.14 -10000 0 -0.36 26 26
RAPGEF1 -0.014 0.17 -10000 0 -0.44 24 24
mol:GTP 0 0 -10000 0 -10000 0 0
CRK -0.031 0.19 -10000 0 -0.5 24 24
PDGFB-D/PDGFRB 0.033 0.036 -10000 0 -0.48 1 1
TLN1 -0.018 0.071 0.2 2 -0.27 7 9
Rap1/GTP -0.005 0.13 -10000 0 -0.33 17 17
IQGAP1 0.034 0.008 -10000 0 -10000 0 0
Rap1/GTP/I-afadin 0.054 0.06 -10000 0 -0.27 6 6
nectin-3(dimer)/I-afadin/I-afadin/nectin-3(dimer)/I-afadin/I-afadin -0.008 0.14 -10000 0 -0.36 26 26
PVR 0.033 0.036 -10000 0 -0.48 1 1
Necl-5(dimer) 0.033 0.036 -10000 0 -0.48 1 1
mol:GDP -0.012 0.21 -10000 0 -0.53 21 21
MLLT4 0.02 0.087 -10000 0 -0.48 6 6
PIK3CA 0.035 0.006 -10000 0 -10000 0 0
PI3K 0.04 0.13 -10000 0 -0.27 28 28
nectin-1(dimer)/I-afadin/I-afadin/nectin-1(dimer)/I-afadin/I-afadin 0.038 0.07 -10000 0 -0.35 6 6
positive regulation of lamellipodium assembly -0.018 0.15 -10000 0 -0.36 22 22
PVRL1 0.034 0.017 -10000 0 -0.2 1 1
PVRL3 -0.027 0.16 -10000 0 -0.4 30 30
PVRL2 0.03 0.043 -10000 0 -0.3 3 3
PIK3R1 0.028 0.062 -10000 0 -0.48 3 3
CDH1 0.011 0.11 -10000 0 -0.48 10 10
CLDN1 -0.031 0.16 -10000 0 -0.4 32 32
JAM-A/CLDN1 -0.015 0.16 -10000 0 -0.3 47 47
SRC -0.052 0.2 -10000 0 -0.54 26 26
ITGB3 0.033 0.018 -10000 0 -0.2 1 1
nectin-1(dimer)/I-afadin/I-afadin 0.038 0.07 -10000 0 -0.35 6 6
FARP2 0.003 0.2 -10000 0 -0.51 17 17
RAC1 0.033 0.011 -10000 0 -10000 0 0
CTNNA1 0.035 0.006 -10000 0 -10000 0 0
nectin-3(dimer)/I-afadin/I-afadin/Necl-5(dimer) 0.015 0.13 -10000 0 -0.32 24 24
nectin-1/I-afadin 0.038 0.07 -10000 0 -0.35 6 6
nectin-2/I-afadin 0.035 0.076 -10000 0 -0.35 7 7
RAC1/GTP/IQGAP1/filamentous actin 0.042 0.017 -10000 0 -10000 0 0
nectin-1(dimer)/I-afadin/I-afadin/nectin-3(dimer/I-afadin/I-afadin 0.014 0.13 -10000 0 -0.31 26 26
CDC42/GTP/IQGAP1/filamentous actin 0.042 0.019 -10000 0 -10000 0 0
F11R 0.022 0.08 -10000 0 -0.48 5 5
positive regulation of filopodium formation -0.001 0.13 -10000 0 -0.31 16 16
alphaV/beta3 Integrin/Talin -0.023 0.11 -10000 0 -0.29 9 9
nectin-2(dimer)/I-afadin/I-afadin/nectin-2(dimer/I-afadin/I-afadin 0.035 0.076 -10000 0 -0.35 7 7
nectin-2(dimer)/I-afadin/I-afadin 0.035 0.076 -10000 0 -0.35 7 7
PIP5K1C -0.019 0.074 -10000 0 -0.2 27 27
VAV2 -0.04 0.26 -10000 0 -0.61 21 21
RAP1/GDP 0.017 0.17 -10000 0 -0.4 19 19
ITGAV 0.021 0.083 -10000 0 -0.4 7 7
nectin-3(dimer)/I-afadin/I-afadin/nectin-2(dimer)/I-afadin/I-afadin 0.012 0.13 -10000 0 -0.31 25 25
nectin-3(dimer)/I-afadin/I-afadin -0.008 0.14 -10000 0 -0.36 26 26
Rac1/GTP -0.019 0.19 -10000 0 -0.44 22 22
PTPRM -0.02 0.084 -10000 0 -0.22 29 29
E-cadherin/beta catenin/alpha catenin 0.051 0.13 -10000 0 -0.32 17 17
adherens junction assembly 0 0 -10000 0 -10000 0 0
CDC42 0.032 0.019 -10000 0 -0.2 1 1
Reelin signaling pathway

Figure S45.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S45.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CDK5R1/CDK5 0.05 0.012 -10000 0 -10000 0 0
VLDLR -0.084 0.2 -10000 0 -0.37 61 61
CRKL 0.029 0.051 -10000 0 -0.48 2 2
LRPAP1 0.035 0.007 -10000 0 -10000 0 0
FYN 0.006 0.11 -10000 0 -0.34 16 16
ITGA3 0.018 0.084 -10000 0 -0.38 8 8
RELN/VLDLR/Fyn -0.033 0.15 -10000 0 -0.32 38 38
MAPK8IP1/MKK7/MAP3K11/JNK1 0.092 0.047 -10000 0 -0.26 1 1
AKT1 -0.031 0.094 -10000 0 -0.23 28 28
MAP2K7 0.03 0.043 -10000 0 -0.3 3 3
RAPGEF1 0.035 0.004 -10000 0 -10000 0 0
DAB1 0.035 0.005 -10000 0 -10000 0 0
RELN/LRP8/DAB1 0.047 0.073 -10000 0 -0.27 9 9
LRPAP1/LRP8 0.031 0.084 -10000 0 -0.35 9 9
RELN/LRP8/DAB1/Fyn 0.042 0.099 -10000 0 -0.26 16 16
DAB1/alpha3/beta1 Integrin -0.023 0.14 -10000 0 -0.26 42 42
long-term memory 0.039 0.11 -10000 0 -0.26 17 17
DAB1/LIS1 -0.011 0.14 -10000 0 -0.25 41 41
DAB1/CRLK/C3G -0.017 0.13 -10000 0 -0.25 40 40
PIK3CA 0.035 0.006 -10000 0 -10000 0 0
DAB1/NCK2 -0.002 0.14 -10000 0 -0.25 41 41
ARHGEF2 0.033 0.018 -10000 0 -0.2 1 1
mol:Src family inhibitors PP1 and PP2 0 0 -10000 0 -10000 0 0
GRIN2A 0.035 0.005 -10000 0 -10000 0 0
CDK5R1 0.035 0.007 -10000 0 -10000 0 0
RELN 0.033 0.018 -10000 0 -0.2 1 1
PIK3R1 0.028 0.062 -10000 0 -0.48 3 3
RELN/LRP8/Fyn 0.028 0.11 -10000 0 -0.3 16 16
GRIN2A/RELN/LRP8/DAB1/Fyn 0.057 0.11 -10000 0 -0.26 16 16
MAPK8 0.035 0.007 -10000 0 -10000 0 0
RELN/VLDLR/DAB1 -0.011 0.12 -10000 0 -0.27 32 32
ITGB1 0.034 0.017 -10000 0 -0.2 1 1
MAP1B -0.045 0.11 -10000 0 -0.24 41 41
RELN/LRP8 0.047 0.08 -10000 0 -0.3 9 9
GRIN2B/RELN/LRP8/DAB1/Fyn 0.046 0.12 -10000 0 -0.27 18 18
PI3K 0.045 0.049 -10000 0 -0.35 3 3
mol:PP2 0 0 -10000 0 -10000 0 0
alpha3/beta1 Integrin 0.035 0.068 -10000 0 -0.35 5 5
RAP1A -0.061 0.1 0.35 1 -0.35 3 4
PAFAH1B1 0.03 0.013 -10000 0 -10000 0 0
MAPK8IP1 0.033 0.023 -10000 0 -0.2 2 2
CRLK/C3G 0.046 0.041 -10000 0 -0.35 2 2
GRIN2B 0.018 0.071 -10000 0 -0.25 12 12
NCK2 0.035 0.017 -10000 0 -0.2 1 1
neuron differentiation 0.02 0.073 -10000 0 -0.29 3 3
neuron adhesion -0.062 0.11 0.33 2 -0.46 2 4
LRP8 0.009 0.11 -10000 0 -0.41 12 12
GSK3B -0.031 0.095 -10000 0 -0.49 2 2
RELN/VLDLR/DAB1/Fyn -0.015 0.14 -10000 0 -0.27 37 37
MAP3K11 0.036 0.004 -10000 0 -10000 0 0
RELN/VLDLR/DAB1/P13K -0.023 0.1 -10000 0 -0.24 32 32
CDK5 0.035 0.006 -10000 0 -10000 0 0
MAPT 0.017 0.13 0.82 5 -0.45 1 6
neuron migration -0.048 0.12 -10000 0 -0.39 4 4
RELN/LRP8/DAB1/Fyn/MAPK8IP1/MKK7/MAP3K11/JNK1 0.02 0.073 -10000 0 -0.29 3 3
RELN/VLDLR -0.017 0.14 -10000 0 -0.27 41 41
Syndecan-3-mediated signaling events

Figure S46.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S46.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CTTN 0.034 0.017 -9999 0 -0.2 1 1
Syndecan-3/Src/Cortactin -0.013 0.14 -9999 0 -0.44 15 15
Syndecan-3/Neurocan -0.025 0.13 -9999 0 -0.46 15 15
POMC 0.02 0.075 -9999 0 -0.29 10 10
EGFR 0.016 0.09 -9999 0 -0.41 8 8
Syndecan-3/EGFR -0.012 0.14 -9999 0 -0.44 17 17
AGRP 0.033 0.023 -9999 0 -0.2 2 2
NCSTN 0.034 0.007 -9999 0 -10000 0 0
PSENEN 0.031 0.04 -9999 0 -0.34 2 2
RP11-540L11.1 0 0 -9999 0 -10000 0 0
APH1B 0.02 0.073 -9999 0 -0.3 9 9
APH1A 0.003 0.11 -9999 0 -0.31 19 19
NCAN 0 0 -9999 0 -10000 0 0
long-term memory 0.003 0.15 -9999 0 -0.47 15 15
Syndecan-3/IL8 -0.082 0.18 -9999 0 -0.48 22 22
PSEN1 0.032 0.019 -9999 0 -0.2 1 1
Src/Cortactin 0.021 0.052 -9999 0 -0.35 3 3
FYN 0.006 0.11 -9999 0 -0.34 16 16
limb bud formation -0.023 0.13 -9999 0 -0.49 14 14
MC4R 0.024 0.017 -9999 0 -10000 0 0
SRC 0.011 0.062 -9999 0 -0.48 3 3
PTN -0.013 0.14 -9999 0 -0.41 22 22
FGFR/FGF/Syndecan-3 -0.024 0.13 -9999 0 -0.5 14 14
neuron projection morphogenesis -0.032 0.13 -9999 0 -0.43 15 15
Syndecan-3/AgRP -0.001 0.14 -9999 0 -0.46 15 15
Syndecan-3/AgRP/MC4R 0.004 0.14 -9999 0 -0.46 14 14
Fyn/Cortactin 0.028 0.085 -9999 0 -0.35 8 8
SDC3 -0.024 0.13 -9999 0 -0.5 14 14
GO:0007205 0 0 -9999 0 -10000 0 0
positive regulation of leukocyte migration -0.081 0.18 -9999 0 -0.47 22 22
IL8 -0.14 0.22 -9999 0 -0.36 90 90
Syndecan-3/Fyn/Cortactin 0.003 0.15 -9999 0 -0.48 15 15
Syndecan-3/CASK -0.025 0.13 -9999 0 -0.46 15 15
alpha-MSH/MC4R 0.024 0.059 -9999 0 -0.34 3 3
Gamma Secretase 0.05 0.099 -9999 0 -0.26 10 10
Stabilization and expansion of the E-cadherin adherens junction

Figure S47.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S47.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
adherens junction organization 0.005 0.07 -10000 0 -0.24 15 15
epithelial cell differentiation 0.041 0.093 -10000 0 -0.26 15 15
CYFIP2 0.009 0.11 -10000 0 -0.46 11 11
ENAH -0.042 0.089 0.28 1 -0.36 5 6
EGFR 0.016 0.09 -10000 0 -0.41 8 8
EPHA2 0.011 0.088 -10000 0 -0.28 15 15
MYO6 -0.009 0.083 -10000 0 -0.25 19 19
CTNNB1 0.011 0.093 -10000 0 -0.3 15 15
ABI1/Sra1/Nap1 0.044 0.089 -10000 0 -0.31 10 10
AQP5 -0.023 0.093 -10000 0 -0.36 9 9
CTNND1 0.036 0.004 -10000 0 -10000 0 0
mol:PI-4-5-P2 -0.005 0.074 -10000 0 -0.25 15 15
regulation of calcium-dependent cell-cell adhesion -0.039 0.1 -10000 0 -0.25 33 33
EGF -0.088 0.19 -10000 0 -0.32 72 72
NCKAP1 0.021 0.068 -10000 0 -0.26 10 10
AQP3 -0.038 0.11 -10000 0 -0.36 16 16
cortical microtubule organization 0.041 0.093 -10000 0 -0.26 15 15
GO:0000145 -0.026 0.064 0.17 3 -0.24 15 18
E-cadherin/Ca2+/beta catenin/alpha catenin/p120 catenin 0.048 0.096 -10000 0 -0.26 15 15
MLLT4 0.02 0.087 -10000 0 -0.48 6 6
ARF6/GDP -0.051 0.089 -10000 0 -0.38 7 7
ARF6 0.028 0.051 -10000 0 -0.48 2 2
Ephrin A1/EPHA2/NCK1/GIT1 0.047 0.097 -10000 0 -0.29 11 11
mol:Ca2+ 0 0 -10000 0 -10000 0 0
VASP -0.015 0.076 -10000 0 -0.26 7 7
PVRL2 0.03 0.043 -10000 0 -0.3 3 3
ZYX -0.006 0.08 -10000 0 -0.25 17 17
ARF6/GTP 0.046 0.1 -10000 0 -0.27 13 13
CDH1 0.011 0.11 -10000 0 -0.48 10 10
EGFR/EGFR/EGF/EGF -0.043 0.14 -10000 0 -0.27 44 44
RhoA/GDP 0.044 0.091 -10000 0 -0.25 15 15
actin cytoskeleton organization -0.016 0.078 -10000 0 -0.24 19 19
IGF-1R heterotetramer 0.03 0.04 -10000 0 -0.34 2 2
GIT1 0.033 0.018 -10000 0 -0.2 1 1
IGF1R 0.03 0.04 -10000 0 -0.34 2 2
IGF1 0.015 0.081 -10000 0 -0.26 14 14
DIAPH1 0.021 0.18 -10000 0 -0.63 11 11
Wnt receptor signaling pathway -0.041 0.093 0.26 15 -10000 0 15
RHOA 0.035 0.004 -10000 0 -10000 0 0
RhoA/GTP -0.05 0.087 -10000 0 -0.4 6 6
CTNNA1 0.035 0.006 -10000 0 -10000 0 0
VCL -0.016 0.079 -10000 0 -0.25 19 19
EFNA1 0.021 0.076 -10000 0 -0.36 7 7
LPP -0.026 0.067 0.17 4 -0.24 15 19
Ephrin A1/EPHA2 0.014 0.12 -10000 0 -0.3 20 20
SEC6/SEC8 -0.014 0.093 -10000 0 -0.3 16 16
MGAT3 -0.04 0.1 -10000 0 -0.25 33 33
HGF/MET 0.028 0.098 -10000 0 -0.26 17 17
HGF 0.03 0.043 -10000 0 -0.3 3 3
E-cadherin/Ca2+/beta catenin/alpha catenin/p120 catenin/EPLIN 0.005 0.07 -10000 0 -0.24 15 15
actin cable formation -0.02 0.1 0.24 7 -0.3 8 15
KIAA1543 -0.035 0.08 -10000 0 -0.27 18 18
KIFC3 -0.007 0.08 -10000 0 -0.25 16 16
NCK1 0.026 0.071 -10000 0 -0.48 4 4
EXOC3 0.035 0.006 -10000 0 -10000 0 0
ACTN1 -0.004 0.076 -10000 0 -0.25 15 15
NCK1/GIT1 0.042 0.058 -10000 0 -0.35 4 4
mol:GDP 0.041 0.093 -10000 0 -0.26 15 15
EXOC4 0.034 0.007 -10000 0 -10000 0 0
STX4 -0.029 0.064 -10000 0 -0.25 15 15
PIP5K1C -0.005 0.075 -10000 0 -0.25 15 15
LIMA1 0 0 -10000 0 -10000 0 0
ABI1 0.035 0.004 -10000 0 -10000 0 0
ROCK1 -0.033 0.093 0.3 1 -0.4 4 5
adherens junction assembly -0.013 0.095 0.38 1 -0.42 3 4
IGF-1R heterotetramer/IGF1 0.019 0.099 -10000 0 -0.25 19 19
nectin-2(dimer)/I-afadin/I-afadin/nectin-2(dimer/I-afadin/I-afadin 0.035 0.076 -10000 0 -0.35 7 7
MET 0.027 0.056 -10000 0 -0.34 4 4
PLEKHA7 -0.003 0.076 -10000 0 -0.25 15 15
mol:GTP 0.045 0.096 -10000 0 -0.29 11 11
establishment of epithelial cell apical/basal polarity -0.026 0.096 -10000 0 -0.38 7 7
cortical actin cytoskeleton stabilization 0.005 0.07 -10000 0 -0.24 15 15
regulation of cell-cell adhesion -0.016 0.078 -10000 0 -0.24 19 19
E-cadherin/Ca2+/beta catenin/alpha catenin/p120 catenin/EPLIN/cortical actin cytoskeleton 0.005 0.07 -10000 0 -0.24 15 15
BCR signaling pathway

Figure S48.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S48.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
JUN -0.083 0.16 -10000 0 -0.4 25 25
IKBKB 0.003 0.089 0.25 2 -0.27 4 6
AKT1 -0.032 0.09 0.28 5 -0.25 9 14
IKBKG 0.003 0.076 0.25 2 -10000 0 2
CALM1 -0.015 0.12 -10000 0 -0.42 10 10
PIK3CA 0.035 0.006 -10000 0 -10000 0 0
MAP3K1 -0.067 0.19 0.47 1 -0.54 18 19
MAP3K7 0.033 0.036 -10000 0 -0.48 1 1
mol:Ca2+ -0.014 0.13 0.23 1 -0.39 14 15
DOK1 0.032 0.039 -10000 0 -0.34 2 2
AP-1 -0.064 0.1 -10000 0 -0.25 21 21
LYN 0.03 0.013 -10000 0 -10000 0 0
BLNK 0.004 0.12 -10000 0 -0.44 13 13
SHC1 0.035 0.007 -10000 0 -10000 0 0
BCR complex 0.011 0.11 -10000 0 -0.32 17 17
CD22 -0.052 0.16 -10000 0 -0.63 11 11
CAMK2G -0.014 0.11 -10000 0 -0.39 9 9
CSNK2A1 0.028 0.015 -10000 0 -10000 0 0
INPP5D 0 0 -10000 0 -10000 0 0
SHC/GRB2/SOS1 0.002 0.089 -10000 0 -0.45 2 2
GO:0007205 -0.015 0.13 0.23 1 -0.4 14 15
SYK 0.029 0.053 -10000 0 -0.39 3 3
ELK1 -0.016 0.12 0.22 1 -0.41 11 12
NFATC1 -0.084 0.18 0.32 2 -0.45 25 27
B-cell antigen/BCR complex 0.011 0.11 -10000 0 -0.32 17 17
PAG1/CSK 0.031 0.066 -10000 0 -0.35 5 5
NFKBIB 0.014 0.043 0.15 1 -0.13 6 7
HRAS -0.003 0.11 0.25 2 -0.4 6 8
NFKBIA 0.014 0.042 0.15 1 -0.12 6 7
NF-kappa-B/RelA/I kappa B beta 0.02 0.038 0.15 1 -10000 0 1
RasGAP/Csk -0.03 0.16 -10000 0 -0.3 41 41
mol:GDP -0.011 0.13 0.22 3 -0.39 13 16
PTEN 0.026 0.062 -10000 0 -0.48 3 3
CD79B 0.001 0.11 -10000 0 -0.32 19 19
NF-kappa-B/RelA/I kappa B alpha 0.021 0.038 0.15 1 -10000 0 1
GRB2 0.034 0.008 -10000 0 -10000 0 0
PI3K/BCAP/CD19 -0.057 0.17 -10000 0 -0.57 13 13
PIK3R1 0.028 0.062 -10000 0 -0.48 3 3
mol:IP3 -0.015 0.13 0.23 1 -0.4 14 15
CSK 0.033 0.01 -10000 0 -10000 0 0
FOS -0.056 0.14 -10000 0 -0.38 22 22
CHUK -0.014 0.11 0.25 2 -0.34 10 12
IBTK 0.029 0.046 -10000 0 -0.27 4 4
CARD11/BCL10/MALT1/TAK1 -0.013 0.13 0.27 3 -0.38 10 13
PTPN6 -0.05 0.15 -10000 0 -0.61 10 10
RELA 0.035 0.004 -10000 0 -10000 0 0
BCL2A1 0.003 0.038 -10000 0 -10000 0 0
VAV2 -0.093 0.21 -10000 0 -0.57 27 27
ubiquitin-dependent protein catabolic process 0.018 0.042 0.15 1 -0.12 6 7
BTK -0.058 0.3 -10000 0 -1.2 14 14
CD19 -0.066 0.17 -10000 0 -0.62 12 12
MAP4K1 0.034 0.018 -10000 0 -0.2 1 1
CD72 -0.028 0.15 -10000 0 -0.35 34 34
PAG1 0.015 0.083 -10000 0 -0.4 7 7
MAPK14 -0.057 0.16 0.45 1 -0.48 15 16
SH3BP5 0.018 0.094 -10000 0 -0.48 7 7
PIK3AP1 -0.033 0.14 -10000 0 -0.43 14 14
B-cell antigen/BCR complex/Btk/LYN/SYK/BLNK/PLCgamma2/CD72 -0.033 0.18 -10000 0 -0.61 12 12
RAF1 -0.003 0.1 0.25 1 -0.38 6 7
RasGAP/p62DOK/SHIP -0.034 0.16 -10000 0 -0.3 41 41
CD79A 0.016 0.079 -10000 0 -0.27 13 13
re-entry into mitotic cell cycle -0.063 0.099 -10000 0 -0.25 20 20
RASA1 0.024 0.073 -10000 0 -0.43 5 5
MAPK3 -0.005 0.1 0.22 2 -0.36 7 9
MAPK1 -0.003 0.089 0.23 1 -0.33 6 7
CD72/SHP1 -0.053 0.18 -10000 0 -0.58 15 15
NFKB1 0.035 0.006 -10000 0 -10000 0 0
MAPK8 -0.056 0.16 0.45 1 -0.48 14 15
actin cytoskeleton organization -0.063 0.19 0.46 2 -0.48 26 28
NF-kappa-B/RelA 0.04 0.073 0.28 1 -10000 0 1
Calcineurin 0.003 0.12 -10000 0 -0.39 9 9
PI3K -0.063 0.14 -10000 0 -0.44 16 16
B-cell antigen/BCR complex/Btk/LYN/SYK/BLNK/PLCgamma2 -0.015 0.14 0.24 4 -0.44 13 17
SOS1 0.036 0.002 -10000 0 -10000 0 0
Bam32/HPK1 -0.15 0.35 -10000 0 -0.81 43 43
DAPP1 -0.19 0.4 -10000 0 -0.94 43 43
cytokine secretion -0.078 0.16 0.32 2 -0.43 24 26
mol:DAG -0.015 0.13 0.23 1 -0.4 14 15
PLCG2 -0.012 0.13 -10000 0 -0.33 27 27
MAP2K1 -0.003 0.097 0.24 1 -0.36 6 7
B-cell antigen/BCR complex/FcgammaRIIB -0.049 0.17 -10000 0 -0.31 49 49
mol:PI-3-4-5-P3 -0.057 0.1 0.21 1 -0.31 16 17
ETS1 -0.015 0.11 -10000 0 -0.38 9 9
B-cell antigen/BCR complex/LYN/SYK/BLNK 0.034 0.12 -10000 0 -0.29 15 15
B-cell antigen/BCR complex/LYN -0.046 0.17 -10000 0 -0.59 14 14
MALT1 0.021 0.039 -10000 0 -0.48 1 1
TRAF6 0.036 0.004 -10000 0 -10000 0 0
RAC1 -0.077 0.2 -10000 0 -0.51 26 26
B-cell antigen/BCR complex/LYN/SYK -0.013 0.16 -10000 0 -0.57 10 10
CARD11 -0.016 0.14 0.26 5 -0.39 12 17
FCGR2B -0.085 0.2 -10000 0 -0.37 61 61
PPP3CA 0.034 0.018 -10000 0 -0.2 1 1
BCL10 0.033 0.036 -10000 0 -0.48 1 1
IKK complex 0.004 0.045 0.16 4 -0.12 2 6
PTPRC -0.025 0.15 -10000 0 -0.37 31 31
PDPK1 -0.032 0.088 0.28 5 -0.22 12 17
PPP3CB 0.035 0.007 -10000 0 -10000 0 0
PPP3CC 0.016 0.073 -10000 0 -0.43 5 5
POU2F2 0.017 0.028 0.14 1 -10000 0 1
a4b1 and a4b7 Integrin signaling

Figure S49.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S49.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
ITGB1 0.034 0.017 -9999 0 -0.2 1 1
ITGB7 0 0.13 -9999 0 -0.48 14 14
ITGA4 0.01 0.11 -9999 0 -0.46 11 11
alpha4/beta7 Integrin 0.005 0.13 -9999 0 -0.36 23 23
alpha4/beta1 Integrin 0.033 0.084 -9999 0 -0.35 9 9
LPA receptor mediated events

Figure S50.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S50.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
GNB1/GNG2 0.03 0.057 -10000 0 -0.22 7 7
NF kappa B1 p50/RelA/I kappa B alpha -0.002 0.091 -10000 0 -0.27 7 7
AP1 -0.069 0.11 -10000 0 -0.23 56 56
mol:PIP3 -0.016 0.069 -10000 0 -0.22 18 18
AKT1 0.02 0.065 0.27 1 -0.36 1 2
PTK2B -0.038 0.091 -10000 0 -0.2 46 46
RHOA 0.015 0.057 0.26 2 -0.26 3 5
PIK3CB 0.033 0.036 -10000 0 -0.48 1 1
mol:Ca2+ -0.02 0.078 0.21 1 -0.25 17 18
MAGI3 0.032 0.036 -10000 0 -0.48 1 1
RELA 0.035 0.004 -10000 0 -10000 0 0
apoptosis 0.004 0.049 -10000 0 -0.22 8 8
HRAS/GDP 0.024 0.028 -10000 0 -0.24 2 2
positive regulation of microtubule depolymerization -0.034 0.087 0.19 1 -0.22 17 18
NF kappa B1 p50/RelA -0.034 0.078 -10000 0 -0.24 17 17
endothelial cell migration -0.007 0.12 -10000 0 -0.33 19 19
ADCY4 -0.031 0.11 -10000 0 -0.32 17 17
ADCY5 -0.012 0.084 -10000 0 -0.3 11 11
ADCY6 -0.013 0.085 -10000 0 -0.3 11 11
ADCY7 -0.015 0.087 -10000 0 -0.3 11 11
ADCY1 -0.014 0.084 -10000 0 -0.3 10 10
ADCY2 -0.014 0.085 -10000 0 -0.29 11 11
ADCY3 -0.022 0.094 -10000 0 -0.29 14 14
ADCY8 -0.014 0.082 -10000 0 -0.28 11 11
ADCY9 -0.016 0.088 -10000 0 -0.3 11 11
GSK3B -0.038 0.09 0.17 2 -0.2 35 37
arachidonic acid secretion -0.015 0.091 -10000 0 -0.29 14 14
GNG2 0.033 0.01 -10000 0 -10000 0 0
TRIP6 -0.014 0.11 -10000 0 -0.43 12 12
GNAO1 0.009 0.054 -10000 0 -0.24 7 7
HRAS 0.032 0.04 -10000 0 -0.34 2 2
NFKBIA -0.026 0.082 -10000 0 -0.27 10 10
GAB1 0.028 0.054 -10000 0 -0.39 3 3
mol:GTP 0 0 -10000 0 -10000 0 0
lamellipodium assembly -0.004 0.23 -10000 0 -0.84 14 14
JUN -0.018 0.15 -10000 0 -0.4 25 25
LPA/LPA2/NHERF2 0.002 0.07 -10000 0 -0.19 20 20
TIAM1 -0.027 0.26 -10000 0 -0.97 15 15
PIK3R1 0.028 0.062 -10000 0 -0.48 3 3
mol:IP3 -0.027 0.075 0.21 1 -0.25 18 19
PLCB3 -0.008 0.085 0.19 4 -0.26 16 20
FOS -0.063 0.17 -10000 0 -0.32 56 56
positive regulation of mitosis -0.015 0.091 -10000 0 -0.29 14 14
LPA/LPA1-2-3 -0.007 0.044 -10000 0 -0.13 19 19
mol:Ca ++ 0 0 -10000 0 -10000 0 0
JNK cascade 0 0.001 -10000 0 -10000 0 0
BCAR1 0.034 0.017 -10000 0 -0.2 1 1
stress fiber formation -0.002 0.063 -10000 0 -0.28 3 3
GNAZ 0.001 0.07 -10000 0 -0.3 8 8
EGFR/PI3K-beta/Gab1 -0.007 0.075 -10000 0 -0.23 18 18
positive regulation of dendritic cell cytokine production -0.007 0.044 -10000 0 -0.13 19 19
LPA/LPA2/MAGI-3 0.017 0.033 -10000 0 -0.29 1 1
ARHGEF1 0.032 0.077 0.2 22 -0.21 7 29
GNAI2 0.002 0.071 -10000 0 -0.28 10 10
GNAI3 0.005 0.061 -10000 0 -0.25 9 9
GNAI1 -0.02 0.099 -10000 0 -0.29 22 22
LPA/LPA3 -0.006 0.022 -10000 0 -0.067 19 19
LPA/LPA2 -0.005 0.022 -10000 0 -0.066 19 19
LPA/LPA1 -0.008 0.059 -10000 0 -0.17 19 19
HB-EGF/EGFR -0.018 0.097 -10000 0 -0.34 14 14
HBEGF -0.022 0.087 -10000 0 -0.35 11 11
mol:DAG -0.027 0.075 0.21 1 -0.25 18 19
cAMP biosynthetic process -0.019 0.091 -10000 0 -0.31 11 11
NFKB1 0.035 0.006 -10000 0 -10000 0 0
SRC 0.011 0.062 -10000 0 -0.48 3 3
GNB1 0.034 0.008 -10000 0 -10000 0 0
LYN 0.001 0.077 0.19 4 -0.26 4 8
GNAQ -0.003 0.018 -10000 0 -0.08 8 8
LPAR2 0 0.001 -10000 0 -10000 0 0
LPAR3 -0.001 0.001 -10000 0 -10000 0 0
LPAR1 -0.006 0.034 -10000 0 -0.1 19 19
IL8 -0.14 0.23 -10000 0 -0.48 59 59
PTK2 0.01 0.045 -10000 0 -0.21 6 6
Rac1/GDP 0.024 0.008 -10000 0 -10000 0 0
CASP3 0.004 0.05 -10000 0 -0.22 8 8
EGFR 0.015 0.089 -10000 0 -0.41 8 8
PLCG1 -0.002 0.031 -10000 0 -0.13 8 8
PLD2 0.01 0.046 -10000 0 -0.2 7 7
G12/G13 0.031 0.058 -10000 0 -0.22 7 7
PI3K-beta 0.006 0.057 -10000 0 -0.4 1 1
cell migration 0.015 0.085 -10000 0 -0.24 13 13
SLC9A3R2 0.008 0.11 -10000 0 -0.4 13 13
PXN -0.002 0.064 -10000 0 -0.29 3 3
HRAS/GTP -0.016 0.093 -10000 0 -0.29 14 14
RAC1 0.033 0.011 -10000 0 -10000 0 0
MMP9 -0.006 0.09 -10000 0 -0.3 15 15
PRKCE 0.033 0.036 -10000 0 -0.48 1 1
PRKCD -0.02 0.078 0.2 1 -0.25 16 17
Gi(beta/gamma) -0.015 0.097 -10000 0 -0.29 17 17
mol:LPA -0.006 0.034 -10000 0 -0.1 19 19
TRIP6/p130 Cas/FAK1/Paxillin 0.029 0.099 -10000 0 -0.4 4 4
MAPKKK cascade -0.015 0.091 -10000 0 -0.29 14 14
contractile ring contraction involved in cytokinesis 0.016 0.057 0.26 2 -0.26 3 5
mol:GDP 0 0 -10000 0 -10000 0 0
GNA14 -0.018 0.081 -10000 0 -0.27 17 17
GNA15 0.003 0.038 -10000 0 -0.22 3 3
GNA12 0.033 0.01 -10000 0 -10000 0 0
GNA13 0.034 0.009 -10000 0 -10000 0 0
MAPT -0.035 0.088 0.19 1 -0.23 17 18
GNA11 0.006 0.034 -10000 0 -0.13 9 9
Rac1/GTP -0.006 0.24 -10000 0 -0.9 14 14
MMP2 -0.008 0.12 -10000 0 -0.33 19 19
E-cadherin signaling events

Figure S51.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S51.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
E-cadherin/beta catenin-gamma catenin 0.032 0.1 -9999 0 -0.3 15 15
E-cadherin/beta catenin 0.014 0.11 -9999 0 -0.36 15 15
CTNNB1 0.011 0.093 -9999 0 -0.3 15 15
JUP 0.033 0.018 -9999 0 -0.2 1 1
CDH1 0.011 0.11 -9999 0 -0.48 10 10
IL2 signaling events mediated by STAT5

Figure S52.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S52.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
GAB2 0.036 0.004 -10000 0 -10000 0 0
ELF1 -0.009 0.11 -10000 0 -0.36 15 15
CCNA2 0.018 0.094 -10000 0 -0.48 7 7
PIK3CA 0.036 0.006 -10000 0 -10000 0 0
JAK3 0.036 0.005 -10000 0 -10000 0 0
PIK3R1 0.028 0.062 -10000 0 -0.48 3 3
JAK1 0.034 0.036 -10000 0 -0.48 1 1
IL2/IL2R alpha/beta/gamma/JAK1/LCK/JAK3/SHC/GAB2/GRB2/SOS1/SHP2/PI3K 0.005 0.17 -10000 0 -0.49 14 14
SHC1 0.035 0.007 -10000 0 -10000 0 0
SP1 -0.017 0.13 -10000 0 -0.34 29 29
IL2RA -0.05 0.19 -10000 0 -0.7 15 15
IL2RB 0.018 0.084 -10000 0 -0.38 8 8
SOS1 0.036 0.003 -10000 0 -10000 0 0
IL2RG -0.02 0.16 -10000 0 -0.44 25 25
G1/S transition of mitotic cell cycle -0.08 0.27 0.34 1 -0.65 33 34
PTPN11 0.03 0.053 -10000 0 -0.39 3 3
CCND2 -0.088 0.26 -10000 0 -0.75 28 28
LCK -0.014 0.14 -10000 0 -0.35 26 26
GRB2 0.035 0.008 -10000 0 -10000 0 0
IL2 0.036 0.005 -10000 0 -10000 0 0
CDK6 0.025 0.066 -10000 0 -0.37 5 5
CCND3 0.009 0.15 -10000 0 -0.54 7 7
Signaling events mediated by PRL

Figure S53.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S53.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CCNE1 0.026 0.058 -10000 0 -0.32 5 5
mol:Halofuginone 0.002 0.021 -10000 0 -0.21 2 2
ITGA1 0.02 0.088 -10000 0 -0.44 7 7
CDKN1A 0.039 0.11 -10000 0 -0.41 5 5
PRL-3/alpha Tubulin -0.009 0.098 -10000 0 -0.29 20 20
mol:Ca2+ -0.039 0.13 0.35 11 -0.36 15 26
AGT -0.051 0.17 -10000 0 -0.32 50 50
CCNA2 0.039 0.14 -10000 0 -0.54 4 4
TUBA1B 0 0 -10000 0 -10000 0 0
EGR1 -0.041 0.12 -10000 0 -0.34 24 24
CDK2/Cyclin E1 0.048 0.12 -10000 0 -0.41 4 4
MAPK3 -0.022 0.11 -10000 0 -0.36 18 18
PRL-2 /Rab GGTase beta 0.05 0.013 -10000 0 -10000 0 0
MAPK1 -0.013 0.093 -10000 0 -0.35 14 14
PTP4A1 -0.021 0.092 -10000 0 -0.71 2 2
PTP4A3 -0.013 0.14 -10000 0 -0.41 20 20
PTP4A2 0.034 0.008 -10000 0 -10000 0 0
ITGB1 -0.015 0.098 -10000 0 -0.36 15 15
SRC 0.011 0.062 -10000 0 -0.48 3 3
RAC1 0.006 0.14 -10000 0 -0.47 12 12
Rab GGTase beta/Rab GGTase alpha 0.047 0.017 -10000 0 -10000 0 0
PRL-1/ATF-5 0.054 0.14 -10000 0 -0.61 3 3
RABGGTA 0.033 0.01 -10000 0 -10000 0 0
BCAR1 0.009 0.099 0.36 15 -10000 0 15
RHOC 0.006 0.15 -10000 0 -0.44 15 15
RHOA 0.011 0.15 -10000 0 -0.47 13 13
cell motility -0.004 0.17 -10000 0 -0.46 16 16
PRL-1/alpha Tubulin -0.026 0.093 -10000 0 -0.61 3 3
PRL-3/alpha1 Integrin 0.003 0.12 -10000 0 -0.35 18 18
ROCK1 -0.001 0.17 -10000 0 -0.47 15 15
RABGGTB 0.035 0.006 -10000 0 -10000 0 0
CDK2 0.02 0.075 -10000 0 -0.29 10 10
mitosis -0.024 0.097 -10000 0 -0.64 3 3
ATF5 0.03 0.043 -10000 0 -0.3 3 3
Ras signaling in the CD4+ TCR pathway

Figure S54.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S54.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
ERK1-2/ELK1 -0.028 0.16 -9999 0 -0.4 16 16
MAP3K8 0.003 0.11 -9999 0 -0.32 18 18
FOS -0.014 0.11 -9999 0 -0.36 8 8
PRKCA 0.023 0.044 -9999 0 -0.35 2 2
PTPN7 -0.002 0.076 -9999 0 -0.21 23 23
HRAS 0.031 0.04 -9999 0 -0.34 2 2
PRKCB -0.003 0.006 -9999 0 -0.015 35 35
NRAS 0.018 0.08 -9999 0 -0.33 9 9
RAS family/GTP 0.046 0.06 -9999 0 -0.26 5 5
MAPK3 0.005 0.089 -9999 0 -0.46 5 5
MAP2K1 -0.005 0.074 -9999 0 -0.3 5 5
ELK1 0.022 0.038 -9999 0 -0.22 3 3
BRAF 0.004 0.043 -9999 0 -0.29 3 3
mol:GTP -0.001 0.002 -9999 0 -0.005 34 34
MAPK1 -0.004 0.11 -9999 0 -0.46 9 9
RAF1 0.005 0.043 -9999 0 -0.29 3 3
KRAS 0.033 0.018 -9999 0 -0.2 1 1
Sphingosine 1-phosphate (S1P) pathway

Figure S55.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S55.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
SPHK2 0.021 0.081 -9999 0 -0.44 6 6
SPHK1 -0.038 0.16 -9999 0 -0.32 42 42
GNAI2 0.024 0.073 -9999 0 -0.43 5 5
mol:S1P -0.02 0.099 -9999 0 -0.29 22 22
GNAO1 0.036 0.002 -9999 0 -10000 0 0
mol:Sphinganine-1-P -0.039 0.12 -9999 0 -0.37 22 22
growth factor activity 0 0 -9999 0 -10000 0 0
S1P/S1P2/G12/G13 0.011 0.09 -9999 0 -0.3 5 5
GNAI3 0.03 0.051 -9999 0 -0.48 2 2
G12/G13 0.046 0.018 -9999 0 -10000 0 0
S1PR3 0 0 -9999 0 -10000 0 0
S1PR2 0 0 -9999 0 -10000 0 0
EDG1 0.003 0.12 -9999 0 -0.38 16 16
S1P1/S1P -0.017 0.13 -9999 0 -0.31 27 27
S1PR5 0 0 -9999 0 -10000 0 0
S1PR4 0 0 -9999 0 -10000 0 0
GNAI1 -0.013 0.14 -9999 0 -0.4 23 23
S1P/S1P5/G12 -0.003 0.087 -9999 0 -0.23 21 21
S1P/S1P3/Gq -0.022 0.11 -9999 0 -0.31 18 18
S1P/S1P4/Gi -0.018 0.12 -9999 0 -0.37 14 14
GNAQ 0 0 -9999 0 -10000 0 0
GNAZ 0.022 0.064 -9999 0 -0.27 8 8
GNA14 -0.021 0.15 -9999 0 -0.37 29 29
GNA15 0.02 0.068 -9999 0 -0.26 10 10
GNA12 0.033 0.01 -9999 0 -10000 0 0
GNA13 0.034 0.009 -9999 0 -10000 0 0
GNA11 0.028 0.054 -9999 0 -0.39 3 3
ABCC1 0.031 0.043 -9999 0 -0.3 3 3
JNK signaling in the CD4+ TCR pathway

Figure S56.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S56.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
LAT/GRAP2/SLP76/HPK1 0.024 0.13 -9999 0 -0.3 22 22
MAP4K1 0.034 0.018 -9999 0 -0.2 1 1
MAP3K8 0.005 0.11 -9999 0 -0.31 18 18
PRKCB 0 0 -9999 0 -10000 0 0
DBNL 0.029 0.034 -9999 0 -0.2 4 4
CRKL 0.029 0.051 -9999 0 -0.48 2 2
MAP3K1 -0.015 0.11 -9999 0 -0.45 7 7
JUN -0.035 0.13 -9999 0 -0.6 7 7
MAP3K7 -0.014 0.11 -9999 0 -0.43 8 8
GRAP2 0.019 0.083 -9999 0 -0.4 7 7
CRK 0.03 0.013 -9999 0 -10000 0 0
MAP2K4 -0.032 0.13 -9999 0 -0.48 10 10
LAT 0.023 0.064 -9999 0 -0.27 8 8
LCP2 -0.027 0.16 -9999 0 -0.37 32 32
MAPK8 -0.009 0.12 -9999 0 -0.62 7 7
LAT/GRAP2/SLP76/HPK1/HIP-55/CRK family -0.006 0.11 -9999 0 -0.48 6 6
LAT/GRAP2/SLP76/HPK1/HIP-55 0.032 0.13 -9999 0 -0.29 19 19
Ceramide signaling pathway

Figure S57.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S57.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
SPHK2 -0.014 0.092 -10000 0 -0.34 13 13
MAP4K4 0.002 0.08 -10000 0 -0.35 5 5
BAG4 0.027 0.051 -10000 0 -0.48 2 2
PKC zeta/ceramide -0.024 0.093 0.14 3 -0.24 21 24
NFKBIA 0.028 0.044 -10000 0 -0.3 3 3
BIRC3 -0.011 0.13 -10000 0 -0.3 28 28
BAX 0.004 0.052 -10000 0 -0.3 3 3
RIPK1 0.036 0.004 -10000 0 -10000 0 0
AKT1 -0.001 0.025 -10000 0 -10000 0 0
BAD -0.026 0.094 0.15 1 -0.24 21 22
SMPD1 0.022 0.049 0.18 2 -0.24 2 4
RB1 0.029 0.12 0.2 44 -0.27 11 55
FADD/Caspase 8 0.014 0.082 -10000 0 -0.43 4 4
MAP2K4 -0.029 0.094 -10000 0 -0.28 16 16
NSMAF 0.027 0.041 -10000 0 -0.34 2 2
response to UV 0 0 -10000 0 -10000 0 0
RAF1 -0.018 0.094 0.18 4 -0.29 10 14
EGF -0.088 0.19 -10000 0 -0.32 72 72
mol:ceramide -0.024 0.1 0.15 9 -0.26 21 30
MADD 0.036 0.002 -10000 0 -10000 0 0
response to oxidative stress 0 0 -10000 0 -10000 0 0
mol:Free Fatty acid -0.003 0.065 -10000 0 -0.33 6 6
ASAH1 0.028 0.015 -10000 0 -10000 0 0
negative regulation of cell cycle 0.028 0.12 0.2 44 -0.27 11 55
cell proliferation 0.007 0.096 -10000 0 -0.32 5 5
BID -0.001 0.15 -10000 0 -0.6 10 10
MAP3K1 -0.027 0.096 0.15 2 -0.25 21 23
EIF2A -0.028 0.083 -10000 0 -0.34 5 5
TRADD 0.036 0.004 -10000 0 -10000 0 0
CRADD 0.025 0.071 -10000 0 -0.48 4 4
MAPK3 -0.014 0.085 0.19 2 -0.35 4 6
response to heat 0 0 -10000 0 -10000 0 0
MAPK1 -0.017 0.085 0.2 1 -0.33 5 6
Cathepsin D/ceramide -0.01 0.1 0.17 1 -0.25 21 22
FADD 0.008 0.066 -10000 0 -0.32 3 3
KSR1 -0.019 0.097 0.17 6 -0.24 19 25
MAPK8 -0.023 0.097 -10000 0 -0.28 14 14
PRKRA -0.024 0.09 0.15 1 -0.23 21 22
PDGFA 0 0.11 -10000 0 -0.3 20 20
TRAF2 0.033 0.024 -10000 0 -0.2 2 2
IGF1 0.015 0.081 -10000 0 -0.26 14 14
mol:GD3 0 0 -10000 0 -10000 0 0
ganglioside biosynthetic process -0.024 0.1 0.15 9 -0.25 21 30
CTSD 0.031 0.043 -10000 0 -0.3 3 3
regulation of nitric oxide biosynthetic process 0.051 0.01 -10000 0 -10000 0 0
response to radiation 0 0 -10000 0 -10000 0 0
ERK1/PKC delta 0.009 0.1 -10000 0 -0.34 5 5
PRKCD 0.035 0.004 -10000 0 -10000 0 0
PRKCZ 0 0 -10000 0 -10000 0 0
mol:GW4869 0 0 -10000 0 -10000 0 0
mol:sphingosine -0.003 0.065 -10000 0 -0.33 6 6
RelA/NF kappa B1 0.051 0.01 -10000 0 -10000 0 0
mol:glutathione 0 0 -10000 0 -10000 0 0
PAWR 0.033 0.036 -10000 0 -0.48 1 1
TNF-alpha/TNFR1A/TRADD/MADD/cIAP2/RIP1/TRAF2/RAIDD 0.016 0.07 -10000 0 -0.34 3 3
TNFR1A/BAG4/TNF-alpha 0.05 0.063 -10000 0 -0.29 4 4
mol:Sphingosine-1-phosphate -0.014 0.092 -10000 0 -0.34 13 13
MAP2K1 -0.019 0.089 0.19 1 -0.41 4 5
mol:C11AG 0 0 -10000 0 -10000 0 0
RELA 0.035 0.004 -10000 0 -10000 0 0
CYCS 0.032 0.072 0.18 4 -0.25 3 7
TNFRSF1A 0.035 0.007 -10000 0 -10000 0 0
NFKB1 0.035 0.006 -10000 0 -10000 0 0
TNFR1A/BAG4 0.042 0.044 -10000 0 -0.35 2 2
EIF2AK2 -0.026 0.085 -10000 0 -0.26 12 12
TNF-alpha/TNFR1A/FAN 0.05 0.056 -10000 0 -0.3 2 2
response to hydrogen peroxide 0 0 -10000 0 -10000 0 0
CASP8 0.025 0.091 -10000 0 -0.52 4 4
MAP2K2 -0.018 0.081 0.19 1 -0.33 4 5
SMPD3 -0.002 0.1 -10000 0 -0.32 17 17
TNF 0.023 0.066 -10000 0 -0.27 9 9
PKC zeta/PAR4 0.024 0.026 -10000 0 -0.35 1 1
mol:PHOSPHOCHOLINE 0.039 0.097 0.22 30 -0.3 2 32
NF kappa B1/RelA/I kappa B alpha 0.069 0.047 -10000 0 -0.26 2 2
AIFM1 0.023 0.08 0.18 8 -0.32 3 11
BCL2 -0.002 0.098 -10000 0 -0.31 16 16
E-cadherin signaling in the nascent adherens junction

Figure S58.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S58.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CTTN -0.01 0.15 -10000 0 -0.51 16 16
KLHL20 0.027 0.12 0.22 9 -0.26 15 24
CYFIP2 0.009 0.11 -10000 0 -0.46 11 11
Rac1/GDP 0.051 0.14 0.28 3 -0.36 11 14
ENAH -0.022 0.16 -10000 0 -0.52 16 16
AP1M1 0.033 0.036 -10000 0 -0.48 1 1
RAP1B 0.035 0.004 -10000 0 -10000 0 0
RAP1A 0.034 0.008 -10000 0 -10000 0 0
CTNNB1 0.011 0.093 -10000 0 -0.3 15 15
CDC42/GTP 0.039 0.1 -10000 0 -0.36 6 6
ABI1/Sra1/Nap1 -0.029 0.058 -10000 0 -0.18 19 19
E-cadherin/beta catenin/alpha catenin/beta7/alphaE Integrin 0.015 0.13 -10000 0 -0.27 28 28
RAPGEF1 0.037 0.16 0.28 3 -0.49 11 14
CTNND1 0.036 0.004 -10000 0 -10000 0 0
regulation of calcium-dependent cell-cell adhesion -0.004 0.16 -10000 0 -0.52 16 16
CRK 0.033 0.17 -10000 0 -0.55 11 11
E-cadherin/gamma catenin/alpha catenin 0.049 0.081 -10000 0 -0.3 10 10
alphaE/beta7 Integrin 0.014 0.1 -10000 0 -0.35 14 14
IQGAP1 0.034 0.008 -10000 0 -10000 0 0
NCKAP1 0.021 0.068 -10000 0 -0.26 10 10
Rap1/GTP/I-afadin 0.054 0.06 -10000 0 -0.27 6 6
DLG1 -0.01 0.15 -10000 0 -0.5 16 16
ChemicalAbstracts:7440-70-2 0 0 -10000 0 -10000 0 0
mol:PI-3-4-5-P3 -0.011 0.055 -10000 0 -0.28 5 5
MLLT4 0.02 0.087 -10000 0 -0.48 6 6
ARF6/GTP/NME1/Tiam1 0.048 0.06 -10000 0 -0.28 5 5
PI3K -0.011 0.074 -10000 0 -0.38 5 5
ARF6 0.028 0.051 -10000 0 -0.48 2 2
mol:Ca2+ 0 0 -10000 0 -10000 0 0
E-cadherin/gamma catenin 0.03 0.087 -10000 0 -0.35 10 10
TIAM1 0.028 0.054 -10000 0 -0.39 3 3
E-cadherin(dimer)/Ca2+ 0.048 0.096 -10000 0 -0.26 15 15
AKT1 0.031 0.068 0.18 3 -0.21 5 8
PIK3R1 0.028 0.062 -10000 0 -0.48 3 3
CDH1 0.011 0.11 -10000 0 -0.48 10 10
RhoA/GDP 0.062 0.14 0.27 4 -0.36 11 15
actin cytoskeleton organization 0.026 0.092 0.18 10 -0.19 15 25
CDC42/GDP 0.057 0.14 0.27 4 -0.36 11 15
E-cadherin/Ca2+/gamma catenin/alpha catenin/p120 catenin 0.015 0.056 -10000 0 -0.23 10 10
ITGB7 0 0.13 -10000 0 -0.48 14 14
RAC1 0.033 0.011 -10000 0 -10000 0 0
E-cadherin/beta catenin/alpha catenin/p120 catenin 0.052 0.1 -10000 0 -0.28 15 15
E-cadherin/Ca2+/beta catenin/alpha catenin 0.031 0.088 -10000 0 -0.26 15 15
mol:GDP 0.047 0.16 0.27 4 -0.43 11 15
CDC42/GTP/IQGAP1 0.042 0.019 -10000 0 -10000 0 0
JUP 0.033 0.018 -10000 0 -0.2 1 1
p120 catenin/RhoA/GDP 0.071 0.15 0.29 3 -0.37 11 14
RAC1/GTP/IQGAP1 0.042 0.017 -10000 0 -10000 0 0
PIP5K1C/AP1M1 0.049 0.03 -10000 0 -0.35 1 1
RHOA 0.035 0.004 -10000 0 -10000 0 0
CDC42 0.032 0.019 -10000 0 -0.2 1 1
CTNNA1 0.035 0.006 -10000 0 -10000 0 0
positive regulation of S phase of mitotic cell cycle 0.025 0.074 0.16 13 -0.2 5 18
NME1 0.031 0.037 -10000 0 -0.48 1 1
clathrin coat assembly 0 0 -10000 0 -10000 0 0
TJP1 -0.011 0.15 -10000 0 -0.51 16 16
regulation of cell-cell adhesion -0.002 0.069 -10000 0 -0.31 6 6
WASF2 0.01 0.053 0.11 9 -0.15 3 12
Rap1/GTP 0.073 0.13 0.29 2 -0.41 6 8
E-cadherin/gamma catenin/alpha catenin/beta7/alphaE Integrin 0.039 0.12 -10000 0 -0.26 24 24
CCND1 0.028 0.088 0.18 12 -0.24 5 17
VAV2 0 0.29 -10000 0 -0.68 25 25
RAP1/GDP 0.075 0.14 0.3 2 -0.43 6 8
adherens junction assembly -0.011 0.14 -10000 0 -0.49 16 16
homophilic cell adhesion 0 0 -10000 0 -10000 0 0
ABI1 0.035 0.004 -10000 0 -10000 0 0
PIP5K1C 0.034 0.007 -10000 0 -10000 0 0
regulation of heterotypic cell-cell adhesion 0.014 0.12 -10000 0 -0.25 28 28
E-cadherin/beta catenin -0.004 0.081 -10000 0 -0.34 11 11
mol:GTP 0 0 -10000 0 -10000 0 0
SRC -0.022 0.14 -10000 0 -0.51 15 15
PIK3CA 0.035 0.006 -10000 0 -10000 0 0
Rac1/GTP -0.047 0.14 -10000 0 -0.39 23 23
E-cadherin/beta catenin/alpha catenin 0.034 0.1 -10000 0 -0.3 15 15
ITGAE 0.026 0.031 -10000 0 -0.2 3 3
E-cadherin/Ca2+/beta catenin/alpha catenin/p120 catenin -0.004 0.16 -10000 0 -0.54 16 16
Syndecan-4-mediated signaling events

Figure S59.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S59.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PTK2 0.009 0.12 -10000 0 -0.45 11 11
Syndecan-4/Syndesmos 0.065 0.17 -10000 0 -0.53 6 6
positive regulation of JNK cascade 0.031 0.2 -10000 0 -0.54 13 13
Syndecan-4/ADAM12 0.037 0.19 -10000 0 -0.55 10 10
CCL5 -0.04 0.16 -10000 0 -0.35 40 40
Rac1/GDP 0.024 0.008 -10000 0 -10000 0 0
DNM2 0.035 0.006 -10000 0 -10000 0 0
ITGA5 0.025 0.049 -10000 0 -0.2 9 9
SDCBP 0.03 0.02 -10000 0 -0.2 1 1
PLG 0.002 0.047 -10000 0 -0.46 1 1
ADAM12 -0.025 0.14 -10000 0 -0.3 36 36
mol:GTP 0 0 -10000 0 -10000 0 0
NUDT16L1 0.035 0.005 -10000 0 -10000 0 0
mol:PI-4-5-P2 0 0 -10000 0 -10000 0 0
Syndecan-4/PKC alpha -0.021 0.026 -10000 0 -10000 0 0
Syndecan-4/Laminin alpha1 0.034 0.16 -10000 0 -0.53 6 6
Syndecan-4/CXCL12/CXCR4 0.033 0.21 -10000 0 -0.57 13 13
Syndecan-4/Laminin alpha3 0.027 0.17 -10000 0 -0.56 7 7
MDK -0.01 0.13 -10000 0 -0.34 25 25
Syndecan-4/FZD7 0.023 0.2 -10000 0 -0.53 12 12
Syndecan-4/Midkine 0.043 0.18 -10000 0 -0.59 7 7
FZD7 -0.058 0.18 -10000 0 -0.36 50 50
Syndecan-4/FGFR1/FGF 0.045 0.19 -10000 0 -0.53 10 10
THBS1 0.016 0.085 -10000 0 -0.36 9 9
integrin-mediated signaling pathway 0.049 0.18 -10000 0 -0.49 12 12
positive regulation of MAPKKK cascade 0.031 0.2 -10000 0 -0.54 13 13
Syndecan-4/TACI 0.044 0.16 -10000 0 -0.53 6 6
CXCR4 -0.028 0.15 -10000 0 -0.32 37 37
cell adhesion -0.005 0.075 0.2 1 -0.3 9 10
Syndecan-4/Dynamin 0.059 0.17 -10000 0 -0.53 6 6
Syndecan-4/TSP1 0.05 0.18 -10000 0 -0.53 10 10
Syndecan-4/GIPC 0.057 0.17 -10000 0 -0.49 10 10
Syndecan-4/RANTES 0.026 0.19 -10000 0 -0.57 9 9
ITGB1 0.034 0.017 -10000 0 -0.2 1 1
LAMA1 0.026 0.016 -10000 0 -10000 0 0
LAMA3 0.004 0.087 -10000 0 -0.28 15 15
RAC1 0.033 0.011 -10000 0 -10000 0 0
PRKCA 0.022 0.14 0.67 8 -0.42 1 9
Syndecan-4/alpha-Actinin 0.052 0.17 -10000 0 -0.52 7 7
TFPI 0.024 0.058 -10000 0 -0.24 9 9
F2 0.036 0.083 -10000 0 -0.4 6 6
alpha5/beta1 Integrin 0.043 0.041 -10000 0 -10000 0 0
positive regulation of cell adhesion 0.017 0.16 -10000 0 -0.57 6 6
ACTN1 0.033 0.01 -10000 0 -10000 0 0
TNC 0.011 0.086 -10000 0 -0.25 18 18
Syndecan-4/CXCL12 0.042 0.19 -10000 0 -0.55 9 9
FGF6 0.027 0.056 -10000 0 -0.34 4 4
RHOA 0.035 0.004 -10000 0 -10000 0 0
CXCL12 -0.014 0.13 -10000 0 -0.32 29 29
TNFRSF13B 0.028 0.022 -10000 0 -0.2 1 1
FGF2 -0.003 0.12 -10000 0 -0.3 24 24
FGFR1 0.022 0.06 -10000 0 -0.3 6 6
Syndecan-4/PI-4-5-P2 -0.026 0.12 -10000 0 -0.48 11 11
mol:GDP 0 0 -10000 0 -10000 0 0
FN1 -0.044 0.12 -10000 0 -0.37 19 19
cell migration -0.011 0.015 -10000 0 -10000 0 0
PRKCD 0.006 0.034 -10000 0 -10000 0 0
vasculogenesis 0.05 0.18 -10000 0 -0.5 11 11
SDC4 -0.016 0.12 -10000 0 -0.51 11 11
Syndecan-4/Tenascin C 0.049 0.18 -10000 0 -0.56 8 8
Syndecan-4/PI-4-5-P2/PKC alpha -0.017 0.02 -10000 0 -10000 0 0
Syndecan-4/Syntenin 0.047 0.16 -10000 0 -0.53 6 6
MMP9 -0.005 0.09 -10000 0 -0.3 15 15
Rac1/GTP -0.005 0.077 0.21 1 -0.31 9 10
cytoskeleton organization 0.064 0.16 -10000 0 -0.5 7 7
GIPC1 0.029 0.053 -10000 0 -0.39 3 3
Syndecan-4/TFPI 0.058 0.18 -10000 0 -0.56 6 6
Aurora B signaling

Figure S60.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S60.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Condensin I complex -0.015 0.045 -10000 0 -0.1 41 41
STMN1 0.006 0.064 -10000 0 -0.43 4 4
Aurora B/RasGAP/Survivin 0.039 0.095 -10000 0 -0.36 9 9
Chromosomal passenger complex/Cul3 protein complex -0.042 0.12 -10000 0 -0.33 19 19
BIRC5 0.023 0.077 -10000 0 -0.45 5 5
DES -0.14 0.32 -10000 0 -0.68 53 53
Aurora C/Aurora B/INCENP 0.036 0.079 -10000 0 -0.27 11 11
Aurora B/TACC1 0.016 0.077 -10000 0 -0.3 9 9
Aurora B/PP2A 0.038 0.047 -10000 0 -0.35 2 2
mol:GTP 0 0 -10000 0 -10000 0 0
CBX5 0.005 0.036 -10000 0 -0.19 6 6
mitotic metaphase/anaphase transition 0.001 0.004 0.012 9 -0.009 2 11
NDC80 0.003 0.043 -10000 0 -0.35 3 3
Cul3 protein complex -0.031 0.14 -10000 0 -0.3 28 28
KIF2C -0.009 0.12 -10000 0 -0.63 6 6
PEBP1 -0.001 0.003 -10000 0 -0.018 4 4
KIF20A 0.026 0.072 -10000 0 -0.49 4 4
mol:GDP 0 0 -10000 0 -10000 0 0
Aurora B/RasGAP 0.029 0.076 -10000 0 -0.35 7 7
SEPT1 0.034 0.018 -10000 0 -0.2 1 1
SMC2 0 0 -10000 0 -10000 0 0
SMC4 0 0 -10000 0 -10000 0 0
NSUN2/NPM1/Nucleolin -0.082 0.24 -10000 0 -0.52 41 41
PSMA3 0.029 0.041 -10000 0 -0.34 2 2
G2/M transition of mitotic cell cycle 0.001 0.004 0.009 27 -0.008 1 28
H3F3B 0.008 0.058 -10000 0 -0.35 5 5
AURKB 0.022 0.065 -10000 0 -0.5 3 3
AURKC 0.033 0.024 -10000 0 -0.2 2 2
CDCA8 0.032 0.039 -10000 0 -0.52 1 1
cytokinesis -0.02 0.16 -10000 0 -0.48 15 15
Aurora B/Septin1 -0.012 0.17 -10000 0 -0.52 10 10
AURKA 0.001 0.004 0.009 27 -0.008 1 28
INCENP 0.013 0.1 -10000 0 -0.41 10 10
KLHL13 -0.098 0.18 -10000 0 -0.29 85 85
BUB1 0.024 0.081 -10000 0 -0.49 5 5
hSgo1/Aurora B/Survivin 0.036 0.087 -10000 0 -0.34 8 8
EVI5 0.031 0.04 -10000 0 -0.34 2 2
RhoA/GTP 0.016 0.15 -10000 0 -0.53 8 8
SGOL1 0.023 0.07 -10000 0 -0.32 7 7
CENPA -0.027 0.13 -10000 0 -0.36 14 14
NCAPG 0 0 -10000 0 -10000 0 0
Aurora B/HC8 Proteasome 0.035 0.06 -10000 0 -0.36 4 4
NCAPD2 0 0 -10000 0 -10000 0 0
Aurora B/PP1-gamma 0.038 0.052 -10000 0 -0.36 3 3
RHOA 0.035 0.004 -10000 0 -10000 0 0
NCAPH 0 0 -10000 0 -10000 0 0
NPM1 -0.051 0.18 -10000 0 -0.66 8 8
RASA1 0.024 0.073 -10000 0 -0.43 5 5
KLHL9 0.032 0.036 -10000 0 -0.48 1 1
mitotic prometaphase -0.001 0.003 -10000 0 -0.018 4 4
proteasomal ubiquitin-dependent protein catabolic process 0.035 0.06 -10000 0 -0.36 4 4
PPP1CC 0.036 0.004 -10000 0 -10000 0 0
Centraspindlin 0.005 0.16 -10000 0 -0.55 9 9
RhoA/GDP 0.026 0.003 -10000 0 -10000 0 0
NSUN2 -0.038 0.14 -10000 0 -0.36 13 13
MYLK 0.007 0.053 -10000 0 -0.31 5 5
KIF23 0.029 0.053 -10000 0 -0.5 2 2
VIM -0.018 0.1 -10000 0 -0.38 13 13
RACGAP1 0.032 0.038 -10000 0 -0.5 1 1
mitosis 0 0 -10000 0 -10000 0 0
NCL -0.052 0.16 -10000 0 -0.34 42 42
Chromosomal passenger complex -0.025 0.14 -10000 0 -0.39 15 15
Chromosomal passenger complex/EVI5 0.054 0.12 -10000 0 -0.34 13 13
TACC1 0.009 0.095 -10000 0 -0.33 13 13
PPP2R5D 0.034 0.017 -10000 0 -0.2 1 1
CUL3 0.032 0.029 -10000 0 -0.2 3 3
response to DNA damage stimulus 0 0 -10000 0 -10000 0 0
Visual signal transduction: Cones

Figure S61.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S61.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Cone Metarhodopsin II/Cone Transducin 0.04 0.067 -10000 0 -0.25 8 8
RGS9BP 0.007 0.1 -10000 0 -0.3 17 17
mol:GTP 0 0 -10000 0 -10000 0 0
GRK1 0 0 -10000 0 -10000 0 0
mol:Na + 0.012 0.08 -10000 0 -0.32 7 7
mol:ADP 0.009 0.01 -10000 0 -0.13 1 1
GNAT2 0.014 0.097 -10000 0 -0.4 10 10
RGS9-1/Gbeta5/R9AP 0.01 0.12 -10000 0 -0.3 20 20
mol:GDP 0 0 -10000 0 -10000 0 0
PDE6H/GNAT2/GTP 0.025 0.085 -10000 0 -0.27 14 14
GRK7 0.034 0.017 -10000 0 -0.2 1 1
CNGB3 0 0.094 -10000 0 -0.26 21 21
Cone Metarhodopsin II/X-Arrestin 0.027 0 -10000 0 -10000 0 0
mol:Ca2+ 0.023 0.1 0.19 30 -0.29 9 39
Cone PDE6 0.02 0.13 -10000 0 -0.28 23 23
Cone Metarhodopsin II 0.022 0.009 -10000 0 -0.096 1 1
Na + (4 Units) 0.025 0.085 -10000 0 -0.29 9 9
GNAT2/GDP 0.012 0.12 -10000 0 -0.28 22 22
GNB5 -0.004 0.13 -10000 0 -0.38 19 19
mol:GMP (4 units) 0 0.08 0.19 3 -0.29 12 15
Cone Transducin 0.043 0.072 -10000 0 -0.27 8 8
SLC24A2 0.029 0.046 -10000 0 -0.27 4 4
GNB3/GNGT2 0.043 0.04 -10000 0 -0.35 1 1
GNB3 0.033 0.018 -10000 0 -0.2 1 1
GNAT2/GTP 0.011 0.07 -10000 0 -0.28 10 10
CNGA3 0.019 0.076 -10000 0 -0.28 11 11
ARR3 0.036 0 -10000 0 -10000 0 0
absorption of light 0 0 -10000 0 -10000 0 0
cGMP/Cone CNG Channel 0.012 0.08 -10000 0 -0.32 7 7
mol:Pi 0.009 0.12 -10000 0 -0.3 20 20
Cone CNG Channel 0.017 0.11 -10000 0 -0.29 15 15
mol:all-trans-retinal 0 0 -10000 0 -10000 0 0
mol:K + 0.029 0.046 -10000 0 -0.27 4 4
RGS9 0.025 0.051 -10000 0 -0.25 6 6
PDE6C 0.025 0.054 -10000 0 -0.24 7 7
GNGT2 0.028 0.046 -10000 0 -0.27 4 4
mol:cGMP (4 units) 0 0 -10000 0 -10000 0 0
PDE6H 0.022 0.08 -10000 0 -0.48 5 5
Signaling events mediated by PTP1B

Figure S62.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S62.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PDGFRB 0.033 0.036 -10000 0 -0.48 1 1
Jak2/Leptin Receptor 0.029 0.13 0.29 1 -0.45 5 6
PTP1B/AKT1 0.023 0.098 -10000 0 -0.28 5 5
FYN 0.006 0.11 -10000 0 -0.34 16 16
p210 bcr-abl/PTP1B 0.017 0.1 0.25 1 -0.29 7 8
EGFR 0.011 0.091 -10000 0 -0.42 8 8
EGF/EGFR -0.013 0.14 -10000 0 -0.31 23 23
CSF1 0.034 0.018 -10000 0 -0.2 1 1
AKT1 0.03 0.03 -10000 0 -0.2 3 3
INSR 0.023 0.075 -10000 0 -0.39 6 6
PTP1B/N-cadherin 0.002 0.11 0.24 1 -0.31 8 9
Insulin Receptor/Insulin 0.04 0.098 -10000 0 -0.36 2 2
HCK -0.013 0.11 -10000 0 -0.35 17 17
CRK 0.03 0.013 -10000 0 -10000 0 0
TYK2 0.018 0.11 0.3 5 -0.29 5 10
EGF -0.087 0.19 -10000 0 -0.32 72 72
YES1 0.028 0.015 -10000 0 -10000 0 0
CAV1 0.026 0.13 0.28 5 -0.34 7 12
TXN 0.034 0.006 -10000 0 -10000 0 0
PTP1B/IRS1/GRB2 0.031 0.12 -10000 0 -0.3 7 7
cell migration -0.017 0.1 0.29 7 -0.25 1 8
STAT3 0.035 0.007 -10000 0 -10000 0 0
PRLR 0.009 0.12 -10000 0 -0.46 12 12
ITGA2B 0.034 0.006 -10000 0 -10000 0 0
CSF1R 0.018 0.09 -10000 0 -0.41 8 8
Prolactin Receptor/Prolactin 0.037 0.096 -10000 0 -0.35 11 11
FGR 0.025 0.044 -10000 0 -0.2 7 7
PTP1B/p130 Cas 0.028 0.11 0.24 1 -0.29 5 6
Crk/p130 Cas 0.029 0.1 -10000 0 -0.29 4 4
DOK1 0.02 0.1 0.23 2 -0.29 5 7
JAK2 0.022 0.12 -10000 0 -0.41 7 7
Jak2/Leptin Receptor/Leptin 0.02 0.13 -10000 0 -0.34 4 4
PIK3R1 0.028 0.062 -10000 0 -0.48 3 3
PTPN1 0.017 0.11 0.25 1 -0.29 7 8
LYN 0.03 0.013 -10000 0 -10000 0 0
CDH2 -0.003 0.095 -10000 0 -0.28 18 18
SRC 0.016 0.12 -10000 0 -0.49 8 8
ITGB3 0.032 0.018 -10000 0 -0.2 1 1
CAT1/PTP1B 0.018 0.18 0.27 23 -0.43 13 36
CAPN1 0.017 0.082 -10000 0 -0.32 10 10
CSK 0.033 0.01 -10000 0 -10000 0 0
PI3K 0.049 0.11 -10000 0 -0.41 3 3
mol:H2O2 -0.001 0.005 -10000 0 -10000 0 0
STAT3 (dimer) 0.019 0.13 -10000 0 -0.35 4 4
negative regulation of transcription 0.022 0.12 -10000 0 -0.4 7 7
FCGR2A -0.028 0.15 -10000 0 -0.36 33 33
FER 0.022 0.051 -10000 0 -0.2 10 10
alphaIIb/beta3 Integrin 0.047 0.017 -10000 0 -10000 0 0
BLK 0.007 0.089 -10000 0 -0.32 12 12
Insulin Receptor/Insulin/Shc 0.059 0.052 -10000 0 -0.3 3 3
RHOA 0.034 0.005 -10000 0 -10000 0 0
LEPR 0.024 0.062 -10000 0 -0.28 7 7
BCAR1 0.034 0.017 -10000 0 -0.2 1 1
p210 bcr-abl/Grb2 0.034 0.008 -10000 0 -10000 0 0
mol:NADPH -0.001 0.003 -10000 0 -10000 0 0
TRPV6 -0.051 0.22 0.23 6 -0.54 22 28
PRL 0.038 0.024 -10000 0 -0.2 2 2
SOCS3 -0.05 0.31 -10000 0 -1.3 12 12
SPRY2 -0.002 0.11 -10000 0 -0.44 12 12
Insulin Receptor/Insulin/IRS1 0.045 0.092 -10000 0 -0.36 8 8
CSF1/CSF1R 0.033 0.12 0.25 1 -0.32 8 9
Ras protein signal transduction -0.002 0.082 0.47 5 -10000 0 5
IRS1 0.013 0.098 -10000 0 -0.38 11 11
INS 0.035 0.008 -10000 0 -10000 0 0
LEP 0.022 0.066 -10000 0 -0.27 9 9
STAT5B 0.027 0.1 0.22 2 -0.28 5 7
STAT5A 0.025 0.11 0.22 2 -0.3 6 8
GRB2 0.034 0.008 -10000 0 -10000 0 0
PDGFB-D/PDGFRB 0.029 0.11 0.24 1 -0.29 8 9
CSN2 0.012 0.05 -10000 0 -10000 0 0
PIK3CA 0.035 0.006 -10000 0 -10000 0 0
LAT -0.011 0.17 -10000 0 -0.5 20 20
YBX1 0.046 0.029 -10000 0 -0.36 1 1
LCK -0.015 0.14 -10000 0 -0.35 26 26
SHC1 0.035 0.007 -10000 0 -10000 0 0
NOX4 -0.043 0.16 -10000 0 -0.31 47 47
p75(NTR)-mediated signaling

Figure S63.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S63.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Sortilin/TRAF6 0.049 0.032 -10000 0 -0.35 1 1
Necdin/E2F1 -0.004 0.091 -10000 0 -0.35 10 10
proNGF (dimer)/p75(NTR)/Sortilin/NADE/14-3-3 E 0.009 0.13 -10000 0 -0.25 35 35
NGF (dimer)/p75(NTR)/BEX1 0.045 0.019 -10000 0 -10000 0 0
NT-4/5 (dimer)/p75(NTR) 0.024 0.012 -10000 0 -0.13 1 1
IKBKB 0.031 0.012 -10000 0 -10000 0 0
AKT1 0.017 0.047 -10000 0 -0.25 3 3
IKBKG 0.035 0.017 -10000 0 -0.2 1 1
BDNF 0.017 0.084 -10000 0 -0.3 12 12
MGDIs/NGR/p75(NTR)/LINGO1 0.032 0.052 -10000 0 -0.3 3 3
FURIN 0.027 0.049 -10000 0 -0.26 5 5
proBDNF (dimer)/p75(NTR)/Sortilin 0.051 0.074 -10000 0 -0.33 5 5
LINGO1 0 0 -10000 0 -10000 0 0
Sortilin/TRAF6/NRIF 0.006 0.084 -10000 0 -0.27 2 2
proBDNF (dimer) 0.017 0.084 -10000 0 -0.3 12 12
NTRK1 0.033 0.018 -10000 0 -0.2 1 1
RTN4R 0.02 0.073 -10000 0 -0.3 9 9
neuron apoptosis -0.031 0.13 -10000 0 -0.48 7 7
IRAK1 0.034 0.023 -10000 0 -0.2 2 2
SHC1 0.018 0.01 -10000 0 -10000 0 0
ARHGDIA 0.035 0.006 -10000 0 -10000 0 0
RhoA/GTP 0.026 0.003 -10000 0 -10000 0 0
Gamma Secretase 0.05 0.099 -10000 0 -0.26 10 10
proNGF (dimer)/p75(NTR)/Sortilin/MAGE-H1 0.022 0.1 -10000 0 -0.26 18 18
MAGEH1 -0.026 0.15 -10000 0 -0.34 34 34
proNGF (dimer)/p75(NTR)/Sortilin/Necdin 0.02 0.1 -10000 0 -0.28 18 18
Mammalian IAPs/DIABLO 0.035 0.085 -10000 0 -0.26 11 11
proNGF (dimer) 0 0 -10000 0 -10000 0 0
MAGED1 0.024 0.075 -10000 0 -0.39 6 6
APP 0.013 0.093 -10000 0 -0.36 11 11
NT-4/5 (dimer) 0 0 -10000 0 -10000 0 0
ZNF274 0.023 0.075 -10000 0 -0.39 6 6
RhoA/GDP/RHOGDI 0.05 0.023 -10000 0 -10000 0 0
NGF 0 0 -10000 0 -10000 0 0
cell cycle arrest -0.009 0.04 0.2 5 -0.23 2 7
NGF (dimer)/p75(NTR)/TRAF6/RIP2/IRAK 0.025 0.04 -10000 0 -0.28 3 3
NT-4/5 (dimer)/p75(NTR)/TRAF6 0.045 0.016 -10000 0 -10000 0 0
NCSTN 0.034 0.007 -10000 0 -10000 0 0
mol:GTP -0.001 0.11 -10000 0 -0.3 23 23
PSENEN 0.031 0.04 -10000 0 -0.34 2 2
mol:ceramide 0.022 0.036 0.19 5 -0.23 2 7
NGF (dimer)/p75(NTR)/TRAF6/RIP2/IRAK/p62/Atypical PKCs 0.02 0.037 -10000 0 -0.22 4 4
p75(NTR)/beta APP 0.032 0.071 -10000 0 -0.35 5 5
BEX1 0.035 0.017 -10000 0 -0.2 1 1
mol:GDP 0.003 0.008 -10000 0 -10000 0 0
NGF (dimer) -0.046 0.14 -10000 0 -0.28 51 51
MGDIs/NGR/p75(NTR)/LINGO1/RHOGDI 0.051 0.055 -10000 0 -0.27 3 3
PIK3R1 0.028 0.062 -10000 0 -0.48 3 3
RAC1/GTP 0.036 0.017 -10000 0 -10000 0 0
MYD88 0.036 0.004 -10000 0 -10000 0 0
CHUK 0.027 0.062 -10000 0 -0.48 3 3
NGF (dimer)/p75(NTR)/PKA 0 0.11 -10000 0 -0.3 23 23
RHOB 0.019 0.081 -10000 0 -0.32 10 10
RHOA 0.035 0.004 -10000 0 -10000 0 0
MAGE-G1/E2F1 0.021 0.047 -10000 0 -0.35 2 2
NT3 (dimer) 0.01 0.097 -10000 0 -0.32 14 14
TP53 -0.04 0.11 -10000 0 -0.27 37 37
PRDM4 0.022 0.036 0.19 5 -0.23 2 7
BDNF (dimer) -0.14 0.21 -10000 0 -0.34 94 94
PIK3CA 0.035 0.006 -10000 0 -10000 0 0
SORT1 0.032 0.04 -10000 0 -0.34 2 2
activation of caspase activity 0.004 0.12 -10000 0 -0.25 35 35
proNGF (dimer)/p75(NTR)/Sortilin/TRAF6 0.061 0.034 -10000 0 -0.23 2 2
RHOC 0.035 0.006 -10000 0 -10000 0 0
XIAP 0 0 -10000 0 -10000 0 0
MAPK10 -0.004 0.093 0.26 3 -0.35 3 6
DIABLO 0.036 0.004 -10000 0 -10000 0 0
SMPD2 0.022 0.036 0.19 5 -0.23 2 7
APH1B 0.02 0.073 -10000 0 -0.3 9 9
APH1A 0.003 0.11 -10000 0 -0.31 19 19
proNGF (dimer)/p75(NTR)/Sortilin 0.042 0.032 -10000 0 -0.25 2 2
PSEN1 0.032 0.019 -10000 0 -0.2 1 1
APAF-1/Pro-Caspase 9 0.027 0.085 -10000 0 -0.34 9 9
NT3 (dimer)/p75(NTR) 0.029 0.077 -10000 0 -0.34 7 7
MAPK8 0.006 0.084 0.26 3 -0.34 3 6
MAPK9 0.005 0.082 0.27 2 -0.34 2 4
APAF1 0.008 0.11 -10000 0 -0.35 15 15
NTF3 0.01 0.097 -10000 0 -0.32 14 14
NTF4 0 0 -10000 0 -10000 0 0
NDN -0.023 0.15 -10000 0 -0.37 29 29
RAC1/GDP 0.024 0.008 -10000 0 -10000 0 0
RhoA-B-C/GDP 0.019 0.11 -10000 0 -0.24 26 26
p75 CTF/Sortilin/TRAF6/NRIF 0.077 0.063 -10000 0 -0.27 5 5
RhoA-B-C/GTP -0.001 0.11 -10000 0 -0.3 23 23
proBDNF (dimer)/p75(NTR)/Sortilin/TRAF6/NRIF 0.072 0.091 -10000 0 -0.29 8 8
proBDNF (dimer)/p75(NTR)/Sortilin/TRAF6 0.068 0.075 -10000 0 -0.3 5 5
PRKACB -0.032 0.17 -10000 0 -0.41 31 31
proBDNF (dimer)/p75 ECD 0.037 0.066 -10000 0 -0.35 4 4
ChemicalAbstracts:86-01-1 0 0 -10000 0 -10000 0 0
BIRC3 -0.011 0.13 -10000 0 -0.3 28 28
BIRC2 0.034 0.018 -10000 0 -0.2 1 1
neuron projection morphogenesis -0.063 0.1 -10000 0 -0.32 18 18
BAD -0.003 0.088 0.26 2 -0.33 3 5
RIPK2 0.022 0.063 -10000 0 -0.48 3 3
NGFR 0.033 0.018 -10000 0 -0.2 1 1
CYCS 0.009 0.057 -10000 0 -0.25 7 7
ADAM17 0.036 0.002 -10000 0 -10000 0 0
NGF (dimer)/p75(NTR)/TRAF6/RIP2 0.049 0.05 -10000 0 -0.29 3 3
BCL2L11 -0.003 0.087 0.26 2 -0.33 3 5
BDNF (dimer)/p75(NTR) 0.035 0.067 -10000 0 -0.35 4 4
PI3K 0.057 0.046 -10000 0 -0.27 3 3
proNGF (dimer)/p75(NTR)/Sortilin/MAGE-G1 0.056 0.039 -10000 0 -0.23 2 2
NDNL2 0.032 0.019 -10000 0 -0.2 1 1
YWHAE 0.03 0.013 -10000 0 -10000 0 0
PRKCI 0.028 0.056 -10000 0 -0.34 4 4
NGF (dimer)/p75(NTR) 0.024 0.012 -10000 0 -0.13 1 1
ChemicalAbstracts:146-91-8 0 0 -10000 0 -10000 0 0
proNGF (dimer)/p75(NTR)/Sortilin/NRAGE 0.053 0.059 -10000 0 -0.26 6 6
TRAF6 0.036 0.004 -10000 0 -10000 0 0
RAC1 0.033 0.011 -10000 0 -10000 0 0
PRKCZ 0 0 -10000 0 -10000 0 0
PLG 0.032 0.036 -10000 0 -0.48 1 1
oligodendrocyte cell fate commitment 0 0 -10000 0 -10000 0 0
CASP6 0.014 0.063 -10000 0 -0.31 6 6
SQSTM1 0.034 0.017 -10000 0 -0.2 1 1
NGFRAP1 -0.063 0.2 -10000 0 -0.44 43 43
CASP3 -0.004 0.083 0.24 1 -0.33 2 3
E2F1 0.014 0.052 -10000 0 -0.48 2 2
CASP9 0.033 0.009 -10000 0 -10000 0 0
IKK complex 0.057 0.059 -10000 0 -0.43 1 1
NGF (dimer)/TRKA 0.025 0.012 -10000 0 -0.13 1 1
MMP7 -0.12 0.22 -10000 0 -0.39 77 77
proNGF (dimer)/p75(NTR)/Sortilin/TRAF6/NRIF 0.067 0.061 -10000 0 -0.24 6 6
MMP3 -0.13 0.22 -10000 0 -0.38 84 84
APAF-1/Caspase 9 -0.021 0.086 -10000 0 -0.37 4 4
PDGFR-alpha signaling pathway

Figure S64.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S64.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PDGFRA 0.004 0.1 -10000 0 -0.43 9 9
PDGF/PDGFRA/CRKL 0.031 0.08 -10000 0 -0.35 8 8
positive regulation of JUN kinase activity 0.066 0.07 -10000 0 -0.26 7 7
CRKL 0.029 0.051 -10000 0 -0.48 2 2
PDGF/PDGFRA/Caveolin-3 0.034 0.075 -10000 0 -0.34 7 7
AP1 -0.11 0.29 -10000 0 -0.76 27 27
mol:IP3 -0.01 0.051 -10000 0 -0.36 3 3
PLCG1 -0.01 0.051 -10000 0 -0.36 3 3
PDGF/PDGFRA/alphaV Integrin 0.024 0.1 -10000 0 -0.37 11 11
RAPGEF1 0.035 0.004 -10000 0 -10000 0 0
CRK 0.03 0.013 -10000 0 -10000 0 0
mol:Ca2+ -0.01 0.05 -10000 0 -0.36 3 3
CAV3 0.034 0.018 -10000 0 -0.2 1 1
CAV1 0.023 0.064 -10000 0 -0.27 8 8
SHC/Grb2/SOS1 0.068 0.071 -10000 0 -0.26 7 7
PDGF/PDGFRA/Shf -0.033 0.14 -10000 0 -0.35 27 27
FOS -0.13 0.27 -10000 0 -0.75 27 27
JUN -0.046 0.096 -10000 0 -0.36 15 15
oligodendrocyte development 0.024 0.1 -10000 0 -0.37 11 11
GRB2 0.034 0.008 -10000 0 -10000 0 0
PIK3R1 0.028 0.062 -10000 0 -0.48 3 3
mol:DAG -0.01 0.051 -10000 0 -0.36 3 3
PDGF/PDGFRA 0.004 0.1 -10000 0 -0.43 9 9
actin cytoskeleton reorganization 0.031 0.078 -10000 0 -0.32 8 8
SRF 0.011 0.03 -10000 0 -0.35 1 1
SHC1 0.035 0.007 -10000 0 -10000 0 0
PI3K 0.05 0.075 -10000 0 -0.29 8 8
PDGF/PDGFRA/Crk/C3G 0.044 0.07 -10000 0 -0.28 7 7
JAK1 -0.005 0.073 -10000 0 -0.34 8 8
ELK1/SRF 0.032 0.091 0.29 2 -0.28 4 6
SHB 0.032 0.029 -10000 0 -0.2 3 3
SHF -0.052 0.16 -10000 0 -0.31 52 52
CSNK2A1 0.025 0.031 -10000 0 -10000 0 0
GO:0007205 -0.007 0.061 0.23 4 -0.38 3 7
SOS1 0.036 0.002 -10000 0 -10000 0 0
Ras protein signal transduction 0.066 0.07 -10000 0 -0.26 7 7
PDGF/PDGFRA/SHB 0.032 0.078 -10000 0 -0.32 8 8
PDGF/PDGFRA/Caveolin-1 0.025 0.092 -10000 0 -0.38 8 8
ITGAV 0.021 0.083 -10000 0 -0.4 7 7
ELK1 -0.013 0.059 0.2 4 -0.3 4 8
PIK3CA 0.035 0.006 -10000 0 -10000 0 0
PDGF/PDGFRA/Crk 0.028 0.074 -10000 0 -0.34 7 7
JAK-STAT cascade -0.005 0.073 -10000 0 -0.34 8 8
cell proliferation -0.034 0.14 -10000 0 -0.35 27 27
IL2 signaling events mediated by PI3K

Figure S65.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S65.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BCL2L1 0.063 0.14 -10000 0 -0.5 3 3
UGCG 0.009 0.093 -10000 0 -0.7 3 3
AKT1/mTOR/p70S6K/Hsp90/TERT -0.022 0.16 -10000 0 -0.45 16 16
mol:GTP 0 0 -10000 0 -10000 0 0
mol:glucosylceramide 0.008 0.092 -10000 0 -0.69 3 3
mol:DAG -0.011 0.015 0.17 1 -10000 0 1
CaM/Ca2+/Calcineurin A alpha-beta B1 -0.036 0.21 -10000 0 -0.54 21 21
FRAP1 -0.056 0.25 -10000 0 -0.65 21 21
FOXO3 -0.038 0.2 -10000 0 -0.48 24 24
AKT1 -0.042 0.21 -10000 0 -0.52 24 24
GAB2 0.035 0.005 -10000 0 -10000 0 0
SMPD1 0.015 0.069 -10000 0 -0.84 1 1
SGMS1 -0.002 0.036 -10000 0 -0.084 20 20
positive regulation of NF-kappaB transcription factor activity 0 0 -10000 0 -10000 0 0
mol:Ca2+ 0 0 -10000 0 -10000 0 0
mol:GDP 0.004 0.038 -10000 0 -0.29 3 3
CALM1 0.032 0.011 -10000 0 -10000 0 0
cell proliferation 0.004 0.11 -10000 0 -0.35 5 5
EIF3A 0 0 -10000 0 -10000 0 0
PI3K 0.048 0.05 -10000 0 -0.35 3 3
RPS6KB1 -0.004 0.13 -10000 0 -0.8 4 4
mol:sphingomyelin -0.011 0.015 0.17 1 -10000 0 1
natural killer cell activation 0 0.003 -10000 0 -0.013 7 7
JAK3 0.037 0.007 -10000 0 -10000 0 0
PIK3R1 0.029 0.062 -10000 0 -0.48 3 3
JAK1 0.035 0.037 -10000 0 -0.48 1 1
NFKB1 0.035 0.006 -10000 0 -10000 0 0
MYC -0.027 0.27 -10000 0 -0.95 12 12
MYB -0.066 0.34 -10000 0 -1.3 15 15
IL2/IL2R alpha/beta/gamma/JAK1/LCK/JAK3/SHC/GAB2/GRB2/SOS1/SHP2/PI3K -0.025 0.18 -10000 0 -0.47 18 18
40S S6 ribosomal protein /40s Ribosomal subunit/eIF3 0.014 0.13 -10000 0 -0.66 5 5
mol:PI-3-4-5-P3 -0.024 0.17 -10000 0 -0.46 18 18
Rac1/GDP 0.023 0.04 -10000 0 -0.27 3 3
T cell proliferation -0.024 0.16 -10000 0 -0.43 18 18
SHC1 0.034 0.007 -10000 0 -10000 0 0
RAC1 0.032 0.011 -10000 0 -10000 0 0
positive regulation of cyclin-dependent protein kinase activity -0.001 0.018 -10000 0 -0.066 15 15
PRKCZ -0.026 0.17 -10000 0 -0.45 18 18
NF kappa B1 p50/RelA -0.023 0.22 -10000 0 -0.54 21 21
IL2/IL2R beta/gamma/JAK1/LCK/JAK3/PI3K -0.004 0.13 -10000 0 -0.44 11 11
HSP90AA1 0 0 -10000 0 -10000 0 0
RELA 0.035 0.004 -10000 0 -10000 0 0
IL2RA -0.039 0.16 -10000 0 -0.35 40 40
IL2RB 0.019 0.084 -10000 0 -0.38 8 8
TERT 0.025 0.066 -10000 0 -0.37 5 5
E2F1 -0.02 0.13 -10000 0 -0.43 17 17
SOS1 0.036 0.004 -10000 0 -10000 0 0
RPS6 0.033 0.024 -10000 0 -0.2 2 2
mol:cAMP 0 0.009 0.032 15 -10000 0 15
PTPN11 0.029 0.054 -10000 0 -0.39 3 3
IL2RG -0.019 0.16 -10000 0 -0.44 25 25
actin cytoskeleton organization -0.024 0.16 -10000 0 -0.43 18 18
GRB2 0.034 0.008 -10000 0 -10000 0 0
IL2 0.037 0.008 -10000 0 -10000 0 0
PIK3CA 0.037 0.008 -10000 0 -10000 0 0
Rac1/GTP 0.051 0.051 -10000 0 -0.25 3 3
LCK -0.013 0.14 -10000 0 -0.35 26 26
BCL2 -0.066 0.27 -10000 0 -0.85 18 18
HIV-1 Nef: Negative effector of Fas and TNF-alpha

Figure S66.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S66.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BAG4 0.027 0.051 -10000 0 -0.48 2 2
Caspase 8 (4 units) -0.019 0.16 -10000 0 -0.44 17 17
NEF -0.015 0.048 -10000 0 -0.17 15 15
NFKBIA 0.017 0.056 -10000 0 -0.31 3 3
BIRC3 -0.02 0.13 -10000 0 -0.49 11 11
CYCS -0.036 0.15 -10000 0 -0.43 17 17
RIPK1 0.036 0.004 -10000 0 -10000 0 0
CD247 -0.015 0.048 -10000 0 -0.17 15 15
MAP2K7 -0.014 0.16 -10000 0 -0.61 8 8
protein ubiquitination 0.015 0.068 0.25 1 -0.31 2 3
CRADD 0.025 0.071 -10000 0 -0.48 4 4
DAXX 0.036 0.004 -10000 0 -10000 0 0
FAS -0.037 0.17 -10000 0 -0.4 34 34
BID -0.046 0.15 -10000 0 -0.41 22 22
NF-kappa-B/RelA/I kappa B alpha 0.038 0.094 -10000 0 -0.27 11 11
TRADD 0.036 0.004 -10000 0 -10000 0 0
MAP3K5 0.011 0.1 -10000 0 -0.35 13 13
CFLAR 0.035 0.004 -10000 0 -10000 0 0
FADD 0.036 0.004 -10000 0 -10000 0 0
NF-kappa-B/RelA/I kappa B alpha/ubiquitin 0.038 0.094 -10000 0 -0.27 11 11
MAPK8 -0.012 0.14 -10000 0 -0.56 8 8
APAF1 0.008 0.11 -10000 0 -0.35 15 15
TRAF1 0.034 0.017 -10000 0 -0.2 1 1
TRAF2 0.033 0.024 -10000 0 -0.2 2 2
FAS/FADD/DAXX/Ask1/Caspase 8/Caspase 8/FASLG -0.042 0.16 -10000 0 -0.44 21 21
TNFR1A/Caspase 2/TNF-alpha/FADD/TRADD/RIP1/cIAP2/TRAF1/TRAF2/Ask1/RAIDD 0.025 0.072 -10000 0 -0.34 2 2
CHUK 0.015 0.072 0.25 1 -0.34 2 3
FAS/FADD/DAXX/Ask1/Caspase 8/Caspase 8 0.027 0.15 -10000 0 -0.31 29 29
TCRz/NEF -0.024 0.081 -10000 0 -0.28 15 15
TNF 0.023 0.066 -10000 0 -0.27 9 9
FASLG -0.041 0.16 -10000 0 -0.58 15 15
NFKB1 0.023 0.039 -10000 0 -0.15 1 1
TNFR1A/BAG4/TNF-alpha 0.05 0.063 -10000 0 -0.29 4 4
CASP6 -0.01 0.17 -10000 0 -0.59 10 10
CASP7 -0.051 0.17 -10000 0 -0.52 16 16
RELA 0.023 0.039 -10000 0 -10000 0 0
CASP2 0.035 0.007 -10000 0 -10000 0 0
CASP3 -0.053 0.17 -10000 0 -0.53 17 17
TNFRSF1A 0.035 0.007 -10000 0 -10000 0 0
TNFR1A/BAG4 0.042 0.044 -10000 0 -0.35 2 2
CASP8 0.028 0.062 -10000 0 -0.48 3 3
CASP9 0.033 0.009 -10000 0 -10000 0 0
MAP3K14 0.021 0.071 -10000 0 -0.35 1 1
APAF-1/Caspase 9 -0.046 0.16 -10000 0 -0.41 21 21
BCL2 -0.027 0.14 -10000 0 -0.56 8 8
Nongenotropic Androgen signaling

Figure S67.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S67.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PTK2 0.008 0.004 -10000 0 -10000 0 0
GNB1/GNG2 0.049 0.05 -10000 0 -0.26 2 2
regulation of S phase of mitotic cell cycle 0.006 0.053 -10000 0 -0.27 6 6
GNAO1 0.036 0.002 -10000 0 -10000 0 0
HRAS 0.031 0.04 -10000 0 -0.34 2 2
SHBG/T-DHT 0.02 0.009 -10000 0 -10000 0 0
PELP1 0.029 0.014 -10000 0 -10000 0 0
AKT1 0.007 0.017 -10000 0 -0.13 3 3
MAP2K1 0.044 0.1 0.27 1 -0.29 1 2
T-DHT/AR 0.015 0.049 -10000 0 -0.17 11 11
G-protein coupled receptor activity 0 0 -10000 0 -10000 0 0
mol:GTP -0.002 0.003 -10000 0 -0.008 41 41
GNAI2 0.024 0.073 -10000 0 -0.43 5 5
GNAI3 0.03 0.051 -10000 0 -0.48 2 2
GNAI1 -0.013 0.14 -10000 0 -0.4 23 23
mol:GDP -0.005 0.041 -10000 0 -0.28 3 3
cell proliferation -0.004 0.18 0.27 2 -0.41 16 18
PIK3CA 0.035 0.006 -10000 0 -10000 0 0
FOS -0.093 0.32 -10000 0 -0.8 33 33
mol:Ca2+ -0.007 0.026 -10000 0 -0.072 22 22
MAPK3 0.019 0.14 0.28 3 -0.37 6 9
MAPK1 0 0.12 -10000 0 -0.44 5 5
PIK3R1 0.028 0.062 -10000 0 -0.48 3 3
mol:IP3 -0.001 0.002 -10000 0 -0.005 33 33
cAMP biosynthetic process 0.003 0.021 -10000 0 -10000 0 0
GNG2 0.033 0.01 -10000 0 -10000 0 0
potassium channel inhibitor activity -0.001 0.002 -10000 0 -0.005 33 33
HRAS/GTP 0.014 0.057 -10000 0 -0.27 3 3
actin cytoskeleton reorganization 0.041 0.041 -10000 0 -0.24 3 3
SRC 0.011 0.062 -10000 0 -0.48 3 3
voltage-gated calcium channel activity -0.001 0.002 -10000 0 -0.005 33 33
PI3K 0.041 0.042 -10000 0 -0.3 3 3
apoptosis 0.009 0.17 0.38 25 -0.24 1 26
T-DHT/AR/PELP1 0.029 0.048 -10000 0 -0.29 2 2
HRAS/GDP 0.043 0.069 -10000 0 -0.29 3 3
CREB1 -0.012 0.18 -10000 0 -0.41 24 24
RAC1-CDC42/GTP 0.052 0.046 -10000 0 -0.24 3 3
AR 0.02 0.07 -10000 0 -0.26 11 11
GNB1 0.034 0.008 -10000 0 -10000 0 0
RAF1 0.059 0.1 0.28 1 -0.26 3 4
RAC1-CDC42/GDP 0.061 0.07 -10000 0 -0.26 3 3
T-DHT/AR/PELP1/Src 0.02 0.054 -10000 0 -0.27 3 3
MAP2K2 0.044 0.1 -10000 0 -0.29 1 1
T-DHT/AR/PELP1/Src/PI3K 0.006 0.054 -10000 0 -0.27 6 6
GNAZ 0.022 0.064 -10000 0 -0.27 8 8
SHBG 0.029 0.014 -10000 0 -10000 0 0
Gi family/GNB1/GNG2/GDP 0.002 0.12 -10000 0 -0.44 8 8
mol:T-DHT -0.001 0.002 -10000 0 -0.004 29 29
RAC1 0.033 0.011 -10000 0 -10000 0 0
GNRH1 0.002 0.039 -10000 0 -0.22 5 5
Gi family/GTP -0.015 0.094 -10000 0 -0.26 21 21
CDC42 0.032 0.019 -10000 0 -0.2 1 1
Regulation of Androgen receptor activity

Figure S68.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S68.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
HDAC1 0.018 0.005 -10000 0 -10000 0 0
SMARCC1 0.015 0.065 -10000 0 -0.73 1 1
REL 0.025 0.071 -10000 0 -0.48 4 4
HDAC7 -0.019 0.11 -10000 0 -0.41 9 9
JUN -0.017 0.15 -10000 0 -0.4 25 25
EP300 0.018 0.088 -10000 0 -0.44 7 7
KAT2B 0 0 -10000 0 -10000 0 0
KAT5 0 0 -10000 0 -10000 0 0
MAPK14 -0.002 0.082 -10000 0 -0.37 9 9
FOXO1 0 0 -10000 0 -10000 0 0
T-DHT/AR 0.019 0.13 -10000 0 -0.45 8 8
MAP2K6 0.006 0.11 -10000 0 -0.42 12 12
BRM/BAF57 0.048 0.032 -10000 0 -0.33 1 1
MAP2K4 0.021 0.053 -10000 0 -0.48 2 2
SMARCA2 0.03 0.051 -10000 0 -0.48 2 2
PDE9A -0.099 0.36 -10000 0 -1 24 24
NCOA2 0.025 0.052 -10000 0 -0.48 2 2
CEBPA 0.015 0.092 -10000 0 -0.37 10 10
EHMT2 0.036 0.003 -10000 0 -10000 0 0
cell proliferation 0.083 0.17 0.37 12 -0.41 7 19
NR0B1 0.023 0.066 -10000 0 -0.27 9 9
EGR1 -0.053 0.17 -10000 0 -0.31 53 53
RXRs/9cRA 0.056 0.054 -10000 0 -0.27 4 4
AR/RACK1/Src 0.072 0.14 0.36 2 -0.37 8 10
AR/GR 0.001 0.085 -10000 0 -0.29 6 6
GNB2L1 0.035 0.007 -10000 0 -10000 0 0
PKN1 0.027 0.064 -10000 0 -0.41 4 4
RCHY1 0.027 0.058 -10000 0 -0.32 5 5
epidermal growth factor receptor activity 0.001 0 -10000 0 -10000 0 0
MAPK8 0.01 0.031 -10000 0 -0.35 1 1
T-DHT/AR/TIF2/CARM1 0.014 0.1 -10000 0 -0.36 9 9
SRC 0.032 0.13 0.19 56 -0.36 8 64
NR3C1 0.019 0.088 -10000 0 -0.44 7 7
KLK3 -0.048 0.11 -10000 0 -10000 0 0
APPBP2 0.03 0.018 -10000 0 -10000 0 0
TRIM24 0.03 0.051 -10000 0 -0.48 2 2
T-DHT/AR/TIP60 -0.022 0.08 -10000 0 -0.33 11 11
TMPRSS2 -0.012 0.19 -10000 0 -0.88 7 7
RXRG 0.02 0.078 -10000 0 -0.34 8 8
mol:9cRA 0 0 -10000 0 -10000 0 0
RXRA 0.035 0.006 -10000 0 -10000 0 0
RXRB 0.036 0.004 -10000 0 -10000 0 0
CARM1 0.036 0.006 -10000 0 -10000 0 0
NR2C2 0.035 0.005 -10000 0 -10000 0 0
KLK2 0.044 0.099 0.31 1 -0.46 2 3
AR -0.001 0.063 -10000 0 -0.26 5 5
SENP1 0.035 0.006 -10000 0 -10000 0 0
HSP90AA1 0 0 -10000 0 -10000 0 0
MDM2 0.033 0.017 -10000 0 -0.2 1 1
SRY 0.028 0.046 -10000 0 -0.28 4 4
GATA2 0.029 0.053 -10000 0 -0.39 3 3
MYST2 0.034 0.008 -10000 0 -10000 0 0
HOXB13 -0.1 0.2 -10000 0 -0.34 78 78
T-DHT/AR/RACK1/Src 0.075 0.14 0.36 4 -0.39 8 12
positive regulation of transcription 0.029 0.053 -10000 0 -0.39 3 3
DNAJA1 0.031 0.025 -10000 0 -0.22 1 1
proteasomal ubiquitin-dependent protein catabolic process 0.021 0.035 -10000 0 -0.32 2 2
NCOA1 0.03 0.08 -10000 0 -0.54 4 4
SPDEF -0.074 0.18 -10000 0 -0.32 65 65
T-DHT/AR/TIF2 0.001 0.1 0.27 3 -0.41 6 9
T-DHT/AR/Hsp90 -0.022 0.08 -10000 0 -0.33 11 11
GSK3B 0.033 0.036 -10000 0 -0.48 1 1
NR2C1 0.034 0.017 -10000 0 -0.2 1 1
mol:T-DHT -0.015 0.075 0.22 2 -0.32 10 12
SIRT1 0.031 0.04 -10000 0 -0.34 2 2
ZMIZ2 -0.001 0.001 -10000 0 -10000 0 0
POU2F1 0.022 0.079 -10000 0 -0.48 3 3
T-DHT/AR/DAX-1 -0.007 0.1 -10000 0 -0.37 10 10
CREBBP 0.033 0.036 -10000 0 -0.48 1 1
SMARCE1 0.035 0.008 -10000 0 -10000 0 0
Hedgehog signaling events mediated by Gli proteins

Figure S69.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S69.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
HDAC1 0.034 0.008 -10000 0 -10000 0 0
HDAC2 0.032 0.036 -10000 0 -0.48 1 1
GNB1/GNG2 0.022 0.097 -10000 0 -0.29 12 12
forebrain development -0.053 0.24 -10000 0 -0.7 19 19
GNAO1 0.036 0.003 -10000 0 -10000 0 0
SMO/beta Arrestin2 -0.001 0.1 -10000 0 -0.34 13 13
SMO -0.02 0.14 -10000 0 -0.3 33 33
ARRB2 0.027 0.038 -10000 0 -0.48 1 1
GLI3/SPOP 0.033 0.13 0.28 1 -0.4 6 7
mol:GTP 0 0.002 -10000 0 -10000 0 0
GSK3B 0.033 0.036 -10000 0 -0.48 1 1
GNAI2 0.024 0.073 -10000 0 -0.43 5 5
SIN3/HDAC complex 0.058 0.051 -10000 0 -0.27 1 1
GNAI1 -0.013 0.14 -10000 0 -0.4 23 23
XPO1 0.034 0.013 -10000 0 -10000 0 0
GLI1/Su(fu) -0.054 0.23 -10000 0 -0.85 12 12
SAP30 0.031 0.037 -10000 0 -0.48 1 1
mol:GDP -0.02 0.14 -10000 0 -0.3 33 33
MIM/GLI2A -0.012 0.13 -10000 0 -0.42 17 17
IFT88 0.004 0.1 -10000 0 -0.48 9 9
GNAI3 0.03 0.051 -10000 0 -0.48 2 2
GLI2 0.011 0.085 -10000 0 -0.41 4 4
GLI3 0.021 0.13 0.31 2 -0.42 6 8
CSNK1D 0.035 0.007 -10000 0 -10000 0 0
CSNK1E 0.025 0.064 -10000 0 -0.41 4 4
SAP18 0.026 0.016 -10000 0 -10000 0 0
embryonic digit morphogenesis 0.004 0.1 -10000 0 -0.48 9 9
GNG2 0.033 0.01 -10000 0 -10000 0 0
Gi family/GTP -0.026 0.13 -10000 0 -0.32 22 22
SIN3B 0.035 0.006 -10000 0 -10000 0 0
SIN3A 0.032 0.019 -10000 0 -0.2 1 1
GLI3/Su(fu) 0.025 0.13 0.31 1 -0.43 5 6
GLI2/Su(fu) 0.003 0.11 -10000 0 -0.47 5 5
FOXA2 -0.11 0.35 -10000 0 -0.95 29 29
neural tube patterning -0.053 0.24 -10000 0 -0.7 19 19
SPOP 0.034 0.008 -10000 0 -10000 0 0
Su(fu)/PIAS1 0.01 0.081 -10000 0 -0.64 1 1
GNB1 0.034 0.008 -10000 0 -10000 0 0
CSNK1G2 0.034 0.007 -10000 0 -10000 0 0
CSNK1G3 0.035 0.006 -10000 0 -10000 0 0
MTSS1 -0.012 0.13 -10000 0 -0.42 17 17
embryonic limb morphogenesis -0.053 0.24 -10000 0 -0.7 19 19
SUFU 0.002 0.072 -10000 0 -0.46 2 2
LGALS3 0.021 0.075 -10000 0 -0.39 6 6
catabolic process 0.033 0.14 -10000 0 -0.42 6 6
GLI3A/CBP 0.007 0.11 -10000 0 -0.37 16 16
KIF3A 0.03 0.051 -10000 0 -0.48 2 2
GLI1 -0.056 0.25 -10000 0 -0.73 19 19
RAB23 0.022 0.071 -10000 0 -0.31 8 8
CSNK1A1 0.035 0.006 -10000 0 -10000 0 0
IFT172 0.004 0.13 -10000 0 -0.48 13 13
RBBP7 0.034 0.023 -10000 0 -0.2 2 2
Su(fu)/Galectin3 0.006 0.094 -10000 0 -0.37 5 5
GNAZ 0.022 0.064 -10000 0 -0.27 8 8
RBBP4 0.031 0.029 -10000 0 -0.2 3 3
CSNK1G1 0.034 0.008 -10000 0 -10000 0 0
PIAS1 0.034 0.009 -10000 0 -10000 0 0
PRKACA 0.035 0.006 -10000 0 -10000 0 0
GLI2/SPOP 0.026 0.09 -10000 0 -0.42 4 4
STK36 0.029 0.045 -10000 0 -0.3 3 3
Gi family/GNB1/GNG2/GDP -0.022 0.13 -10000 0 -0.4 15 15
PTCH1 -0.045 0.21 -10000 0 -0.61 19 19
MIM/GLI1 -0.069 0.27 -10000 0 -0.65 28 28
CREBBP 0.007 0.11 -10000 0 -0.37 16 16
Su(fu)/SIN3/HDAC complex 0.022 0.1 -10000 0 -0.37 7 7
Arf6 downstream pathway

Figure S70.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S70.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PLAUR -0.02 0.19 -10000 0 -1.1 6 6
regulation of axonogenesis 0 0.064 0.34 5 -10000 0 5
myoblast fusion -0.012 0.081 0.37 8 -10000 0 8
mol:GTP 0.001 0.077 -10000 0 -0.27 9 9
regulation of calcium-dependent cell-cell adhesion -0.034 0.086 0.26 10 -10000 0 10
ARF1/GTP 0.023 0.068 -10000 0 -0.3 2 2
mol:GM1 -0.005 0.055 -10000 0 -0.23 5 5
mol:Choline 0.001 0.052 -10000 0 -0.27 5 5
lamellipodium assembly -0.021 0.13 -10000 0 -0.38 22 22
MAPK3 0 0.088 -10000 0 -0.31 12 12
ARF6/GTP/NME1/Tiam1 0.035 0.086 -10000 0 -0.26 10 10
ARF1 0.035 0.006 -10000 0 -10000 0 0
ARF6/GDP 0.012 0.081 -10000 0 -0.37 8 8
ARF1/GDP 0.005 0.1 -10000 0 -0.33 10 10
ARF6 0.027 0.069 -10000 0 -0.58 2 2
RAB11A 0.03 0.04 -10000 0 -0.34 2 2
TIAM1 0.027 0.055 -10000 0 -0.39 3 3
fibronectin binding 0 0 -10000 0 -10000 0 0
MAPK1 0.008 0.077 -10000 0 -0.32 8 8
actin filament bundle formation -0.009 0.1 0.31 12 -10000 0 12
KALRN 0.007 0.063 -10000 0 -0.31 7 7
RAB11FIP3/RAB11A 0.041 0.061 -10000 0 -0.38 4 4
RhoA/GDP 0.009 0.1 -10000 0 -0.32 12 12
NME1 0.03 0.039 -10000 0 -0.48 1 1
Rac1/GDP 0.008 0.1 -10000 0 -0.32 10 10
substrate adhesion-dependent cell spreading 0.001 0.076 -10000 0 -0.27 9 9
cortical actin cytoskeleton organization -0.021 0.13 -10000 0 -0.38 22 22
RAC1 0.033 0.011 -10000 0 -10000 0 0
liver development 0.001 0.076 -10000 0 -0.27 9 9
ARF6/GTP 0.001 0.077 -10000 0 -0.27 9 9
RhoA/GTP 0.023 0.068 -10000 0 -0.26 3 3
mol:GDP -0.014 0.099 -10000 0 -0.33 14 14
ARF6/GTP/RAB11FIP3/RAB11A 0.035 0.086 -10000 0 -0.32 6 6
RHOA 0.035 0.004 -10000 0 -10000 0 0
PLD1 0 0.072 -10000 0 -0.26 8 8
RAB11FIP3 0.028 0.062 -10000 0 -0.48 3 3
tube morphogenesis -0.021 0.13 -10000 0 -0.38 22 22
ruffle organization 0 0.064 -10000 0 -0.34 5 5
regulation of epithelial cell migration 0.001 0.076 -10000 0 -0.27 9 9
PLD2 0.013 0.047 -10000 0 -0.3 2 2
PIP5K1A 0 0.065 -10000 0 -0.34 5 5
mol:Phosphatidic acid 0.001 0.052 -10000 0 -0.27 5 5
Rac1/GTP -0.021 0.13 -10000 0 -0.38 22 22
mTOR signaling pathway

Figure S71.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S71.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
GBL 0.034 0.017 -10000 0 -0.2 1 1
MKNK1 0.035 0.005 -10000 0 -10000 0 0
mol:PIP3 -0.003 0.066 0.25 2 -0.29 8 10
FRAP1 -0.029 0.18 -10000 0 -0.52 21 21
AKT1 -0.006 0.074 0.22 5 -0.28 8 13
INSR 0.023 0.075 -10000 0 -0.39 6 6
Insulin Receptor/Insulin 0.039 0.046 -10000 0 -0.3 3 3
mol:GTP 0.022 0.082 0.28 2 -0.31 3 5
eIF4E/eIF4G1/eIF4A1/eIF4B/RNA/eIF3/40s Ribosomal subunit -0.006 0.06 -10000 0 -0.2 11 11
TSC2 0.035 0.005 -10000 0 -10000 0 0
RHEB/GDP 0.01 0.066 -10000 0 -0.28 3 3
TSC1 0.033 0.036 -10000 0 -0.48 1 1
Insulin Receptor/IRS1 0.01 0.09 -10000 0 -0.34 11 11
eIF4E/eIF4G1/eIF4A1/eIF4B/RNA 0.011 0.078 -10000 0 -0.25 8 8
mol:GDP 0 0 -10000 0 -10000 0 0
EIF3A 0 0 -10000 0 -10000 0 0
RPS6KB1 -0.001 0.11 0.25 2 -0.34 12 14
MAP3K5 -0.008 0.071 -10000 0 -0.3 10 10
PIK3R1 0.028 0.062 -10000 0 -0.48 3 3
apoptosis -0.008 0.071 -10000 0 -0.3 10 10
mol:LY294002 0 0 0.001 2 -0.001 7 9
EIF4B 0 0.1 0.25 3 -0.31 11 14
40S S6 ribosomal protein /40s Ribosomal subunit/eIF3 0.01 0.095 0.23 2 -0.29 12 14
eIF4E/eIF4G1/eIF4A1 -0.009 0.1 -10000 0 -0.33 16 16
KIAA1303 0 0 -10000 0 -10000 0 0
PI3K 0.032 0.079 -10000 0 -0.28 10 10
mTOR/RHEB/GTP/Raptor/GBL 0.02 0.07 0.23 4 -0.25 2 6
FKBP1A 0.026 0.039 -10000 0 -0.49 1 1
RHEB/GTP 0.03 0.078 0.26 2 -0.28 3 5
mol:Amino Acids 0 0 0.001 2 -0.001 7 9
FKBP12/Rapamycin 0.019 0.028 -10000 0 -0.35 1 1
PDPK1 -0.014 0.063 0.2 3 -0.27 8 11
EIF4E 0.035 0.006 -10000 0 -10000 0 0
ASK1/PP5C -0.019 0.2 -10000 0 -0.56 19 19
mTOR/RHEB/GTP/Raptor/GBL/eIF4E 0.027 0.043 -10000 0 -10000 0 0
TSC1/TSC2 0.026 0.089 0.28 3 -0.34 3 6
tumor necrosis factor receptor activity 0 0 0.001 7 -0.001 2 9
RPS6 0.033 0.024 -10000 0 -0.2 2 2
PPP5C 0.034 0.017 -10000 0 -0.2 1 1
EIF4G1 0.027 0.058 -10000 0 -0.32 5 5
IRS1 -0.005 0.072 -10000 0 -0.33 9 9
INS 0.034 0.007 -10000 0 -10000 0 0
PTEN 0.026 0.062 -10000 0 -0.48 3 3
PDK2 -0.015 0.061 0.2 2 -0.27 8 10
EIF4EBP1 -0.052 0.3 -10000 0 -1.1 15 15
PIK3CA 0.035 0.006 -10000 0 -10000 0 0
PPP2R5D -0.022 0.16 -10000 0 -0.46 21 21
peptide biosynthetic process 0.011 0.081 0.19 7 -0.32 9 16
RHEB 0.035 0.006 -10000 0 -10000 0 0
EIF4A1 0.029 0.014 -10000 0 -10000 0 0
mol:Rapamycin 0 0.001 0.004 9 -0.003 8 17
EEF2 0.011 0.081 0.19 7 -0.32 9 16
eIF4E/4E-BP1 -0.031 0.28 -10000 0 -1 15 15
RXR and RAR heterodimerization with other nuclear receptor

Figure S72.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S72.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TGFB1 0.021 0.068 -10000 0 -10000 0 0
VDR 0.022 0.081 -10000 0 -0.44 6 6
FAM120B 0 0 -10000 0 -10000 0 0
RXRs/LXRs/DNA/9cRA 0.033 0.085 -10000 0 -0.48 2 2
RXRs/LXRs/DNA/Oxysterols 0.036 0.11 -10000 0 -0.43 7 7
MED1 0 0 -10000 0 -10000 0 0
mol:9cRA 0.003 0.011 -10000 0 -10000 0 0
RARs/THRs/DNA/Src-1 0.013 0.079 -10000 0 -0.24 15 15
RXRs/NUR77 0.062 0.083 -10000 0 -0.26 4 4
RXRs/PPAR 0.003 0.099 -10000 0 -0.28 13 13
NCOR2 0.032 0.04 -10000 0 -0.34 2 2
VDR/VDR/Vit D3 0.016 0.058 -10000 0 -0.31 6 6
RARs/VDR/DNA/Vit D3 0.056 0.08 -10000 0 -0.26 10 10
RARA 0.034 0.009 -10000 0 -10000 0 0
NCOA1 0.026 0.071 -10000 0 -0.48 4 4
VDR/VDR/DNA 0.022 0.081 -10000 0 -0.44 6 6
RARs/RARs/DNA/9cRA 0.049 0.056 -10000 0 -0.25 5 5
RARG 0.029 0.053 -10000 0 -0.39 3 3
RPS6KB1 0.029 0.097 0.54 7 -10000 0 7
RARs/THRs/DNA/SMRT 0.014 0.08 -10000 0 -0.25 12 12
THRA 0.015 0.091 -10000 0 -0.39 9 9
mol:Bile acids 0 0 -10000 0 -10000 0 0
VDR/Vit D3/DNA 0.016 0.058 -10000 0 -0.31 6 6
RXRs/PPAR/9cRA/PGJ2/DNA 0.057 0.072 -10000 0 -0.26 4 4
NR1H4 -0.07 0.17 -10000 0 -0.3 65 65
RXRs/LXRs/DNA 0.092 0.1 -10000 0 -0.38 3 3
NR1H2 0.036 0.019 -10000 0 -10000 0 0
NR1H3 0.029 0.069 -10000 0 -0.43 4 4
RXRs/VDR/DNA/Vit D3 0.062 0.083 -10000 0 -0.25 9 9
NR4A1 0.018 0.062 -10000 0 -0.2 15 15
mol:ATRA 0 0 -10000 0 -10000 0 0
RXRs/FXR/9cRA/MED1 -0.016 0.092 -10000 0 -0.24 24 24
RXRG 0.021 0.079 -10000 0 -0.34 8 8
RXR alpha/CCPG 0.027 0.013 -10000 0 -10000 0 0
RXRA 0.036 0.018 -10000 0 -10000 0 0
RXRB 0.037 0.02 -10000 0 -10000 0 0
THRB 0.022 0.066 -10000 0 -0.27 9 9
PPARG -0.021 0.16 -10000 0 -0.45 24 24
PPARD 0.036 0.004 -10000 0 -10000 0 0
TNF 0.022 0.14 -10000 0 -0.92 3 3
mol:Oxysterols 0.003 0.009 -10000 0 -10000 0 0
cholesterol transport 0.036 0.1 -10000 0 -0.43 7 7
PPARA 0.029 0.04 -10000 0 -0.34 2 2
mol:Vit D3 0 0 -10000 0 -10000 0 0
RARB 0.021 0.078 -10000 0 -0.34 8 8
RXRs/NUR77/BCL2 -0.007 0.077 -10000 0 -0.27 11 11
SREBF1 0.015 0.13 -10000 0 -0.76 4 4
RXRs/RXRs/DNA/9cRA 0.057 0.073 -10000 0 -0.26 4 4
ABCA1 0.022 0.16 -10000 0 -0.96 4 4
RARs/THRs 0.064 0.097 -10000 0 -0.26 12 12
RXRs/FXR 0.004 0.14 -10000 0 -0.28 24 24
BCL2 -0.002 0.098 -10000 0 -0.31 16 16
Signaling mediated by p38-gamma and p38-delta

Figure S73.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S73.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
EEF2K -0.011 0.035 -10000 0 -0.3 3 3
SNTA1 0.013 0.054 -10000 0 -0.39 3 3
response to hypoxia 0 0 -10000 0 -10000 0 0
STMN1 -0.012 0.04 -10000 0 -0.3 4 4
MAPK12 -0.022 0.084 0.21 4 -0.27 17 21
CCND1 -0.003 0.063 -10000 0 -0.41 3 3
p38 gamma/SNTA1 -0.013 0.086 0.2 2 -0.27 16 18
MAP2K3 0.03 0.013 -10000 0 -10000 0 0
PKN1 0.026 0.064 -10000 0 -0.41 4 4
G2/M transition checkpoint -0.022 0.084 0.21 4 -0.26 17 21
MAP2K6 -0.014 0.09 0.24 4 -0.27 19 23
MAPT -0.006 0.052 0.2 2 -0.23 4 6
MAPK13 0.013 0.036 -10000 0 -0.35 2 2
hyperosmotic response 0 0 -10000 0 -10000 0 0
ZAK 0.002 0.072 -10000 0 -0.31 10 10
Integrins in angiogenesis

Figure S74.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S74.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
VEGFR2 homodimer/VEGFA homodimer 0.024 0.028 -10000 0 -0.35 1 1
alphaV beta3 Integrin 0.032 0.094 -10000 0 -0.29 11 11
PTK2 0.038 0.11 0.33 4 -0.36 3 7
IGF1R 0.03 0.04 -10000 0 -0.34 2 2
PI4KB 0 0 -10000 0 -10000 0 0
MFGE8 0.017 0.085 -10000 0 -0.36 9 9
SRC 0.011 0.062 -10000 0 -0.48 3 3
CDKN1B 0.014 0.061 -10000 0 -0.39 3 3
VEGFA 0 0 -10000 0 -10000 0 0
ILK 0.021 0.034 -10000 0 -10000 0 0
ROCK1 0.028 0.015 -10000 0 -10000 0 0
AKT1 0.012 0.031 -10000 0 -10000 0 0
PTK2B 0.01 0.049 -10000 0 -0.25 5 5
alphaV/beta3 Integrin/JAM-A 0.038 0.1 -10000 0 -0.27 14 14
CBL 0.035 0.005 -10000 0 -10000 0 0
mol:GTP 0 0 -10000 0 -10000 0 0
alphaV beta3 Integrin/ANGPTL3 0.048 0.08 -10000 0 -0.31 8 8
IGF-1R heterotetramer/IGF1/IRS1/Shp2 0.046 0.1 -10000 0 -0.29 12 12
VEGF/Rho/ROCK/alphaV/beta3 Integrin 0.017 0.043 -10000 0 -0.33 2 2
alphaV/beta3 Integrin/Syndecan-1 0.057 0.065 -10000 0 -0.32 5 5
PI4KA 0 0 -10000 0 -10000 0 0
IGF-1R heterotetramer/IGF1/IRS1 -0.012 0.14 -10000 0 -0.45 8 8
PI4 Kinase 0 0 -10000 0 -10000 0 0
PIK3CA 0.035 0.006 -10000 0 -10000 0 0
alphaV/beta3 Integrin/Osteopontin -0.091 0.16 -10000 0 -0.3 65 65
RPS6KB1 -0.063 0.1 -10000 0 -0.42 8 8
TLN1 0.035 0.006 -10000 0 -10000 0 0
MAPK3 -0.026 0.14 -10000 0 -0.51 12 12
GPR124 0.02 0.064 -10000 0 -0.27 8 8
MAPK1 -0.024 0.14 -10000 0 -0.52 12 12
PXN 0.036 0.004 -10000 0 -10000 0 0
PIK3R1 0.028 0.062 -10000 0 -0.48 3 3
alphaV/beta3 Integrin/Tumstatin 0.055 0.062 -10000 0 -0.3 4 4
cell adhesion 0.024 0.1 -10000 0 -0.28 17 17
ANGPTL3 0.022 0.076 -10000 0 -0.36 7 7
VEGFR2 homodimer/VEGFA homodimer/Src 0.02 0.046 -10000 0 -0.3 3 3
IGF-1R heterotetramer 0.03 0.04 -10000 0 -0.34 2 2
Rac1/GDP 0.024 0.008 -10000 0 -10000 0 0
TGFBR2 0.03 0.051 -10000 0 -0.48 2 2
ITGB3 0.033 0.018 -10000 0 -0.2 1 1
IGF1 0.015 0.081 -10000 0 -0.26 14 14
RAC1 0.033 0.011 -10000 0 -10000 0 0
regulation of cell-matrix adhesion 0.042 0.075 -10000 0 -0.31 6 6
apoptosis 0.021 0.082 -10000 0 -0.4 7 7
CD47 0.022 0.081 -10000 0 -0.44 6 6
alphaV/beta3 Integrin/CD47 0.049 0.084 -10000 0 -0.33 8 8
VCL 0.032 0.036 -10000 0 -0.48 1 1
alphaV/beta3 Integrin/Del1 0.008 0.13 -10000 0 -0.31 27 27
CSF1 0.034 0.018 -10000 0 -0.2 1 1
PIK3C2A 0.014 0.067 -10000 0 -0.46 3 3
PI4 Kinase/Pyk2 0.006 0.065 -10000 0 -0.22 10 10
VEGFR2 homodimer/VEGFA homodimer/alphaV beta3 Integrin 0.053 0.059 -10000 0 -0.27 5 5
FAK1/Vinculin 0.055 0.1 0.27 4 -0.31 2 6
alphaV beta3/Integrin/ppsTEM5 0.042 0.075 -10000 0 -0.31 6 6
RHOA 0.035 0.004 -10000 0 -10000 0 0
VTN 0.034 0.008 -10000 0 -10000 0 0
BCAR1 0.034 0.017 -10000 0 -0.2 1 1
FGF2 -0.003 0.12 -10000 0 -0.3 24 24
F11R -0.013 0.091 -10000 0 -0.36 11 11
alphaV/beta3 Integrin/Lactadherin 0.043 0.083 -10000 0 -0.29 10 10
alphaV/beta3 Integrin/TGFBR2 0.054 0.068 -10000 0 -0.3 6 6
alphaV/beta3 Integrin/c-FMS/Cbl/Cas 0.073 0.065 -10000 0 -0.27 5 5
HSP90AA1 0 0 -10000 0 -10000 0 0
alphaV/beta3 Integrin/Talin 0.054 0.054 -10000 0 -0.27 4 4
mol:GDP 0 0 -10000 0 -10000 0 0
FN1 -0.016 0.13 -10000 0 -0.48 11 11
alphaV/beta3 Integrin/Pyk2 0.038 0.056 -10000 0 -0.25 5 5
SDC1 0.033 0.036 -10000 0 -0.48 1 1
VAV3 -0.047 0.12 -10000 0 -0.26 43 43
PTPN11 0.029 0.053 -10000 0 -0.39 3 3
IRS1 0.013 0.098 -10000 0 -0.38 11 11
FAK1/Paxillin 0.058 0.1 0.27 4 -0.31 2 6
cell migration 0.049 0.097 0.24 6 -0.28 2 8
ITGAV 0.021 0.083 -10000 0 -0.4 7 7
PI3K 0.045 0.11 -10000 0 -0.32 2 2
SPP1 -0.17 0.22 -10000 0 -0.36 109 109
KDR 0.032 0.04 -10000 0 -0.34 2 2
mol:PI-4-5-P2 0 0 -10000 0 -10000 0 0
alphaV/beta3 Integrin/Caspase 8 0.021 0.082 -10000 0 -0.4 7 7
COL4A3 0.031 0.033 -10000 0 -0.2 4 4
angiogenesis -0.022 0.15 -10000 0 -0.53 12 12
Rac1/GTP -0.029 0.11 -10000 0 -0.32 4 4
EDIL3 -0.035 0.17 -10000 0 -0.39 34 34
cell proliferation 0.053 0.067 -10000 0 -0.3 6 6
Regulation of p38-alpha and p38-beta

Figure S75.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S75.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
RIP1/MEKK3 0.045 0.012 -10000 0 -10000 0 0
response to insulin stimulus 0 0 -10000 0 -10000 0 0
RIPK1 0.036 0.004 -10000 0 -10000 0 0
response to stress 0 0 -10000 0 -10000 0 0
MAP2K6 0.008 0.11 -10000 0 -0.41 12 12
mol:GTP 0 0 -10000 0 -10000 0 0
MAP2K4 0.023 0.052 -10000 0 -0.48 2 2
RAC1-CDC42/GTP/PAK family 0.02 0.021 -10000 0 -0.2 1 1
response to UV 0 0 -10000 0 -10000 0 0
YES1 0.028 0.015 -10000 0 -10000 0 0
interleukin-1 receptor activity 0 0 -10000 0 -10000 0 0
tumor necrosis factor receptor activity 0 0 -10000 0 -10000 0 0
MAP3K3 0.034 0.009 -10000 0 -10000 0 0
FYN 0.006 0.11 -10000 0 -0.34 16 16
MAP3K12 0.035 0.005 -10000 0 -10000 0 0
FGR 0.025 0.044 -10000 0 -0.2 7 7
p38 alpha/TAB1 -0.019 0.18 0.25 6 -0.41 24 30
PRKG1 0.035 0.007 -10000 0 -10000 0 0
DUSP8 0.021 0.083 -10000 0 -0.4 7 7
PGK/cGMP/p38 alpha -0.025 0.17 0.21 2 -0.38 26 28
apoptosis -0.018 0.17 0.24 6 -0.39 24 30
RAL/GTP 0.036 0.054 -10000 0 -0.3 5 5
LYN 0.03 0.013 -10000 0 -10000 0 0
DUSP1 0 0.1 -10000 0 -0.26 25 25
PAK1 0.031 0.051 -10000 0 -0.48 2 2
SRC 0.011 0.062 -10000 0 -0.48 3 3
RAC1/OSM/MEKK3/MKK3 0.067 0.041 -10000 0 -10000 0 0
TRAF6 0.036 0.004 -10000 0 -10000 0 0
RAC1 0.033 0.011 -10000 0 -10000 0 0
epidermal growth factor receptor activity 0 0 -10000 0 -10000 0 0
mol:LPS 0 0 -10000 0 -10000 0 0
mol:cGMP 0 0 -10000 0 -10000 0 0
CCM2 0.034 0.009 -10000 0 -10000 0 0
RAC1-CDC42/GTP 0.04 0.021 -10000 0 -10000 0 0
MAPK11 -0.014 0.18 0.32 6 -0.46 17 23
BLK 0.007 0.089 -10000 0 -0.32 12 12
HCK -0.013 0.11 -10000 0 -0.35 17 17
MAP2K3 0.03 0.013 -10000 0 -10000 0 0
DUSP16 0.022 0.075 -10000 0 -0.39 6 6
DUSP10 0.012 0.099 -10000 0 -0.37 12 12
TRAF6/MEKK3 0.043 0.012 -10000 0 -10000 0 0
MAP3K7IP1 0.034 0.009 -10000 0 -10000 0 0
MAPK14 -0.031 0.19 0.26 6 -0.42 27 33
positive regulation of innate immune response -0.03 0.22 0.32 7 -0.54 18 25
LCK -0.015 0.14 -10000 0 -0.35 26 26
p38alpha-beta/MKP7 -0.022 0.22 0.34 6 -0.54 17 23
p38alpha-beta/MKP5 -0.024 0.22 0.34 6 -0.51 20 26
PGK/cGMP 0.026 0.005 -10000 0 -10000 0 0
PAK2 0.035 0.006 -10000 0 -10000 0 0
p38alpha-beta/MKP1 -0.027 0.22 0.34 6 -0.51 21 27
CDC42 0.032 0.019 -10000 0 -0.2 1 1
RALB 0.023 0.08 -10000 0 -0.48 5 5
RALA 0.033 0.01 -10000 0 -10000 0 0
PAK3 0.036 0 -10000 0 -10000 0 0
Class I PI3K signaling events

Figure S76.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S76.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
ARF5/GTP -0.018 0.055 0.21 3 -0.24 6 9
DAPP1 -0.039 0.2 0.24 6 -0.52 21 27
Src family/SYK family/BLNK-LAT/BTK-ITK -0.061 0.24 0.3 1 -0.54 30 31
mol:DAG 0.016 0.12 0.19 37 -0.27 9 46
HRAS 0.032 0.038 -10000 0 -0.33 2 2
RAP1A 0.034 0.012 -10000 0 -10000 0 0
ARF5/GDP 0.041 0.1 -10000 0 -0.28 7 7
PLCG2 -0.012 0.13 -10000 0 -0.33 27 27
PLCG1 0.019 0.018 -10000 0 -10000 0 0
ARF5 0.03 0.051 -10000 0 -0.48 2 2
mol:GTP -0.016 0.05 0.19 3 -0.25 4 7
ARF1/GTP -0.009 0.047 0.19 3 -0.23 4 7
RHOA 0.035 0.004 -10000 0 -10000 0 0
YES1 0.028 0.015 -10000 0 -10000 0 0
RAP1A/GTP -0.012 0.057 0.2 3 -0.24 4 7
ADAP1 -0.017 0.046 0.18 3 -0.24 4 7
ARAP3 -0.016 0.049 0.18 3 -0.24 4 7
INPPL1 0.032 0.04 -10000 0 -0.34 2 2
PREX1 0.002 0.083 -10000 0 -0.38 8 8
ARHGEF6 0.03 0.053 -10000 0 -0.39 3 3
ARHGEF7 0.027 0.016 -10000 0 -10000 0 0
ARF1 0.035 0.006 -10000 0 -10000 0 0
NRAS 0.02 0.08 -10000 0 -0.33 9 9
FYN 0.006 0.11 -10000 0 -0.34 16 16
ARF6 0.028 0.051 -10000 0 -0.48 2 2
FGR 0.025 0.044 -10000 0 -0.2 7 7
mol:Ca2+ 0.016 0.07 0.16 11 -0.16 2 13
mol:IP4 0 0 -10000 0 -10000 0 0
TIAM1 0.028 0.054 -10000 0 -0.39 3 3
ZAP70 0.03 0.053 -10000 0 -0.39 3 3
mol:IP3 0.012 0.087 0.19 11 -0.2 7 18
LYN 0.03 0.013 -10000 0 -10000 0 0
ARF1/GDP 0.044 0.099 -10000 0 -0.28 7 7
RhoA/GDP 0.045 0.08 0.24 3 -0.27 1 4
PDK1/Src/Hsp90 0.02 0.046 -10000 0 -0.3 3 3
BLNK 0.004 0.12 -10000 0 -0.44 13 13
actin cytoskeleton reorganization 0.032 0.1 0.25 4 -0.35 4 8
SRC 0.011 0.062 -10000 0 -0.48 3 3
PLEKHA2 -0.006 0.02 -10000 0 -0.29 1 1
RAC1 0.033 0.011 -10000 0 -10000 0 0
PTEN 0.027 0.06 -10000 0 -0.46 3 3
HSP90AA1 0 0 -10000 0 -10000 0 0
ARF6/GTP -0.017 0.056 0.21 3 -0.24 6 9
RhoA/GTP -0.012 0.058 0.2 3 -0.24 4 7
Src family/SYK family/BLNK-LAT -0.043 0.15 -10000 0 -0.51 13 13
BLK 0.007 0.089 -10000 0 -0.32 12 12
PDPK1 0.032 0.04 -10000 0 -0.34 2 2
CYTH1 -0.017 0.046 0.18 3 -0.24 4 7
HCK -0.013 0.11 -10000 0 -0.35 17 17
CYTH3 -0.017 0.046 0.18 3 -0.24 4 7
CYTH2 -0.017 0.046 0.18 3 -0.24 4 7
KRAS 0.033 0.02 -10000 0 -0.2 1 1
GO:0030676 0 0 -10000 0 -10000 0 0
FOXO3 0.001 0.046 0.18 1 -0.25 4 5
SGK1 0.001 0.048 0.18 1 -0.27 4 5
INPP5D 0 0 -10000 0 -10000 0 0
mol:GDP 0.031 0.097 -10000 0 -0.28 9 9
SOS1 0.036 0.002 -10000 0 -10000 0 0
SYK 0.029 0.053 -10000 0 -0.39 3 3
ARF6/GDP 0.024 0.078 0.23 3 -0.29 2 5
mol:PI-3-4-5-P3 -0.017 0.051 0.23 3 -0.25 4 7
ARAP3/RAP1A/GTP -0.012 0.057 0.2 3 -0.25 4 7
VAV1 -0.004 0.13 -10000 0 -0.42 18 18
mol:PI-3-4-P2 0.008 0.027 -10000 0 -0.24 2 2
RAS family/GTP/PI3K Class I 0.049 0.065 -10000 0 -0.25 4 4
PLEKHA1 -0.007 0.021 -10000 0 -0.29 1 1
Rac1/GDP 0.04 0.097 -10000 0 -0.28 7 7
LAT 0.023 0.064 -10000 0 -0.27 8 8
Rac1/GTP 0.003 0.07 -10000 0 -0.44 3 3
ITK -0.025 0.056 0.18 2 -0.24 8 10
Src family/SYK family/BLNK-LAT/BTK-ITK/PLC-gamma 0.006 0.14 0.25 8 -0.38 10 18
LCK -0.015 0.14 -10000 0 -0.35 26 26
BTK -0.035 0.077 0.18 3 -0.26 16 19
Regulation of Telomerase

Figure S77.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S77.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Telomerase catalytic core complex -0.057 0.19 -10000 0 -0.94 5 5
RAD9A 0.036 0.004 -10000 0 -10000 0 0
AP1 -0.068 0.16 -10000 0 -0.34 45 45
IFNAR2 0.034 0.02 -10000 0 -0.2 1 1
AKT1 0.023 0.033 -10000 0 -10000 0 0
ER alpha/Oestrogen 0.019 0.052 -10000 0 -0.35 4 4
NFX1/SIN3/HDAC complex 0.033 0.067 -10000 0 -0.3 2 2
EGF -0.087 0.19 -10000 0 -0.32 72 72
SMG5 0 0 -10000 0 -10000 0 0
SMG6 0 0 -10000 0 -10000 0 0
SP3/HDAC2 0.05 0.033 -10000 0 -0.35 1 1
TERT/c-Abl -0.045 0.18 -10000 0 -0.88 5 5
SAP18 0.026 0.016 -10000 0 -10000 0 0
MRN complex 0.055 0.046 -10000 0 -0.3 2 2
WT1 -0.2 0.22 -10000 0 -0.36 125 125
WRN 0.029 0.014 -10000 0 -10000 0 0
SP1 0.034 0.021 -10000 0 -0.2 1 1
SP3 0.036 0.007 -10000 0 -10000 0 0
TERF2IP 0.036 0.002 -10000 0 -10000 0 0
Telomerase/Nucleolin -0.04 0.18 -10000 0 -0.77 6 6
Mad/Max 0.043 0.044 -10000 0 -0.35 1 1
TERT -0.059 0.2 -10000 0 -0.99 5 5
CCND1 -0.063 0.21 -10000 0 -1 7 7
MAX 0.033 0.01 -10000 0 -10000 0 0
RBBP7 0.034 0.023 -10000 0 -0.2 2 2
RBBP4 0.031 0.029 -10000 0 -0.2 3 3
TERF2 0.031 0.034 -10000 0 -0.43 1 1
PTGES3 0.035 0.004 -10000 0 -10000 0 0
SIN3A 0.032 0.019 -10000 0 -0.2 1 1
Telomerase/911 0.035 0.055 -10000 0 -0.36 2 2
CDKN1B -0.08 0.15 -10000 0 -0.33 41 41
RAD1 0.031 0.04 -10000 0 -0.34 2 2
XRCC5 0.036 0.004 -10000 0 -10000 0 0
XRCC6 0.034 0.009 -10000 0 -10000 0 0
SAP30 0.032 0.037 -10000 0 -0.48 1 1
TRF2/PARP2 0.044 0.042 -10000 0 -0.33 2 2
UBE3A 0.033 0.01 -10000 0 -10000 0 0
JUN -0.017 0.15 -10000 0 -0.4 25 25
E6 0 0.002 -10000 0 -10000 0 0
HPV-16 E6/E6AP 0.025 0.011 -10000 0 -10000 0 0
FOS -0.062 0.17 -10000 0 -0.32 56 56
IFN-gamma/IRF1 -0.075 0.18 -10000 0 -0.34 54 54
PARP2 0.031 0.037 -10000 0 -0.48 1 1
BLM 0.021 0.08 -10000 0 -0.48 5 5
Telomerase 0.031 0.045 -10000 0 -10000 0 0
IRF1 0 0.11 -10000 0 -0.29 23 23
ESR1 0.025 0.071 -10000 0 -0.48 4 4
KU/TER 0.05 0.013 -10000 0 -10000 0 0
ATM/TRF2 0.046 0.041 -10000 0 -0.28 2 2
ubiquitin-dependent protein catabolic process 0.014 0.068 -10000 0 -0.29 4 4
HPV-16 E6/E6AP/NFX1/SIN3/HDAC complex 0.014 0.069 -10000 0 -0.3 4 4
HDAC1 0.034 0.008 -10000 0 -10000 0 0
HDAC2 0.032 0.039 -10000 0 -0.48 1 1
ATM 0.012 0.033 0.2 1 -0.39 1 2
SMAD3 0.012 0.041 -10000 0 -0.32 3 3
ABL1 0.035 0.005 -10000 0 -10000 0 0
MXD1 0.027 0.054 -10000 0 -0.24 7 7
MRE11A 0.035 0.005 -10000 0 -10000 0 0
HUS1 0.03 0.04 -10000 0 -0.34 2 2
RPS6KB1 0.034 0.008 -10000 0 -10000 0 0
TERT/NF kappa B1/14-3-3 -0.02 0.19 -10000 0 -1.1 3 3
NR2F2 0.031 0.019 -10000 0 -0.2 1 1
MAPK3 0.011 0.052 -10000 0 -0.35 4 4
MAPK1 0.018 0.009 -10000 0 -10000 0 0
TGFB1/TGF beta receptor Type II 0.034 0.017 -10000 0 -0.2 1 1
NFKB1 0.035 0.006 -10000 0 -10000 0 0
HNRNPC 0 0 -10000 0 -10000 0 0
DNA damage response signal transduction by p53 class mediator resulting in induction of apoptosis 0.012 0.033 0.2 1 -0.39 1 2
NBN 0.027 0.038 -10000 0 -0.48 1 1
EGFR 0.016 0.09 -10000 0 -0.41 8 8
mol:Oestrogen 0 0.002 -10000 0 -10000 0 0
EGF/EGFR -0.054 0.15 -10000 0 -0.35 34 34
MYC 0.004 0.11 -10000 0 -0.48 10 10
IL2 0.036 0.014 -10000 0 -10000 0 0
KU 0.05 0.013 -10000 0 -10000 0 0
RAD50 0.03 0.051 -10000 0 -0.48 2 2
HSP90AA1 0 0 -10000 0 -10000 0 0
TGFB1 0.034 0.017 -10000 0 -0.2 1 1
TRF2/BLM 0.038 0.066 -10000 0 -0.33 6 6
FRAP1 0.031 0.037 -10000 0 -0.48 1 1
KU/TERT -0.035 0.19 -10000 0 -0.88 5 5
SP1/HDAC2 0.049 0.038 -10000 0 -0.35 1 1
PINX1 0.024 0.042 -10000 0 -0.34 2 2
Telomerase/EST1A -0.047 0.16 -10000 0 -0.78 5 5
Smad3/Myc 0.011 0.081 -10000 0 -0.31 11 11
911 complex 0.06 0.045 -10000 0 -0.3 2 2
IFNG -0.1 0.2 -10000 0 -0.32 81 81
Telomerase/PinX1 -0.043 0.17 -10000 0 -0.79 5 5
Telomerase/AKT1/mTOR/p70S6K 0.021 0.056 -10000 0 -10000 0 0
SIN3B 0.035 0.006 -10000 0 -10000 0 0
YWHAE 0.03 0.013 -10000 0 -10000 0 0
Telomerase/EST1B -0.047 0.16 -10000 0 -0.78 5 5
response to DNA damage stimulus 0.002 0.023 -10000 0 -0.12 3 3
MRN complex/TRF2/Rap1 0.077 0.059 -10000 0 -0.26 3 3
TRF2/WRN 0.04 0.034 -10000 0 -0.34 1 1
Telomerase/hnRNP C1/C2 -0.047 0.16 -10000 0 -0.78 5 5
E2F1 0.014 0.053 -10000 0 -0.48 2 2
ZNFX1 0 0.001 -10000 0 -10000 0 0
PIF1 0 0 -10000 0 -10000 0 0
NCL 0.026 0.071 -10000 0 -0.48 4 4
DKC1 0.035 0.017 -10000 0 -0.2 1 1
telomeric DNA binding 0 0 -10000 0 -10000 0 0
Insulin Pathway

Figure S78.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S78.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CBL/APS/CAP 0.021 0.11 -10000 0 -0.28 21 21
TC10/GTP 0.012 0.085 -10000 0 -0.24 17 17
Insulin Receptor/Insulin/IRS1/Shp2 0.079 0.11 -10000 0 -0.38 8 8
HRAS 0.032 0.04 -10000 0 -0.34 2 2
APS homodimer 0 0 -10000 0 -10000 0 0
GRB14 -0.17 0.22 -10000 0 -0.35 108 108
FOXO3 -0.019 0.026 -10000 0 -10000 0 0
AKT1 -0.076 0.12 0.3 1 -0.38 9 10
INSR 0.037 0.076 -10000 0 -0.42 5 5
Insulin Receptor/Insulin 0.099 0.1 -10000 0 -0.4 2 2
mol:GTP 0 0 -10000 0 -10000 0 0
GRB10 -0.008 0.13 -10000 0 -0.4 20 20
SORBS1 -0.021 0.15 -10000 0 -0.36 29 29
CRK 0.03 0.013 -10000 0 -10000 0 0
PTPN1 0.005 0.052 -10000 0 -0.4 2 2
CAV1 0.022 0.088 0.2 4 -0.29 10 14
CBL/APS/CAP/Crk-II/C3G 0.031 0.097 -10000 0 -0.26 16 16
Insulin Receptor/Insulin/IRS1/NCK2 0.082 0.096 -10000 0 -0.32 8 8
mol:GDP 0 0 -10000 0 -10000 0 0
mol:PI-3-4-5-P3 0.057 0.091 -10000 0 -0.31 9 9
Insulin Receptor/Insuli/IRS1/GRB2/SHC/PTP1B 0.067 0.11 -10000 0 -0.54 4 4
RPS6KB1 -0.072 0.11 0.28 1 -0.35 9 10
PARD6A 0.008 0.11 -10000 0 -0.38 14 14
CBL 0.035 0.005 -10000 0 -10000 0 0
tumor necrosis factor-mediated signaling pathway 0 0 -10000 0 -10000 0 0
DOK1 0.026 0.062 -10000 0 -0.82 1 1
PIK3R1 0.028 0.062 -10000 0 -0.48 3 3
Insulin Receptor/Insuli/IRS1/GRB2/Shc -0.048 0.13 -10000 0 -0.37 8 8
HRAS/GTP 0.012 0.064 -10000 0 -0.36 3 3
Insulin Receptor 0.037 0.076 -10000 0 -0.42 5 5
Insulin Receptor/Insuli/IRS1/GRB2/SHC 0.09 0.097 -10000 0 -0.3 8 8
PRKCI 0.011 0.094 -10000 0 -0.63 3 3
Insulin Receptor/Insulin/GRB14/PDK1 -0.065 0.14 -10000 0 -0.28 33 33
SHC1 0.035 0.007 -10000 0 -10000 0 0
negative regulation of MAPKKK cascade 0.048 0.089 -10000 0 -0.55 3 3
PI3K 0.073 0.097 -10000 0 -0.31 9 9
NCK2 0.035 0.017 -10000 0 -0.2 1 1
RHOQ 0.031 0.043 -10000 0 -0.3 3 3
mol:H2O2 0.001 0.008 -10000 0 -10000 0 0
HRAS/GDP 0.024 0.028 -10000 0 -0.24 2 2
AKT2 -0.071 0.12 0.26 2 -0.37 10 12
PRKCZ -0.002 0.067 -10000 0 -0.75 1 1
SH2B2 0 0 -10000 0 -10000 0 0
SHC/SHIP 0.028 0.076 0.18 3 -0.28 8 11
F2RL2 0.013 0.11 -10000 0 -0.48 9 9
TRIP10 0.035 0.005 -10000 0 -10000 0 0
Insulin Receptor/Insulin/Shc 0.074 0.053 -10000 0 -0.24 3 3
TC10/GTP/CIP4/Exocyst 0.044 0.029 -10000 0 -0.3 1 1
Insulin Receptor/Insulin/SHC/GRB2/Sos1 0.1 0.063 -10000 0 -0.24 2 2
RAPGEF1 0.035 0.004 -10000 0 -10000 0 0
RASA1 0.024 0.073 -10000 0 -0.43 5 5
NCK1 0.026 0.071 -10000 0 -0.48 4 4
CBL/APS/CAP/Crk-II 0.019 0.095 -10000 0 -0.27 16 16
TC10/GDP 0.023 0.03 -10000 0 -0.2 3 3
Insulin Receptor/Insulin/SHC/GRB10 0.061 0.11 -10000 0 -0.27 15 15
INPP5D -0.002 0.067 -10000 0 -0.3 8 8
SOS1 0.036 0.002 -10000 0 -10000 0 0
SGK1 -0.01 0.011 -10000 0 -10000 0 0
mol:cAMP 0 0 -10000 0 -10000 0 0
PTPN11 0.029 0.053 -10000 0 -0.39 3 3
IRS1 0.013 0.098 -10000 0 -0.38 11 11
p62DOK/RasGAP 0.048 0.09 -10000 0 -0.56 3 3
INS 0.047 0.02 -10000 0 -10000 0 0
mol:PI-3-4-P2 -0.002 0.066 -10000 0 -0.29 8 8
GRB2 0.034 0.008 -10000 0 -10000 0 0
EIF4EBP1 -0.073 0.11 0.28 1 -0.39 7 8
PTPRA 0.033 0.043 -10000 0 -0.49 1 1
PIK3CA 0.035 0.006 -10000 0 -10000 0 0
TC10/GTP/CIP4 0.044 0.029 -10000 0 -0.3 1 1
PDPK1 0.032 0.04 -10000 0 -0.34 2 2
Insulin Receptor/Insuli/IRS1/GRB2/SHC/Sos 0.035 0.074 -10000 0 -0.5 2 2
Insulin Receptor/Insulin/IRS1 0.062 0.089 -10000 0 -0.32 8 8
Insulin Receptor/Insulin/IRS3 0.064 0.06 -10000 0 -0.34 3 3
Par3/Par6 0.045 0.1 -10000 0 -0.26 19 19
Plasma membrane estrogen receptor signaling

Figure S79.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S79.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
GNB1/GNG2 0.064 0.056 -10000 0 -0.26 4 4
ER alpha/Gai/GDP/Gbeta gamma -0.013 0.14 -10000 0 -0.51 10 10
AKT1 0.017 0.16 -10000 0 -0.72 9 9
PIK3CA 0.035 0.006 -10000 0 -10000 0 0
E2/ER alpha (dimer)/PELP1/Src/PI3K 0.022 0.16 -10000 0 -0.72 9 9
mol:Ca2+ -0.036 0.14 -10000 0 -0.39 16 16
IGF1R 0.03 0.04 -10000 0 -0.34 2 2
E2/ER alpha (dimer)/Striatin 0.037 0.055 -10000 0 -0.3 5 5
SHC1 0.035 0.007 -10000 0 -10000 0 0
apoptosis -0.018 0.16 0.68 9 -10000 0 9
RhoA/GTP 0.017 0.057 -10000 0 -0.23 8 8
E2/ER alpha (dimer)/PELP1/Src/p130 Cas 0.063 0.14 -10000 0 -0.39 6 6
regulation of stress fiber formation 0.025 0.079 0.3 3 -10000 0 3
E2/ERA-ERB (dimer) 0.036 0.05 -10000 0 -0.3 4 4
KRAS 0.033 0.018 -10000 0 -0.2 1 1
G13/GTP 0.036 0.044 -10000 0 -0.27 4 4
pseudopodium formation -0.025 0.079 -10000 0 -0.3 3 3
E2/ER alpha (dimer)/PELP1 0.033 0.049 -10000 0 -0.29 4 4
GRB2 0.034 0.008 -10000 0 -10000 0 0
GNG2 0.033 0.01 -10000 0 -10000 0 0
GNAO1 0.036 0.002 -10000 0 -10000 0 0
HRAS 0.032 0.04 -10000 0 -0.34 2 2
mol:GTP 0 0 -10000 0 -10000 0 0
mol:NO 0.005 0.14 -10000 0 -0.46 10 10
E2/ER beta (dimer) 0.024 0.013 -10000 0 -10000 0 0
mol:GDP 0.006 0.071 -10000 0 -0.39 4 4
mol:NADP 0.005 0.14 -10000 0 -0.46 10 10
PIK3R1 0.028 0.062 -10000 0 -0.48 3 3
mol:IP3 -0.047 0.13 -10000 0 -0.4 16 16
IGF-1R heterotetramer 0.03 0.04 -10000 0 -0.34 2 2
PLCB1 -0.051 0.13 -10000 0 -0.32 35 35
PLCB2 -0.028 0.12 -10000 0 -0.4 18 18
IGF1 0.015 0.081 -10000 0 -0.26 14 14
mol:L-citrulline 0.005 0.14 -10000 0 -0.46 10 10
RHOA 0.035 0.004 -10000 0 -10000 0 0
Gai/GDP 0.006 0.16 -10000 0 -0.73 8 8
JNK cascade 0.023 0.013 -10000 0 -10000 0 0
BCAR1 0.034 0.017 -10000 0 -0.2 1 1
ESR2 0.032 0.019 -10000 0 -0.2 1 1
GNAQ 0 0 -10000 0 -10000 0 0
ESR1 0.025 0.071 -10000 0 -0.48 4 4
Gq family/GDP/Gbeta gamma -0.02 0.16 -10000 0 -0.56 12 12
E2/ER alpha (dimer)/PELP1/Src/p52 SHC/GRB2/SOS1 0.044 0.1 -10000 0 -0.54 3 3
E2/ER alpha (dimer)/PELP1/Src/p52 SHC 0.063 0.14 -10000 0 -0.4 5 5
GNAZ 0.022 0.064 -10000 0 -0.27 8 8
E2/ER alpha (dimer) 0.019 0.051 -10000 0 -0.35 4 4
STRN 0.031 0.043 -10000 0 -0.3 3 3
GNAL 0.022 0.035 -10000 0 -0.2 4 4
PELP1 0.03 0.014 -10000 0 -10000 0 0
MAPK11 0.015 0.015 -10000 0 -10000 0 0
GNAI2 0.024 0.073 -10000 0 -0.43 5 5
GNAI3 0.03 0.051 -10000 0 -0.48 2 2
GNAI1 -0.013 0.14 -10000 0 -0.4 23 23
HBEGF 0.092 0.18 0.33 55 -0.45 5 60
cAMP biosynthetic process 0.023 0.044 -10000 0 -0.23 4 4
SRC 0.056 0.14 -10000 0 -0.45 4 4
PI3K 0.045 0.049 -10000 0 -0.35 3 3
GNB1 0.034 0.008 -10000 0 -10000 0 0
G13/GDP/Gbeta gamma 0.042 0.078 -10000 0 -0.35 4 4
SOS1 0.036 0.002 -10000 0 -10000 0 0
IGF-1R heterotetramer/IGF1 -0.013 0.08 -10000 0 -0.38 4 4
Gs family/GTP 0.03 0.048 -10000 0 -0.24 4 4
EntrezGene:2778 0 0 -10000 0 -10000 0 0
RAS family/GTP 0.051 0.059 -10000 0 -0.25 5 5
vasodilation 0.006 0.13 -10000 0 -0.43 11 11
mol:DAG -0.047 0.13 -10000 0 -0.4 16 16
Gs family/GDP/Gbeta gamma 0.012 0.065 -10000 0 -0.33 4 4
MSN -0.027 0.083 -10000 0 -0.32 3 3
Gq family/GTP -0.022 0.13 -10000 0 -0.4 19 19
mol:PI-3-4-5-P3 0.023 0.16 -10000 0 -0.69 9 9
NRAS 0.019 0.079 -10000 0 -0.33 9 9
mol:E2 0 0 -10000 0 -10000 0 0
cell adhesion -0.006 0.13 0.43 11 -10000 0 11
GRB2/SOS1 0.051 0.012 -10000 0 -10000 0 0
RhoA/GDP 0.025 0.078 -10000 0 -0.37 4 4
NOS3 0.004 0.14 -10000 0 -0.49 10 10
GNA11 0.028 0.054 -10000 0 -0.39 3 3
MAPKKK cascade 0.044 0.15 -10000 0 -0.48 9 9
E2/ER alpha (dimer)/PELP1/Src 0.063 0.14 0.28 2 -0.4 6 8
ruffle organization -0.025 0.079 -10000 0 -0.3 3 3
ROCK2 -0.022 0.082 -10000 0 -0.28 1 1
GNA14 -0.021 0.15 -10000 0 -0.37 29 29
GNA15 0.02 0.068 -10000 0 -0.26 10 10
GNA13 0.034 0.009 -10000 0 -10000 0 0
MMP9 0.098 0.19 0.38 52 -0.47 3 55
MMP2 0.043 0.15 0.28 3 -0.48 6 9
VEGFR1 specific signals

Figure S80.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S80.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
VEGFR1 homodimer/VEGFB homodimer 0.006 0.1 -10000 0 -0.44 7 7
VEGFR1 homodimer/NRP1 -0.007 0.091 -10000 0 -0.5 5 5
mol:DAG 0.007 0.1 -10000 0 -0.55 4 4
VEGFR1 homodimer/NRP1/VEGFR 121 -0.006 0.084 -10000 0 -0.47 5 5
CaM/Ca2+ 0.015 0.1 -10000 0 -0.52 4 4
HIF1A 0.023 0.071 -10000 0 -0.26 10 10
GAB1 0.028 0.054 -10000 0 -0.39 3 3
AKT1 0.031 0.12 0.3 2 -0.52 4 6
PLCG1 0.007 0.1 -10000 0 -0.55 4 4
NOS3 0.082 0.14 0.31 26 -0.52 4 30
CBL 0.035 0.005 -10000 0 -10000 0 0
mol:NO 0.086 0.14 0.31 27 -0.5 4 31
FLT1 -0.006 0.1 -10000 0 -0.58 5 5
PGF 0.025 0.044 -10000 0 -0.2 7 7
VEGFR1 homodimer/NRP2/VEGFR121 0.006 0.093 -10000 0 -0.45 6 6
CALM1 0.032 0.011 -10000 0 -10000 0 0
PIK3CA 0.035 0.006 -10000 0 -10000 0 0
eNOS/Hsp90 0.072 0.14 0.29 26 -0.48 4 30
endothelial cell proliferation 0.082 0.15 0.34 28 -0.55 4 32
mol:Ca2+ 0.007 0.1 -10000 0 -0.54 4 4
MAPK3 -0.006 0.095 0.26 2 -0.45 4 6
MAPK1 -0.004 0.093 0.26 1 -0.49 4 5
PIK3R1 0.028 0.062 -10000 0 -0.48 3 3
PLGF homodimer 0.025 0.044 -10000 0 -0.2 7 7
PRKACA 0.035 0.006 -10000 0 -10000 0 0
RP11-342D11.1 0 0 -10000 0 -10000 0 0
CAV1 0.023 0.064 -10000 0 -0.27 8 8
VEGFA homodimer 0 0 -10000 0 -10000 0 0
VEGFR1 homodimer/VEGFA homodimer -0.007 0.091 -10000 0 -0.5 5 5
platelet activating factor biosynthetic process 0.065 0.15 0.33 24 -0.49 3 27
PI3K 0.067 0.12 -10000 0 -0.41 7 7
PRKCA 0.001 0.097 -10000 0 -0.51 4 4
PRKCB 0.001 0.094 -10000 0 -0.51 4 4
VEGFR1 homodimer/PLGF homodimer 0.006 0.1 -10000 0 -0.48 6 6
VEGFA 0 0 -10000 0 -10000 0 0
VEGFB 0.031 0.051 -10000 0 -0.48 2 2
mol:IP3 0.007 0.1 -10000 0 -0.55 4 4
RASA1 0.034 0.13 -10000 0 -0.41 8 8
NRP2 0.03 0.046 -10000 0 -0.27 4 4
VEGFR1 homodimer -0.005 0.1 -10000 0 -0.57 5 5
VEGFB homodimer 0.031 0.051 -10000 0 -0.48 2 2
NCK1 0.026 0.071 -10000 0 -0.48 4 4
eNOS/Caveolin-1 0.09 0.14 0.31 24 -0.47 5 29
PTPN11 0.029 0.053 -10000 0 -0.39 3 3
mol:PI-3-4-5-P3 0.065 0.12 -10000 0 -0.4 7 7
mol:L-citrulline 0.086 0.14 0.31 27 -0.5 4 31
VEGFR1 homodimer/VEGFA homodimer/CBL/CD2AP 0.021 0.092 -10000 0 -0.51 4 4
VEGFR1 homodimer/VEGFA homodimer/NCK1 0.005 0.095 -10000 0 -0.43 7 7
CD2AP 0.033 0.036 -10000 0 -0.48 1 1
PI3K/GAB1 0.071 0.13 -10000 0 -0.56 4 4
PDPK1 0.034 0.12 0.35 1 -0.5 4 5
VEGFR1 homodimer/VEGFA homodimer/SHP2 0.005 0.093 -10000 0 -0.41 7 7
mol:NADP 0.086 0.14 0.31 27 -0.5 4 31
HSP90AA1 0 0 -10000 0 -10000 0 0
ubiquitin-dependent protein catabolic process 0.019 0.09 -10000 0 -0.5 4 4
VEGFR1 homodimer/NRP2 0.006 0.1 -10000 0 -0.49 6 6
S1P3 pathway

Figure S81.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S81.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PDGFRB 0.033 0.036 -10000 0 -0.48 1 1
mol:S1P 0.001 0.002 -10000 0 -10000 0 0
S1P1/S1P/Gi -0.01 0.12 -10000 0 -0.32 19 19
GNAO1 0.037 0.003 -10000 0 -10000 0 0
S1P/S1P3/G12/G13 0.042 0.017 -10000 0 -10000 0 0
AKT1 -0.016 0.14 -10000 0 -0.38 25 25
AKT3 0.012 0.066 -10000 0 -10000 0 0
mol:GTP 0 0 -10000 0 -10000 0 0
PDGFB-D/PDGFRB 0.033 0.036 -10000 0 -0.48 1 1
GNAI2 0.026 0.073 -10000 0 -0.43 5 5
GNAI3 0.031 0.051 -10000 0 -0.49 2 2
GNAI1 -0.012 0.14 -10000 0 -0.4 23 23
mol:GDP 0 0 -10000 0 -10000 0 0
S1PR3 0.001 0.002 -10000 0 -0.012 1 1
S1PR2 0 0 -10000 0 -10000 0 0
EDG1 0.003 0.12 -10000 0 -0.38 16 16
mol:Ca2+ 0 0.099 -10000 0 -0.32 12 12
MAPK3 -0.009 0.1 0.2 1 -0.3 15 16
MAPK1 -0.002 0.091 -10000 0 -0.31 11 11
JAK2 0.031 0.11 0.23 2 -0.35 7 9
CXCR4 -0.033 0.12 -10000 0 -0.32 24 24
FLT1 0.011 0.076 -10000 0 -0.28 11 11
RhoA/GDP 0.026 0.003 -10000 0 -10000 0 0
Rac1/GDP 0.024 0.008 -10000 0 -10000 0 0
SRC 0.001 0.065 -10000 0 -0.33 4 4
S1P/S1P3/Gi 0 0.1 -10000 0 -0.32 12 12
RAC1 0.033 0.011 -10000 0 -10000 0 0
RhoA/GTP 0.017 0.098 -10000 0 -0.3 11 11
VEGFA 0.002 0.003 -10000 0 -0.015 2 2
S1P/S1P2/Gi -0.002 0.098 -10000 0 -0.32 12 12
VEGFR1 homodimer/VEGFA homodimer 0.012 0.055 -10000 0 -0.19 11 11
RHOA 0.035 0.004 -10000 0 -10000 0 0
S1P/S1P3/Gq -0.011 0.087 -10000 0 -0.27 19 19
GNAQ 0 0 -10000 0 -10000 0 0
GNAZ 0.023 0.065 -10000 0 -0.27 8 8
G12/G13 0.046 0.018 -10000 0 -10000 0 0
GNA14 -0.021 0.15 -10000 0 -0.37 29 29
GNA15 0.02 0.068 -10000 0 -0.26 10 10
GNA12 0.033 0.01 -10000 0 -10000 0 0
GNA13 0.034 0.009 -10000 0 -10000 0 0
GNA11 0.028 0.054 -10000 0 -0.39 3 3
Rac1/GTP 0.015 0.095 -10000 0 -0.3 11 11
Hypoxic and oxygen homeostasis regulation of HIF-1-alpha

Figure S82.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S82.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
HIF3A 0.034 0.017 -9999 0 -0.2 1 1
oxygen homeostasis 0 0 -9999 0 -10000 0 0
TCEB2 0.035 0.006 -9999 0 -10000 0 0
TCEB1 0.029 0.021 -9999 0 -0.2 1 1
HIF1A/p53 -0.029 0.11 -9999 0 -0.25 38 38
HIF1A -0.004 0.073 -9999 0 -0.32 8 8
COPS5 0.028 0.038 -9999 0 -0.48 1 1
VHL/Elongin B/Elongin C/RBX1/CUL2 0.075 0.058 -9999 0 -0.26 1 1
FIH (dimer) 0.033 0.018 -9999 0 -0.2 1 1
CDKN2A -0.035 0.15 -9999 0 -0.32 41 41
ARNT/IPAS 0.047 0.033 -9999 0 -0.35 1 1
HIF1AN 0.033 0.018 -9999 0 -0.2 1 1
GNB2L1 0.035 0.006 -9999 0 -10000 0 0
HIF1A/ARNT 0.002 0.084 -9999 0 -0.31 10 10
CUL2 0.036 0.004 -9999 0 -10000 0 0
OS9 0.034 0.017 -9999 0 -0.2 1 1
RACK1/Elongin B/Elongin C 0.057 0.034 -9999 0 -10000 0 0
response to hypoxia 0 0 -9999 0 -10000 0 0
HIF1A/Hsp90 -0.013 0.075 -9999 0 -0.31 9 9
PHD1-3/OS9 0.026 0.11 -9999 0 -0.27 16 16
HIF1A/RACK1/Elongin B/Elongin C 0.027 0.088 -9999 0 -0.3 8 8
VHL 0.028 0.056 -9999 0 -0.34 4 4
HSP90AA1 0 0 -9999 0 -10000 0 0
HIF1A/JAB1 0.005 0.082 -9999 0 -0.31 9 9
EGLN3 -0.038 0.16 -9999 0 -0.33 40 40
EGLN2 0.035 0.006 -9999 0 -10000 0 0
EGLN1 0.035 0.007 -9999 0 -10000 0 0
TP53 -0.048 0.18 -9999 0 -0.47 32 32
VHL/Elongin B/Elongin C/RBX1/CUL2/HIF1A 0.031 0.098 -9999 0 -0.52 6 6
ARNT 0.032 0.036 -9999 0 -0.48 1 1
ARD1A 0.034 0.023 -9999 0 -0.2 2 2
RBX1 0.033 0.019 -9999 0 -0.2 1 1
HIF1A/p19ARF -0.026 0.11 -9999 0 -0.31 14 14
PDGFR-beta signaling pathway

Figure S83.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S83.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
S1P1/Sphingosine-1-phosphate 0.06 0.17 0.29 6 -0.38 9 15
PDGFB-D/PDGFRB/SLAP 0.029 0.068 -10000 0 -0.35 4 4
PDGFB-D/PDGFRB/APS/CBL 0.045 0.026 -10000 0 -0.29 1 1
AKT1 0.054 0.12 0.32 6 -10000 0 6
mol:PI-4-5-P2 0 0.001 -10000 0 -10000 0 0
mol:Sphingosine-1-phosphate 0.053 0.16 0.26 8 -0.36 8 16
PIK3CA 0.035 0.006 -10000 0 -10000 0 0
FGR 0.004 0.15 -10000 0 -0.59 9 9
mol:Ca2+ 0.058 0.13 0.24 10 -0.35 4 14
MYC 0.045 0.26 0.42 21 -0.81 10 31
SHC1 0.035 0.007 -10000 0 -10000 0 0
HRAS/GDP 0.067 0.083 -10000 0 -0.25 1 1
LRP1/PDGFRB/PDGFB 0.064 0.037 -10000 0 -0.29 1 1
GRB10 -0.008 0.13 -10000 0 -0.4 20 20
PTPN11 0.029 0.053 -10000 0 -0.39 3 3
GO:0007205 0.058 0.13 0.25 7 -0.36 4 11
PTEN 0.026 0.062 -10000 0 -0.48 3 3
GRB2 0.034 0.008 -10000 0 -10000 0 0
GRB7 0.028 0.051 -10000 0 -0.48 2 2
PDGFB-D/PDGFRB/SHP2 0.046 0.051 -10000 0 -0.35 3 3
PDGFB-D/PDGFRB/GRB10 0.015 0.11 -10000 0 -0.35 15 15
cell cycle arrest 0.029 0.068 -10000 0 -0.35 4 4
HRAS 0.032 0.04 -10000 0 -0.34 2 2
HIF1A 0.045 0.11 0.3 6 -0.28 1 7
GAB1 0.023 0.17 0.3 3 -0.44 10 13
mol:GTP 0 0 -10000 0 -10000 0 0
DNM2 0.04 0.16 0.29 11 -0.38 10 21
PDGFB-D/PDGFRB 0.024 0.044 -10000 0 -0.3 1 1
mol:GDP 0 0 -10000 0 -10000 0 0
PDGFB-D/PDGFRB/LMW-PTP 0.05 0.03 -10000 0 -0.35 1 1
S1P1/Sphingosine-1-phosphate/PDGFB-D/PDGFRB -0.006 0.13 -10000 0 -0.34 11 11
positive regulation of MAPKKK cascade 0.045 0.051 -10000 0 -0.35 3 3
PIK3R1 0.028 0.062 -10000 0 -0.48 3 3
mol:IP3 0.058 0.13 0.25 7 -0.36 4 11
E5 0 0.002 -10000 0 -10000 0 0
CSK 0.031 0.01 -10000 0 -10000 0 0
PDGFB-D/PDGFRB/GRB7 0.044 0.05 -10000 0 -0.35 3 3
SHB 0.032 0.029 -10000 0 -0.2 3 3
BLK -0.05 0.19 -10000 0 -0.49 25 25
PTPN2 0.029 0.017 -10000 0 -10000 0 0
PDGFB-D/PDGFRB/SNX15 0.05 0.032 -10000 0 -0.35 1 1
BCAR1 0.034 0.017 -10000 0 -0.2 1 1
VAV2 0.023 0.19 0.3 9 -0.47 11 20
CBL 0.035 0.005 -10000 0 -10000 0 0
PDGFB-D/PDGFRB/DEP1 0.048 0.043 -10000 0 -0.28 3 3
LCK -0.03 0.2 -10000 0 -0.56 21 21
PDGFRB 0.034 0.037 -10000 0 -0.48 1 1
ACP1 0.036 0.004 -10000 0 -10000 0 0
HCK -0.045 0.19 -10000 0 -0.62 18 18
ABL1 0.026 0.17 0.24 11 -0.41 12 23
PDGFB-D/PDGFRB/CBL 0.01 0.17 -10000 0 -0.46 12 12
PTPN1 0.015 0.039 -10000 0 -0.49 1 1
SNX15 0.034 0.017 -10000 0 -0.2 1 1
STAT3 0.034 0.007 -10000 0 -10000 0 0
STAT1 0.015 0.067 -10000 0 -0.2 18 18
cell proliferation 0.049 0.24 0.41 22 -0.71 10 32
SLA 0.012 0.078 -10000 0 -0.27 12 12
actin cytoskeleton reorganization 0.096 0.093 0.35 1 -10000 0 1
SRC 0.004 0.099 -10000 0 -0.7 3 3
PI3K -0.012 0.058 -10000 0 -0.24 11 11
PDGFB-D/PDGFRB/GRB7/SHC 0.059 0.05 -10000 0 -0.3 3 3
SH2B2 0 0 -10000 0 -10000 0 0
PLCgamma1/SPHK1 0.053 0.16 0.27 8 -0.37 8 16
LYN 0.015 0.083 -10000 0 -0.56 2 2
LRP1 0.035 0.005 -10000 0 -10000 0 0
SOS1 0.036 0.002 -10000 0 -10000 0 0
STAT5B 0.034 0.007 -10000 0 -10000 0 0
STAT5A 0.027 0.049 -10000 0 -0.26 5 5
NCK1-2/p130 Cas 0.039 0.06 -10000 0 -0.25 1 1
SPHK1 -0.035 0.16 -10000 0 -0.32 42 42
EDG1 0.006 0.12 -10000 0 -0.38 16 16
mol:DAG 0.058 0.13 0.25 7 -0.36 4 11
PLCG1 0.058 0.13 0.25 7 -0.37 4 11
NHERF/PDGFRB 0.039 0.094 -10000 0 -0.3 13 13
YES1 -0.042 0.21 -10000 0 -0.57 24 24
cell migration 0.038 0.093 -10000 0 -0.3 13 13
SHC/Grb2/SOS1 0.038 0.056 -10000 0 -0.25 1 1
SLC9A3R2 0.008 0.11 -10000 0 -0.4 13 13
SLC9A3R1 0.025 0.064 -10000 0 -0.41 4 4
NHERF1-2/PDGFRB/PTEN 0.048 0.1 -10000 0 -0.27 15 15
FYN -0.012 0.17 -10000 0 -0.69 10 10
DOK1 0.064 0.09 -10000 0 -0.27 2 2
HRAS/GTP 0.024 0.028 -10000 0 -0.24 2 2
PDGFB 0.032 0.025 -10000 0 -0.2 2 2
RAC1 0.031 0.21 0.4 14 -0.44 19 33
PRKCD 0.065 0.088 0.2 2 -0.28 1 3
FER 0.061 0.093 0.2 3 -0.28 1 4
MAPKKK cascade 0.086 0.1 0.3 11 -10000 0 11
RASA1 0.064 0.088 0.2 1 -0.28 1 2
NCK1 0.026 0.071 -10000 0 -0.48 4 4
NCK2 0.035 0.017 -10000 0 -0.2 1 1
p62DOK/Csk 0.078 0.083 -10000 0 -0.26 2 2
PDGFB-D/PDGFRB/SHB 0.047 0.038 -10000 0 -0.19 4 4
chemotaxis 0.027 0.16 0.23 32 -0.4 12 44
STAT1-3-5/STAT1-3-5 0.016 0.063 -10000 0 -0.24 1 1
Bovine Papilomavirus E5/PDGFRB 0.023 0.028 -10000 0 -0.34 1 1
PTPRJ 0.032 0.04 -10000 0 -0.34 2 2
Regulation of nuclear SMAD2/3 signaling

Figure S84.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S84.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
EP300 0.017 0.089 -10000 0 -0.44 7 7
HSPA8 0.035 0.005 -10000 0 -10000 0 0
SMAD3/SMAD4/ER alpha 0.022 0.095 -10000 0 -0.27 7 7
AKT1 0.026 0.034 -10000 0 -0.2 3 3
GSC -0.019 0.16 -10000 0 -0.65 5 5
NKX2-5 0.027 0.033 -10000 0 -0.2 1 1
muscle cell differentiation 0.041 0.16 0.52 10 -10000 0 10
SMAD2-3/SMAD4/SP1 0.026 0.12 -10000 0 -0.32 8 8
SMAD4 0.005 0.076 -10000 0 -0.47 3 3
CBFB 0.036 0.004 -10000 0 -10000 0 0
SAP18 0.026 0.016 -10000 0 -10000 0 0
Cbp/p300/MSG1 0.019 0.11 -10000 0 -0.33 12 12
SMAD3/SMAD4/VDR 0.03 0.12 -10000 0 -0.32 7 7
MYC 0.004 0.11 -10000 0 -0.48 10 10
CDKN2B -0.038 0.22 -10000 0 -1.5 4 4
AP1 -0.062 0.17 -10000 0 -0.45 23 23
SMAD2/SMAD2/SMAD4/SnoN/SIN3/HDAC complex/NCoR1 -0.023 0.14 -10000 0 -0.4 15 15
SMAD2-3/SMAD4/FOXO1-3a-4/FOXG1 -0.048 0.12 -10000 0 -0.32 21 21
SP3 0.036 0.015 -10000 0 -10000 0 0
CREB1 0.036 0.002 -10000 0 -10000 0 0
FOXH1 0.018 0.05 -10000 0 -0.35 2 2
SMAD3/SMAD4/GR 0.014 0.1 -10000 0 -0.33 10 10
GATA3 0.028 0.058 -10000 0 -0.38 3 3
SKI/SIN3/HDAC complex/NCoR1 0.023 0.082 -10000 0 -0.31 6 6
MEF2C/TIF2 0.006 0.14 -10000 0 -0.49 11 11
endothelial cell migration -0.002 0.15 1.4 2 -10000 0 2
MAX 0.033 0.011 -10000 0 -10000 0 0
RBBP7 0.034 0.023 -10000 0 -0.2 2 2
RBBP4 0.031 0.029 -10000 0 -0.2 3 3
RUNX2 0.034 0.017 -10000 0 -0.2 1 1
RUNX3 -0.024 0.15 -10000 0 -0.35 31 31
RUNX1 0.014 0.089 -10000 0 -0.32 12 12
CTBP1 0.035 0.007 -10000 0 -10000 0 0
NR3C1 0.019 0.089 -10000 0 -0.44 7 7
VDR 0.022 0.081 -10000 0 -0.44 6 6
CDKN1A -0.035 0.22 -10000 0 -1.2 6 6
KAT2B 0 0.003 -10000 0 -10000 0 0
SMAD2/SMAD2/SMAD4/FOXH1 0.022 0.086 -10000 0 -0.37 4 4
DCP1A 0.035 0.004 -10000 0 -10000 0 0
SKI 0.034 0.009 -10000 0 -10000 0 0
SERPINE1 0.001 0.15 -10000 0 -1.4 2 2
SMAD3/SMAD4/ATF2 0.023 0.084 -10000 0 -0.26 4 4
SMAD3/SMAD4/ATF3 0.011 0.095 -10000 0 -0.3 5 5
SAP30 0.031 0.037 -10000 0 -0.48 1 1
Cbp/p300/PIAS3 0.047 0.075 -10000 0 -0.3 7 7
JUN -0.073 0.16 -10000 0 -0.45 23 23
SMAD3/SMAD4/IRF7 0.026 0.091 -10000 0 -0.26 6 6
TFE3 0.036 0.024 -10000 0 -10000 0 0
COL1A2 -0.06 0.24 -10000 0 -0.84 17 17
mesenchymal cell differentiation -0.022 0.084 0.25 5 -10000 0 5
DLX1 0.028 0.043 -10000 0 -0.2 7 7
TCF3 0.027 0.062 -10000 0 -0.48 3 3
FOS -0.073 0.17 -10000 0 -0.35 46 46
SMAD3/SMAD4/Max 0.022 0.084 -10000 0 -0.25 5 5
Cbp/p300/SNIP1 0.05 0.072 -10000 0 -0.3 7 7
ZBTB17 0.034 0.011 -10000 0 -10000 0 0
LAMC1 -0.003 0.087 -10000 0 -0.46 4 4
TGIF2/HDAC complex/SMAD3/SMAD4 -0.007 0.1 -10000 0 -0.34 13 13
IRF7 0.036 0.02 -10000 0 -10000 0 0
ESR1 0.029 0.066 -10000 0 -0.42 4 4
HNF4A 0.008 0.071 -10000 0 -0.48 4 4
MEF2C 0.009 0.15 0.34 1 -0.53 10 11
SMAD2-3/SMAD4 0.018 0.094 -10000 0 -0.28 5 5
Cbp/p300/Src-1 0.045 0.084 -10000 0 -0.3 10 10
IGHV3OR16-13 0.004 0.028 -10000 0 -10000 0 0
TGIF2/HDAC complex -0.011 0.12 -10000 0 -0.48 12 12
CREBBP 0.032 0.037 -10000 0 -0.48 1 1
SKIL 0.002 0.12 -10000 0 -0.4 16 16
HDAC1 0.034 0.008 -10000 0 -10000 0 0
HDAC2 0.032 0.036 -10000 0 -0.48 1 1
SNIP1 0.035 0.006 -10000 0 -10000 0 0
GCN5L2 0.032 0.037 -10000 0 -0.48 1 1
SMAD3/SMAD4/TFE3 0.027 0.095 -10000 0 -0.26 7 7
MSG1/HSC70 0.017 0.087 -10000 0 -0.35 5 5
SMAD2 0.018 0.049 -10000 0 -0.54 1 1
SMAD3 0.008 0.071 -10000 0 -0.46 2 2
SMAD3/E2F4-5/DP1/p107/SMAD4 -0.012 0.079 -10000 0 -0.29 8 8
SMAD2/SMAD2/SMAD4 -0.067 0.096 -10000 0 -0.21 59 59
NCOR1 0.029 0.014 -10000 0 -10000 0 0
NCOA2 0.025 0.052 -10000 0 -0.48 2 2
NCOA1 0.026 0.071 -10000 0 -0.48 4 4
MYOD/E2A 0.028 0.078 -10000 0 -0.37 5 5
SMAD2-3/SMAD4/SP1/MIZ-1 0.035 0.13 -10000 0 -0.35 4 4
IFNB1 -0.005 0.084 -10000 0 -0.49 3 3
SMAD3/SMAD4/MEF2C 0.014 0.16 -10000 0 -0.54 10 10
CITED1 -0.01 0.11 -10000 0 -0.24 34 34
SMAD2-3/SMAD4/ARC105 0.019 0.085 -10000 0 -0.25 5 5
RBL1 0.011 0.062 -10000 0 -0.48 3 3
SMAD2-3/SMAD4/FOXO1-3a-4/CEBPB -0.002 0.13 -10000 0 -0.44 10 10
RUNX1-3/PEBPB2 0.008 0.12 -10000 0 -0.3 21 21
SMAD7 -0.062 0.19 -10000 0 -0.56 10 10
MYC/MIZ-1 0.021 0.088 -10000 0 -0.35 10 10
SMAD3/SMAD4 -0.044 0.13 0.33 1 -0.45 8 9
IL10 -0.002 0.075 -10000 0 -0.32 2 2
PIASy/HDAC complex 0.03 0.041 -10000 0 -0.34 2 2
PIAS3 0.032 0.025 -10000 0 -0.2 2 2
CDK2 0.019 0.075 -10000 0 -0.29 10 10
IL5 -0.007 0.084 -10000 0 -0.37 1 1
CDK4 0.035 0.009 -10000 0 -10000 0 0
PIAS4 0.031 0.041 -10000 0 -0.34 2 2
ATF3 0.016 0.069 -10000 0 -0.22 15 15
SMAD3/SMAD4/SP1 0.013 0.12 -10000 0 -0.31 11 11
FOXG1 -0.001 0.003 -10000 0 -10000 0 0
FOXO3 0.007 0.022 -10000 0 -10000 0 0
FOXO1 0.007 0.022 -10000 0 -10000 0 0
FOXO4 0.007 0.022 -10000 0 -10000 0 0
heart looping 0.009 0.15 0.34 1 -0.52 10 11
CEBPB 0.015 0.04 -10000 0 -0.48 1 1
SMAD3/SMAD4/DLX1 0.02 0.088 -10000 0 -0.26 6 6
MYOD1 0.014 0.079 -10000 0 -0.24 17 17
SMAD3/SMAD4/HNF4 0.005 0.08 -10000 0 -0.34 5 5
SMAD3/SMAD4/GATA3 0.021 0.1 -10000 0 -0.32 4 4
SnoN/SIN3/HDAC complex/NCoR1 0.002 0.12 -10000 0 -0.4 16 16
SMAD3/SMAD4/RUNX1-3/PEBPB2 0.005 0.14 -10000 0 -0.29 21 21
SMAD3/SMAD4/SP1-3 0.031 0.12 -10000 0 -0.39 4 4
MED15 0 0 -10000 0 -10000 0 0
SP1 0.015 0.063 -10000 0 -0.21 7 7
SIN3B 0.035 0.006 -10000 0 -10000 0 0
SIN3A 0.032 0.019 -10000 0 -0.2 1 1
SMAD2/SMAD2/SMAD4/FOXH1/NKX2-5 0.029 0.11 -10000 0 -0.34 9 9
ITGB5 -0.011 0.1 -10000 0 -0.46 5 5
TGIF/SIN3/HDAC complex/CtBP 0.035 0.067 -10000 0 -0.36 2 2
SMAD3/SMAD4/AR 0.012 0.094 -10000 0 -0.27 7 7
AR 0.021 0.07 -10000 0 -0.25 11 11
negative regulation of cell growth -0.009 0.084 -10000 0 -0.37 4 4
SMAD3/SMAD4/MYOD 0.008 0.1 -10000 0 -0.3 8 8
E2F5 0.006 0.11 -10000 0 -0.46 10 10
E2F4 0.034 0.017 -10000 0 -0.2 1 1
SMAD2/SMAD2/SMAD4/FOXH1/SMIF 0.035 0.1 -10000 0 -0.3 8 8
SMAD2-3/SMAD4/FOXO1-3a-4 -0.012 0.11 -10000 0 -0.41 11 11
TFDP1 0.024 0.039 -10000 0 -0.48 1 1
SMAD3/SMAD4/AP1 -0.05 0.18 -10000 0 -0.46 23 23
SMAD3/SMAD4/RUNX2 0.022 0.085 -10000 0 -0.26 5 5
TGIF2 -0.011 0.12 -10000 0 -0.48 12 12
TGIF1 0 0 -10000 0 -10000 0 0
ATF2 0.036 0.004 -10000 0 -10000 0 0
ErbB4 signaling events

Figure S85.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S85.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
ErbB4/ErbB4/HBEGF/HBEGF 0.047 0.098 -10000 0 -0.61 1 1
epithelial cell differentiation 0.007 0.13 -10000 0 -0.5 3 3
ITCH 0.021 0.022 -10000 0 -10000 0 0
WWP1 0.009 0.1 -10000 0 -1.3 1 1
FYN 0.006 0.11 -10000 0 -0.34 16 16
EGFR 0.016 0.09 -10000 0 -0.41 8 8
PRL 0.033 0.023 -10000 0 -0.2 2 2
neuron projection morphogenesis 0.04 0.081 0.27 4 -0.43 1 5
PTPRZ1 0.009 0.1 -10000 0 -0.34 14 14
ErbB4/ErbB4/neuregulin 1 beta/neuregulin 1 beta/GRB2/SHC 0.06 0.08 -10000 0 -0.47 1 1
ErbB4 CYT2/ErbB4 CYT2/neuregulin 1 beta/neuregulin 1 beta 0.035 0.066 -10000 0 -0.53 1 1
ADAM17 0.031 0.019 -10000 0 -10000 0 0
ErbB4/ErbB4 0.011 0.063 -10000 0 -0.67 1 1
ErbB4/ErbB4/neuregulin 3/neuregulin 3 0.06 0.087 -10000 0 -0.61 1 1
NCOR1 0.029 0.014 -10000 0 -10000 0 0
ErbB4/ErbB4/neuregulin 1 beta/neuregulin 1 beta/Fyn 0.034 0.088 -10000 0 -0.49 2 2
GRIN2B 0.016 0.089 0.27 1 -0.42 3 4
ErbB4/ErbB2/betacellulin 0.046 0.096 -10000 0 -0.73 1 1
STAT1 0.015 0.067 -10000 0 -0.2 18 18
HBEGF -0.008 0.13 -10000 0 -0.33 25 25
PRLR 0.005 0.12 -10000 0 -0.44 13 13
E4ICDs/ETO2 0.016 0.12 -10000 0 -0.61 1 1
axon guidance -0.001 0.085 0.31 1 -0.78 1 2
NEDD4 0.002 0.1 -10000 0 -0.39 12 12
Prolactin receptor/Prolactin receptor/Prolactin 0.027 0.095 -10000 0 -0.36 11 11
CBFA2T3 -0.073 0.18 -10000 0 -0.32 64 64
ErbB4/ErbB2/HBEGF 0.045 0.091 -10000 0 -0.41 2 2
MAPK3 0.036 0.078 0.27 1 -0.44 1 2
STAT1 (dimer) 0.057 0.084 -10000 0 -0.6 1 1
MAPK1 0.041 0.069 0.27 1 -0.44 1 2
JAK2 0.015 0.078 -10000 0 -0.27 12 12
ErbB4/ErbB2/neuregulin 1 beta 0.032 0.07 -10000 0 -0.41 2 2
NRG1 0.009 0.039 -10000 0 -0.36 2 2
NRG3 0.024 0.073 -10000 0 -0.43 5 5
NRG2 0.028 0.056 -10000 0 -0.34 4 4
NRG4 0.017 0.071 -10000 0 -0.25 12 12
heart development -0.001 0.085 0.31 1 -0.78 1 2
neural crest cell migration 0.032 0.069 -10000 0 -0.41 2 2
ERBB2 0.015 0.029 -10000 0 -0.36 1 1
WWOX/E4ICDs 0.046 0.077 -10000 0 -0.61 1 1
SHC1 0.035 0.007 -10000 0 -10000 0 0
ErbB4/EGFR/neuregulin 4 0.054 0.1 -10000 0 -0.88 1 1
apoptosis -0.013 0.11 0.41 6 -10000 0 6
ErbB4/ErbB4/neuregulin 2 beta/neuregulin 2 beta 0.062 0.081 -10000 0 -0.61 1 1
ErbB4/ErbB2/epiregulin -0.034 0.15 -10000 0 -0.35 9 9
ErbB4/ErbB4/betacellulin/betacellulin 0.047 0.1 -10000 0 -0.84 1 1
ErbB4/ErbB4/HBEGF/HBEGF/Prolactin receptor/Prolactin receptor/Prolactin/JAK2 0.051 0.13 -10000 0 -0.4 4 4
MDM2 0.006 0.059 0.26 1 -0.61 1 2
ErbB4 JM-B/ErbB4 JM-B/neuregulin 1 beta/neuregulin 1 beta 0.013 0.051 -10000 0 -0.42 1 1
STAT5A 0.013 0.095 0.34 2 -0.76 1 3
ErbB4/EGFR/neuregulin 1 beta 0.035 0.088 -10000 0 -0.73 1 1
DLG4 0.029 0.014 -10000 0 -10000 0 0
GRB2/SHC 0.049 0.015 -10000 0 -10000 0 0
E4ICDs/TAB2/NCoR1 0.064 0.076 -10000 0 -0.56 1 1
STAT5A (dimer) 0.021 0.14 -10000 0 -0.54 3 3
MAP3K7IP2 0.035 0.006 -10000 0 -10000 0 0
STAT5B (dimer) 0.038 0.095 -10000 0 -0.76 1 1
LRIG1 -0.018 0.16 -10000 0 -0.47 22 22
EREG -0.18 0.23 -10000 0 -0.37 109 109
BTC -0.004 0.13 -10000 0 -0.37 20 20
ErbB4/ErbB4/neuregulin 1 beta/neuregulin 1 beta -0.004 0.081 -10000 0 -0.79 1 1
ERBB4 0.011 0.063 -10000 0 -0.67 1 1
STAT5B 0.034 0.007 -10000 0 -10000 0 0
YAP1 -0.001 0.081 -10000 0 -0.47 5 5
GRB2 0.034 0.008 -10000 0 -10000 0 0
ErbB4/ErbB2/neuregulin 4 0.053 0.079 -10000 0 -0.59 1 1
glial cell differentiation -0.064 0.075 0.56 1 -10000 0 1
WWOX 0.024 0.039 -10000 0 -0.48 1 1
cell proliferation 0.01 0.11 0.3 1 -0.6 2 3
Lissencephaly gene (LIS1) in neuronal migration and development

Figure S86.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S86.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
DYNC1H1 0.032 0.011 -10000 0 -10000 0 0
VLDLR -0.084 0.2 -10000 0 -0.37 61 61
LRPAP1 0.035 0.007 -10000 0 -10000 0 0
NUDC 0.034 0.009 -10000 0 -10000 0 0
RELN/LRP8 0.047 0.08 -10000 0 -0.3 9 9
CaM/Ca2+ 0.024 0.008 -10000 0 -10000 0 0
KATNA1 0.035 0.006 -10000 0 -10000 0 0
GO:0030286 0 0 -10000 0 -10000 0 0
ABL1 0.012 0.07 -10000 0 -0.27 9 9
IQGAP1/CaM 0.046 0.019 -10000 0 -10000 0 0
DAB1 0.035 0.005 -10000 0 -10000 0 0
IQGAP1 0.034 0.008 -10000 0 -10000 0 0
PLA2G7 -0.05 0.18 -10000 0 -0.38 43 43
CALM1 0.032 0.011 -10000 0 -10000 0 0
DYNLT1 0.035 0.006 -10000 0 -10000 0 0
mol:Ca2+ 0 0 -10000 0 -10000 0 0
LRPAP1/LRP8 0.031 0.084 -10000 0 -0.35 9 9
UniProt:Q4QZ09 0 0 -10000 0 -10000 0 0
CLIP1 0 0 -10000 0 -10000 0 0
CDK5R1 0.035 0.007 -10000 0 -10000 0 0
LIS1/Poliovirus Protein 3A 0.01 0.007 -10000 0 -10000 0 0
CDK5R2 0.036 0.002 -10000 0 -10000 0 0
mol:PP1 0 0 -10000 0 -10000 0 0
RELN/VLDLR/DAB1 -0.015 0.14 -10000 0 -0.3 32 32
YWHAE 0.03 0.013 -10000 0 -10000 0 0
NDEL1/14-3-3 E 0.026 0.075 0.33 3 -10000 0 3
MAP1B 0.005 0.018 0.18 1 -10000 0 1
RAC1 0.013 0.01 -10000 0 -10000 0 0
p35/CDK5 0.018 0.063 -10000 0 -0.24 9 9
RELN 0.033 0.018 -10000 0 -0.2 1 1
PAFAH/LIS1 -0.013 0.099 -10000 0 -0.29 20 20
LIS1/CLIP170 0.01 0.007 -10000 0 -10000 0 0
LIS1/NDEL1/Katanin 60/Dynein Light chain/Dynein heavy chain 0.02 0.062 -10000 0 -10000 0 0
RELN/VLDLR/DAB1/LIS1/PAFAH1B2/PAFAH1B3 -0.016 0.12 -10000 0 -0.26 33 33
GO:0005869 0 0 -10000 0 -10000 0 0
NDEL1 0.013 0.07 0.33 3 -10000 0 3
LIS1/IQGAP1 0.028 0.019 -10000 0 -10000 0 0
RHOA 0.014 0.01 -10000 0 -10000 0 0
PAFAH1B1 0.013 0.009 -10000 0 -10000 0 0
PAFAH1B3 0.033 0.036 -10000 0 -0.48 1 1
PAFAH1B2 0.03 0.043 -10000 0 -0.3 3 3
MAP1B/LIS1/Dynein heavy chain 0.018 0.04 -10000 0 -0.25 1 1
NDEL1/Katanin 60/Dynein heavy chain 0.033 0.087 0.35 4 -10000 0 4
LRP8 0.009 0.11 -10000 0 -0.41 12 12
NDEL1/Katanin 60 0.019 0.08 0.33 3 -10000 0 3
P39/CDK5 0.02 0.064 -10000 0 -0.24 9 9
LIS1/NudC/Dynein intermediate chain/microtubule organizing center 0.028 0.019 -10000 0 -10000 0 0
CDK5 -0.017 0.06 0.19 5 -0.26 9 14
PPP2R5D 0.034 0.017 -10000 0 -0.2 1 1
LIS1/CLIP170/Dynein Complex/Dynactin Complex 0.009 0.006 -10000 0 -10000 0 0
CSNK2A1 0.028 0.015 -10000 0 -10000 0 0
RELN/VLDLR/DAB1/LIS1 0.006 0.13 -10000 0 -0.26 29 29
RELN/VLDLR -0.017 0.14 -10000 0 -0.27 41 41
CDC42 0.013 0.013 -10000 0 -10000 0 0
EPO signaling pathway

Figure S87.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S87.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BCL2L1 0.017 0.085 -10000 0 -10000 0 0
CRKL 0.027 0.082 0.31 4